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ABSTRACT 
Alcohol abuse is a growing crisis within South Africa, with severe health and socio-
economic implications. Alcohol compromises the function of the blood-brain barrier 
(BBB), and thus its ability to regulate the homeostatic environment of the CNS is 
interrupted. In this study, an in vitro model of the BBB was utilized to study the 
effects of selected concentrations of alcohol (25mM-200mM) and the ameliorating 
effects of fermented rooibos (Aspalathus linearis) (0.003125%-1%), in an attempt to 
reverse the harmful oxidative effects of alcohol. The literature clearly states that 
alcohol (ethanol) compromises the BBB by reactive oxygen species (ROS) 
production and, therefore, rooibos, a shrub high in antioxidants and widely utilized 
nationally, was added to alcohol-exposed mouse brain endothelial (bEnd5) cells with 
the view to reverse the alcohol-induced effects on the BBB model. 
Alcohol-treated (25mM-400mM) bEnd5 monolayers expressed no toxicity, 
however, cell numbers were significantly suppressed (P<0.0274). To validate this 
finding, the activity of the mitochondria was investigated in order to understand if 
the cell’s metabolism was related to the decrease in cell division. Results showed 
that for both acute and chronic exposure there was a decrease in mitochondrial 
activity (MA) for a period of 24-48 hours, thereafter, the MA of the bEnd5 cells 
returned to normality. However, in experiments which chronically (600mM and 
800mM) exposed cells to alcohol over a period of 96 hours, MA was suppressed and 
did not return to normal. 
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Fermented rooibos caused a biphasic response to cellular proliferation at 24-72 
hours, where the lower concentrations (0.0625-0.125 %) caused an increase in 
cellular proliferation and the higher concentrations (0.5-1%) resulted in a relative 
decrease in cellular proliferation. The long-term effect, after acute exposure, 
however, resulted in cell suppression at 96 hours (P<0.0073). With respect to the 
MA, bEnd5 cells exposed to fermented rooibos showed that lower concentrations 
(0.003125-0.0125%) were suppressed at 24 hours and was elevated at 48 hours and 
96 hours for all concentrations. The exception being the highest concentration 
(0.1%), which showed a depression in MA (P<0.05). Treating cells with both 
alcohol and rooibos, resulted in exacerbated suppressing of the MA. 
The physiological function of the BBB model was investigated by monitoring the 
permeability using transendothelial electrical resistance (TEER) studies and the in 
vitro model used in this study was endorsed for the first time using high resolution 
scanning electron microscopy. TEER indicated incidental changes in the 
permeability, only at 24 hours, for both acute and chronic exposure to alcohol and 
rooibos. 
A novel finding, within this study, was the increase in electrical resistance across the 
formation of the cell monolayer, after treatment with alcohol. The data lead to the 
hypothesis for the effect of ROS on resistivity and provides a rationale to explain the 
effects of combinatory treatments that were expected to ameliorate the negative 
effect of alcohol, however, this study showed synergistically negative effects on the 
bEnd5 cells.  
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In summary the main findings in this study were: (a) alcohol was not toxic on bEnd5 
cells, (b) alcohol increased the permeability across monolayers of bEnd5 cells and 
(c) rooibos did not significantly reverse the ROS-induced effects of alcohol, but 
exacerbated the effects. Rooibos treatment caused the following: (i) biphasic effect 
on cellular proliferation, (ii) an increase in MA, and (iii) a cyclic effect in TEER 
studies. 
Key words: Blood brain barrier; TEER, alcohol, rooibos, mitochondrial activity, viability, 
proliferation. 
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CHAPTER 1: Literature Review  
The chapter aims to provide substantial evidence on the national health concern 
related to alcohol abuse and to provide an overview on the adverse effects of alcohol 
in the disruption of the blood-brain barrier (BBB) integrity. Furthermore, the 
antioxidant (AO) properties of the indigenous South African herb, Aspalathus 
linearis (rooibos) as a potential therapeutic agent for the amelioration of the adverse 
effects of alcohol on the BBB is reviewed. 
1.1 Socio-economic impact of alcohol abuse-burden of disease 
Official provisional statistics reported findings on elevated substance abuse, within 
the Western Cape (WC) over the past 5 years. The South African police services has 
reported the province to have the highest number of cases in drug-related crime in 
2008/2009 which was reported at 52 000 cases, four times higher than the Kwazulu 
Natal (KZN) province, with 1000 per 100 000 in the WC in comparison to 235 per 
100 000 in KZN. The WC, therefore, accounts for almost half of the drug-related ills 
in South Africa (SA) (See Appendix A, Table 1.). The modernisation programme 
(2010), conducted by the SA police services (SAPS), brought several pertinent 
factors to light. For example, the WC has one of the highest rates of fetal alcohol 
spectrum disorders (FASD) in the world (Modernisation programme, 2010). It has 
been reported that in WC, 75 out of every 1000 children suffered from fetal alcohol 
syndrome (FAS). This data is supported by FAS statistics for Cape Town, WC; 
which was reported as occurring in 1 per 282 live births (Modernisation programme, 
2010).  
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The aforementioned data are supported by research conducted by Viljoen et al. 
(2005), of a community secondary primary school in SA. It was found that the rates 
of FAS being reported were of the highest in the overall global community, with 
65.2-74.2 per 1.000 children. Comparatively, rates in the United States (U.S.) ranged 
between 0.33-2.2 per 1.000 children, making FAS prevalence, within a local 
community in SA, 33-148 times greater than estimates in the U.S. Within regional 
context, in the U.S, clinic-based African Americans of low socio-economic status 
from inner-city areas showed rates of 2.29 per 1000 children, while FAS rates within 
American Indian reservation communities very rarely exceeding 10 per 1000 
children (Viljoen et al., 2005; Abel 1995; Abel, 1998; Abel and Sokol, 1987; May 
2001) (See Appendix A, Table 2.).  
Survey studies conducted by the Modernisation programme, (2010) have shown 
alcohol to be the most commonly abused substance in the WC province. Research 
conducted between the years 2002 to 2004, for annual prevalence studies and 
lifetime prevalence studies, found the WC to be the second highest (7.1%) for 
annual prevalence studies and the highest ranked (18.5%) for lifetime prevalence 
studies. In addition the province is reported to have the greatest incidence in alcohol 
abuse at 16%, while rural areas appear to have higher rates in binge drinking as 
opposed to urban regions (Modernisation programme, 2010). 
Prevalence studies conducted in the Northern Cape and WC, SA, found incidences 
of FASD, in high risk areas, and according to a policy brief on FASD in Cape Town, 
SA, numbers reached as high as 119 per 1000 children (Modernisation programme, 
2010; Policy brief on FASD, 2008). 
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According to the FASD policy brief, (2008) farm-based women, in the WC, are at 
higher risk of being affected by alcohol exposure than their urban counterparts. 
Despite the governmental measures to minimize possible alcohol misuse by women 
and children, researched evidence has shown that cheap wine sold on the market 
contains unacceptable levels of chemical contaminants such as: mercury, phthalates, 
and ochratoxin. The addition of a combination of these chemicals to alcohol in wine 
may exacerbate the damage observed in the developing fetus (Modernisation 
programme, 2010). 
The increase in FASD in the WC, in particular, made it important to characterize 
and classify vulnerable groups, such as women at risk of alcohol exposure during 
pregnancy. In support of the national health system in SA, the Medical Research 
Council (MRC) has established the Burden of Disease and The Alcohol and Drug 
Abuse Unit. The primary aims of these units were to incorporate drug discovery 
tools for developing drug treatments and the integration of African natural products. 
According to these units, national statistics for FAS for the year 2000 estimated the 
incidence rates to range from 11.8 per 1000 births to 103 per 1000 births. The 
estimated national incidence rate is 14 per 1000 births. This figure is based on a FAS 
incidence of 11.8 per 1000 births occurring in 92% births in the year 2000 in SA and 
is contrasted against the highest incidences of 40 per 1000 in 8% births occurring in 
the coloured population (Schneider et al., 2007). 
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1.2 Maternal adverse effects of alcohol 
Alcohol is characterized as a teratogen and as a result, it has the ability to induce 
abnormal prenatal development by exerting its effects on the biological system 
(Hannigan, 1996; Tsai et al., 2007). It readily crosses the placenta, resulting in blood 
alcohol levels of the fetus reaching levels similar to that of its mother. The degree to 
which a developing fetus is affected as a result of alcohol exposure depends on a 
range of factors such as: time, pattern, socio-economic status and the dose (the 
absolute amount of alcohol consumed) (Brocardo et al., 2011; Gil-Mohapel et al., 
2010; Hannigan, 1996; Tsai et al., 2007).  
Excessive use of alcohol damages most, if not all bodily tissues, and may result in 
an array of abnormalities, including fetal origins of adult disease which will progress 
and become a major public health concern. In the context of this study, at issue, is 
the damage of cells which cannot recover from this alcohol insult, causing long-term 
injury to the brain tissue, impacting on children’s ability to learn and free themselves 
from social shackles. 
Legalistic measures are being implemented to create awareness amongst the general 
population by the incorporation of warning labels on alcoholic beverages, informing 
the consumer about the deleterious effects of alcohol on the development of the 
fetus. Such measures are significant, since it has been shown that women, who are 
inclined to excessive drinking habits during pregnancy, place themselves at higher 
risk of giving birth to children with alcohol-associated deficits, as opposed to 
women who are pregnant and are not abusing alcohol (Thomas and Riley, 1998). 
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Chronic maternal drinking results in a cluster of characteristic anomalies termed 
FASD (Thomas and Riley, 1998). 
 
 
 
 
 
 
 
Figure 1. FASD as an umbrella concept (Thomas and Riley, 1998) 
FASD is a broad concept incorporating an array of permanent pathological 
conditions within the developing fetus as a result of maternal alcohol exposure. It is 
one of the most common preventable causes of developmental disability and is, to 
date, one of the most critical public health concerns in SA (Floyd et al., 2007).  
FAS, a subset of FASD, was found to be the most severe condition, occurring upon 
the exposure of alcohol to the developing fetus, in utero. FAS is associated with a 
pattern of cranio-facial dysmorphologies that results from alcohol-induced damage, 
during the formation of the facial bones, growth retardation and central nervous 
system (CNS) anomalies. Symptoms also include: an abnormally small head 
(microcephaly) and behavioral problems, such as attention deficits, hyperactivity, 
motor dysfunction, mental retardation and learning and social skills deficits. 
(Brocardo et al., 2011; Manning and Hoyme, 2007; Thomas and Riley, 1998, Gil-
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Mohapel et al., 2010). These physical anomalies are said to be closely related to 
intelligence quotient (IQ) and development (Viljoen et al., 2005). 
1.2.1 Prenatal care 
Women, who have acquired insufficient information regarding prenatal care, are 
prone to inadequate practicing of such prenatal care (Salihu, et al., 2011). Maternal 
consumption of alcohol, involves the entry of alcohol into the mothers’ bloodstream 
and subsequent circulating directly to the fetus. The developing fetus has a lower 
metabolic rate than an adult, causing the half-life exposure to alcohol in the blood to 
occur over a longer period of time. Alcohol has the ability to kill off brain cells and 
subsequently retard primordial cell growth as the brain is very susceptible to the 
alcohol during gestation (Floyd et al., 2007). Alcohol has been found to contribute to 
an array of conditions; such as the development of vascular lesions leading to 
adverse pregnancy outcomes as it has the ability to readily cross the placenta, 
causing dose-dependent placental vasoconstriction and decrease in placental weight 
(Khong, 2004; Burd et al., 2007; Salihu et al., 2011). 
Prenatal alcohol exposure (PAE) has also been shown to increase oxidative stress in 
developing organs, including the brain. Brief exposure to alcohol during gestation is 
able to produce an imbalance in the brains intracellular reduction-oxidation (redox) 
state (Brocardo et al., 2011; Dong et al., 2010). The pattern of exposure, 
developmental timing of the exposure, epigenetics, maternal characteristics, and 
synergistic reactions with other drugs (Riley and McGee, 2005) are associated with 
determining the nature and the extent of the effects of PAE (Rendall-Mkosi et al., 
2008).  
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Within the context of the above, research on animals has demonstrated that the times 
prior to and after pregnancy are both critical periods for alcohol exposure. Paternal 
and maternal alcohol consumption, occurring even before pregnancy and alcohol 
consumption by lactating mothers will influence the health of the offspring 
(Hannigan, 1996). 
Buske, (2013) investigated the effects of embryonic alcohol exposure; in order to 
better elucidate the cause of FASD was conducted on the eggs of the zebrafish 
(Danio rerio). The alcohol was administered in a petridish, containing the D. rerio 
eggs and system water, as these eggs are able to develop externally from its mother. 
The research findings further validated that minute amounts of alcohol can penetrate 
the chorion. The alcohol doses used in the study ranged from as small as 0-1% v/v 
of which only 1/30
th
 was able to penetrate the chorion (Fernandes and Gerlai 2009). 
Behavioral changes were evident within the embryonic D. rerio exposed to EtOH, 
without finding any morphological changes in the phenotype of the brain itself. A 
single treatment with the alcohol, at low concentrations, showed changes in the 
social habits of the D. rerio. No real distinction could be made between the alcohol 
groups. When compared to controls, however, the whole brains of alcohol treated D. 
rerio were reduced in comparison to the controls, demonstrating reduced levels of 
dopamine and serotonin, two vital neurotransmitters associated with social 
behaviour (Buske, 2013; Fernandes and Gerlai, 2009). 
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1.3 The chemistry of ethanol 
Alcohol is described as a compound composed of carbon, hydrogen and oxygen. 
The three common alcohols are methyl alcohol (methanol/MeOH), isopropyl alcohol 
(isopropanol) and ethyl alcohol (ethanol/EtOH). All alcohols have similar structure 
containing an hydroxyl group, “OH”, attached to a carbon molecule (Brick, 2005). 
 
 
Figure 2. Chemical structure of EtOH (http://medical-
dictionary.thefreedictionary.com/_/viewer.aspx?path=dorland&name=formula_structural.jpg) 
EtOH or grain alcohol, which is the subject of this research, has a melting point of -
114ºC, boils at 78.5ºC, with a density of 0.789 g/mL at 20ºC and a molecular weight 
of 46.07 g/mol. It has a vapour pressure of 57.3 hPa at 20ºC and a flash point of 13-
14ºC (Li et al., 2005; OECD SIDS, 2004). EtOH, is the form of alcohol found in 
alcoholic beverages consumed by many people and will be referred to as EtOH in 
the text.  
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1.3.1 Bioavailability of ethanol 
The bioavailability (BA) refers to the availability of a drug substance in the nervous 
system, which refers to its ability to cross over into the BBB (Hoheisel et al., 1998). 
Irrespective of exogenous alcohol consumption, it is also naturally found within the 
body. Its’ endogenous presence is due to the metabolism of intestinal microflora, 
producing blood alcohol concentrations (BACs) of between 0.062mg/L to 0.73mg/L 
(Sprung et al.,1981; OECD SIDS, 2004).  
EtOH levels in the brain are difficult to measure, therefore, BACs are used to assess 
the degree of intoxication. Most people show measurable mental impairments at 
0.05% (±8.6mM) blood alcohol. Above 0.5% (86mM) the breathing center of the 
brain or the heart rate is suppressed, which could result in death and according to the 
BAC laws implemented by the Center for Public Health Excellence (Killoran et al., 
2010), there exists strong evidence that any one person’s ability to drive is impaired 
if they have any trace of alcohol in their blood system. An individual with BAC of 
between 0.02% (3.4mM) and 0.05% (8.6mM) has greater risk of dying in a vehicle 
accident as opposed to an individual who has not consumed alcohol (Killoran et al., 
2010). BACs, even after moderate consumption of alcohol (2-3 drinks/day) 
(International Drinking Guidelines, 2010), are considered to fall within the range of 
0.046% (8mM) and 0.092% (15.8mM). The normal blood alcohol range which 
people have consumed is between 10-20mM (Zakhari, 2006). In addition, BAC’s of 
chronic alcoholics are able to reach 50mM (Dietrich and Harris, 1996). Based on the 
aforementioned data, it can be deduced that the physiologically relevant levels of 
alcohol fall within the range of 0-50mM (Barnes and Singletary, 2000; Dietrich and 
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Harris, 1996). Anything above these values would be considered supraphysiological 
concentrations of alcohol (Cofan et al., 2000). 
1.4 The blood-brain barrier 
The blood-brain barrier (BBB) is described as being the interface regulating the 
exchange of substances between cerebral microvasculature and brain parenchymal 
tissue, and, in so doing, maintaining homeostasis of the CNS (Gumbleton and Audus 
2001; Wilhelm et al., 2011; Cardoso et al., 2010). This is crucial for the functioning 
of the neurons of the CNS in that a change in the homeostatic milieu of the brain 
microenvironment could cause impaired thought processing and motor function. In 
addition to the BBB, the brain has additional mechanisms of defense. These include 
the blood cerebrospinal fluid (blood-CSF) barrier and the arachnoid barrier with all 
three barriers having similar constituents (Yang et al., 2007; Cardoso et al., 2010).  
1.4.1 The neurovascular unit 
The establishment and maintenance of the BBB is supported by a complex cellular 
system denoted as the neuro-vascular unit (Weiss et al., 2008). The principle cellular 
components are: brain microvascular endothelial cells (BMVECs), which are 
ensheathed by tubular astrocytic end-feet (Janzer, 1993; Yang et al., 2007; Wilhelm 
et al., 2011). Other important cellular constituents, which contribute the neuro-
vascular unit and subsequent structural integrity of the BBB, include pericytes, 
perivascular microglia, the basal lamina, proteins and cytoskeletal elements (Yang et 
al., 2007; Cardoso et al., 2010). 
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1.4.1.1 Brain endothelial cells 
The brain capillary endothelium forms the anatomical basis of the BBB and is 
comprised of brain endothelial cells (ECs). These cells lack fenestrations and have 
extensively distributed intercellular, protein tight junction (TJ) complexes and 
minimal pinocytosis. The brain EC TJs limit the paracellular transport of an array of 
hydrophilic molecule across the BBB (Ballabh et al., 2004) and, therefore, possesses 
properties which accomplish barrier functions between both the apical and luminal 
interstitium (See Fig 3.). This barrier ensures a chemically stable brain environment, 
with respect to vertebrates (Weidenfeller et al., 2005; Cardoso et al., 2010). This is 
crucial for the functioning of the neurons of the CNS. 
1.4.1.2 Astrocytes 
The astrocytes, which are extended, foot-like projections, ensheath the cerebral 
capillary endothelial vessels and play an important role by inducing the expression 
of barrier specific properties in ECs (Yang et al., 2007). During development, 
astrocytes modulate angiogenesis and endothelial TJ formation by releasing growth 
and neurotrophic factors and in an adult brain participates in maintaining BBB 
integrity (Zhao et al., 2006). In addition the astrocyte makes provision for essential 
modulatory factors such as tissue growth factor beta (TGF-ß), interleukin-6 (IL-6), 
and glial fibrillary acidic protein (GFAP). Astrocytes with insufficient GFAP are 
reported to have an inability in enhancing BBB properties (Pekny et al., 1998; 
Wilhelm et al., 2011). Thus, astrocytes’ role is collective, since it is involved in the 
induction, maintenance and repair of the BBB and in the angiogenesis of the brain 
microvasculature (Janzer, 1993; Weiss et al., 2008). 
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1.4.1.3 The basal lamina 
In vivo, the EC’s are orientated to sit on a base known as the basement membrane, 
also referred to as the basal lamina. This membrane consists of three layers 
comprised of a complexity of proteins. The ECs produce one layer made up of 
laminin 4 and 5, the second layer derived by the astrocytes, containing laminin 1 and 
2; and the middle layer which contains collagen type IV. Other complex proteins 
include fibronectin and heparin sulfate (HS) proteoglycans, found within the 
basement membrane of the brain (Weiss et al., 2008). The basement membrane is 
essentially a product of the epithelium and its underlying stroma. The stromal 
factors serve to differentiate the regulated function of the cell as well as provide a 
barrier between cell compartments and stromal compartments (Freshney et al., 
2002).  
1.4.1.4 Pericytes 
Embedded between the basement membrane and the EC membrane are pericytes. 
The pericyte covers an estimated 22-32% of the brain endothelium. Its role is to 
regulate EC proliferation, angiogenesis and inflammatory processes and for the 
synthesis of most elements of the basement membrane (a considerable amount of 
proteoglycans) (Dore-Duffy, 2008, Cardoso et al., 2010). Without the pericyte the 
brain will undergo various alterations in its normal functioning, resulting in 
abnormal vasculogenesis, endothelial hyperplasia and increased permeability 
(Armulik et al., 2010). 
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Figure 3. Schematic diagram of the anatomical basis of the neuro-vascular unit in vivo (Wilhelm et 
al., 2011) 
1.4.2 Protective properties of the blood-brain barrier  
The BBB serves as protection of the brain from an array of toxic substances within 
the circulatory milieu. It also affects selective transport and modulates blood and/or 
brain borne substances (Ribatti et al., 2006).  
The BBB is comprised of four different restrictive barriers, which enable it to 
regulate the movement of foreign substances: (1) the first protective barrier is the 
paracellular restriction provided by the endothelial junctions, such as the TJs and the 
adherens junctions (AJs), which assists in TJ formation. This barrier prevents the 
movement of water soluble compounds between adjacent ECs’, (2) the transcellular 
barrier, which serves to inhibit cytoplasmic transport of substances, is characterized 
by a low rate of transcytosis and endocytosis, (3) the enzymatic barrier, comprised 
of an array of enzymes such as: acetylcholinesterase, alkaline phosphatase, gamma 
glutamyl transpeptidase, monoamine oxidase and a variety of other drug 
metabolizing enzymes. The last protective measure of the BBB is the EC membrane 
transporters, which are efflux transporters serving as a means to pump drugs out of 
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the CNS, namely: the ATP-binding cassette (ABC) transporters: ABC1 (P-
glycoprotein)/ BCRP, ABCC1, ABCC4 and ABCG2 (Wilhelm et al., 2011). These 
efflux protein transporters are abundant and highly expressed in the luminal 
compartment of the EC (Passeleu-LeBourdonnec et al., 2013) (See Fig 4 and Fig 5).  
The BBB is, therefore, impenetrable by hydrophilic molecules, as well as, 
hydrophobic low molecular weight organic solutes, demonstrating restrictive 
properties of the BBB which inhibit the crossing over of foreign molecules into the 
CNS (Ballabh et al., 2004; Omidi et al., 2003). 
1.4.2.1 Protective surface structures of the endothelial cell membrane  
The cell membrane carbohydrates make up approximately 3% of the cell membrane 
weight (Martini, 2006). Based on the literature, the cell membrane surface of the 
brain EC cells presents with a network of structures. These structures appear to span 
the entire surface of the EC. The EC membrane comprises of a diversity of 
membrane bound macromolecules. The carbohydrate proteins of these molecules 
have been shown to extend toward the outer surface (luminal) of the cell membrane 
establishing the structure known as the glycocalyx (Weinbaum et al., 2007). The 
glycocalyx is associated with transport properties which influences the flux of 
molecules, sized between water (approximately 3Å) and molecules the size of 
albumin, which equates to 69,000 Daltons (Da). The glycocalyx is, however, unable 
to regulate permeability in the event of TJs being compromised, due to the size of 
the junctions, thus, permeability as a result of the glycocalyx structure is little to 
none. Solutes which traverse this layer are usually much smaller than its fiber 
spacing (Tarbell et al., 2010). 
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The features of the brain ECs compared to the peripheral ECs were reported by 
(Reese and Karnovsky, 1967; Ballabh et al., 2004; Pekny et al., 1998; Begley, 
2004), and have been described in the table below: 
Table 1. Comparison between brain and peripheral endothelial cells 
Characteristics of membrane 
permeability 
Brain endothelium Peripheral 
endothelium 
1. Fenestrations and 
pinocytic vesicles 
Absent Present 
2. Tight junctions Reinforced Absent 
3. Mitochondria  High prevalence Low prevalence 
4. Enzymes: γ-glutamyl-
transpeptidase (γ-GT), 
monamine oxidae 
(MAO) and alkaline 
phosphatase (AP) 
High prevalence Low prevalence 
5. Efflux pumps Present Absent 
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1.4.3 Transport system across the blood-brain barrier 
 
Figure 4. Schematic diagram illustrating the physiological transport system across a typical brain EC 
monolayer (Ohtsuki and Terasaki, 2007) 
 
Figure 5. Schematic diagram of the substances which traverse the BBB in vivo (Re et al., 2012) 
A transport barrier exists across the brain EC membrane. This barrier system 
consists of a very low rate of receptor-mediated transcytotic vesicular transport, 
absorptive transcytosis and transport proteins such as enzymes, carrier systems and 
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brain EC-specific molecules of unknown function (Janzer, 1993). Specialized TJs of 
the CNS endothelia are the main structures establishing barrier properties and are 
locally found on the apical region of the brain EC (Cardoso et al., 2010). Apart from 
these structures, the brain EC exhibits a specific distribution pattern of unique 
receptors, transporters and non-selective drug export pumps on its apical and 
basolateral surfaces. These transport mechanisms serve to protect the CNS from a 
plethora of toxic/harmful hydrophobic compounds found within the blood (Perrière 
et al., 2007). As a result, a very low rate of trancytosis is prevalent across the 
cerebral capillary endothelium (Tuma et al., 2003). The mechanism with which a 
compound crosses the BBB depends on its polarity, size and lipophilic nature. 
Possible pathways of passage across the BBB are: saturable transport systems, 
passive diffusion (across the membrane along a concentration gradient), leakage 
(extracellular pathways) and endocytosis or diapedesis (Banks, 2009), which 
involves the extravasation of blood cells, particularly white blood cells, across intact 
vascular endothelium (Petri and Bixel, 2006). The molecules allowed to cross the 
BBB can be classified into three distinct categories: (1) Lipid soluble compounds 
(Lipophillic solutes), namely, carbon dioxide (CO2), oxygen (O2), (Ballabh et al., 
2004); ammonia (NH3), morphine and nicotine; (2) small alcohols, namely, EtOH; 
(3) lipids, namely, steroids and prostaglandins (Banks, 2009), all of which are able 
to diffuse across the endothelial cell membrane into the brain interstitium.  
The transport of water and water-soluble compounds, namely: sodium, hydrogen, 
potassium and chloride are, however, controlled by channels in both the apical and 
basolateral cell membrane surfaces. These compounds are either actively or 
passively transported across the cell (Martini, 2006). 
 
 
 
 
CHAPTER 1: Literature Review 
 
18 
 
1.4.4 Mouse brain endothelial cell histology 
Based on research conducted by Navone et al. (2013), findings on brain 
microvascular ECs (BMVECs) expressed phenotypical and morphological cell 
monolayers which expressed a cobblestone-like appearance. In addition light phase 
contrast and scanning electron microscopy (SEM) expressed cultured human ECs in 
monolayers of large cells in close proximity (Jaffe et al., 1973). Research conducted 
by Jaffe et al. (1973), using high resolution SEM, showed cultured ECs exhibiting 
large (30x50µm), flat cells growing within a monolayer with definite boundaries and 
an array of cytoplasmic projections and pits on its surfaces (Jaffe et al., 1973).  
Technology has elucidated the cytoskeleton structure of the EC. The literature 
reports that the mouse brain endothelial (bEnd5) cells show a longitudinal type 
pattern of filamentous-actin (F-actin) distribution compared to the more organized 
orientation of apical rings in the primary mouse brain microvascular ECs 
(pMBMECs), throughout the entire cell body (Steiner et al., 2011). The bEnd5 cells 
expressed a more spindle-shape cell morphology when compared to the pMBMECs 
(Steiner et al., 2011). 
Structural and surface morphological studies are imperative for elucidating the brain 
EC as the anatomical basis of the BBB. It has been firmly established that the 
malfunctioning and pathology of brain ECs has led to the increasing need to 
establish effective in vitro BBB model systems (James, 1992; Kalaria, 1992; Navone 
et al., 2013). 
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1.4.5 Molecular basis for blood-brain barrier function 
A technique, such as immunocytochemistry, has further endorsed the hypothetical 
model of the BBB by allowing for the investigation of the internal structures of the 
brain ECs, and has shed light on the molecular structures from a histological point of 
view. The TJs are composed of a combination of transmembrane and cytoplasmic 
proteins interconnected with an intracellular-based actin cytoskeleton. This allows 
for it to form a barrier while functioning as a rapid modulator and regulator of 
permeability. The paracellular permeability of the BBB depends on the arrangement 
of the TJs, which is a process that involves the intricate interaction between an array 
of protein complexes (Chen et al., 2009). 
The transmembrane proteins complexes forming these TJs include: occludins and 
claudins. In addition, there are cytoplasmic proteins, which are classified as plaque 
proteins, namely, the zonula occludin-1, 2 and 3 (ZO-1, ZO-2 and ZO-3), which are 
among the molecules that are important to the TJ structure and play a critical role in 
the maintenance of BBB function (Wilhelm et al., 2011; Passeleu-LeBourdonnec et 
al., 2013). 
In the BBB, the expressed proteins: claudin-3, claudin-5, and claudin-12 are 
associated with increased transendothelial electrical resistance (TEER) readings, 
with claudin-5 being an essential component in the establishment of the BBB as it 
restricts small molecules up to 800 Da (Schreibelt et al., 2007). The claudin-5 has 
been shown to be the main adhesion protein molecule involved in the maintenance 
of a functional BBB (Nitta et al., 2003). It is the most abundantly expressed subtype 
among claudins in mouse brain capillary ECs at the mRNA level (Ohtsuk et al., 
2008; Kashiwamura et al., 2011). 
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Occludin shows high prevalence and is present in a distinct, continuous pattern 
along cellular margins in the cerebral endothelium (Hawkins and Davis 2005). The 
occludin is a 60-65 kDa protein with a carboxy(C)-terminal domain and joins to 
associate recruiting proteins of the ZO-1 protein (Schreibelt et al., 2007). 
While the claudin-5 is important for the formation of TJs, occludin maintains the 
tightness of the TJ. The ZO serve as anchoring proteins which interact with the 
cytoplasmic domains of the claudins, occludin and adhesion molecules which link 
these proteins to the actin cytoskeleton (Colgan et al., 2008; Fashori and Kachar 
1999, Haorah and Heilman et al., 2005). 
Other transmembrane proteins include: Junctional Adhesion Molecules (JAM), 
namely: JAM-A, JAM-B and JAM-C and the vascular-endothelial-cadherin (VE-
cadherin) proteins. These proteins are present on the lateral surfaces of brain ECs 
and are essential for the stabilization of the paracellular space between brain ECs, 
but do not play a role in the paracellular permeability between adjacent brain ECs. 
They are, however, a prerequisite for the formation and maintenance of TJ proteins. 
(Colgan et al., 2008; Fashori and Kachar, 1999; Haorah and Heilman et al., 2005). 
TJ integrity is greatly dependent on an elevated occludin/claudin-5 expression and 
intracellular signaling processes that control the phosphorylation state of the TJ 
proteins (Rubin and Staddon, 1999; Haorah and Heilman et al., 2005). With respect 
to the in vitro situation, the transmembrane TJ, claudin-5, appeared to be confined to 
the cell-to-cell junctions in both primary and immortalized cell lines. In addition, the 
distribution of ZO-1 and ZO-2 showed junctional localization, and was also 
expressed in both models, whereas the occludin proteins, which were overly 
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expressed in the pMBMECs, were poorly expressed in the immortalized cell line 
(Steiner et al., 2011).  
The disruption of the BBB can, therefore, result in a range of autoimmune disorders 
linked to the peripheral nervous system, including: Guillain-Barré Syndrome, 
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and 
Paraprotemic neuropathy (Kanda et al., 2000; Kanda et al., 2004; Lach et al., 1993). 
1.5 Establishing the immortalized mouse brain endothelial cell line 
The immortalized mouse brain endothelium (bEnd5) is a cell line that has been 
transfected with a polyoma middle-T-oncogene. This particular cell line expresses 
specific EC proteins such as the vascular cell adhesion molecule (VCAM)-1, 
specific for T-cell adhesion and the intercellular cell adhesion molecules: (ICAM)-1 
and ICAM-2 which are role players in T-cell diapedesis (Reiss et al., 1998). 
The bEnd5 cells simulate the barrier properties of the BBB, similar to the 
pMBMECs. Both pMBMECs and bEnd5s are associated with the establishment of a 
highly restrictive barrier which minimizes the permeability across the in vitro BBB 
model. The bEnd5 cells have been carefully profiled and express an array of EC 
specific proteins, such as VE-cadherin, von Willebrand factor, platelet endothelial 
cell adhesion molecule-1, endoglin, ICAM-2 and claudin-5. In addition, the bEnd5s 
have also been found to show an upregulation in cytokine-induced expression of 
VCAM-1 and ICAM-1 (Coisne et al., 2005; Reiss et al., 1998; Rohnelt et al., 1997; 
Steiner et al., 2011). A disadvantage of the bEnd5 cell line is its inability to express 
the TJ protein, occludin, in its intercellular junctions and for this reason lacks in its 
barrier integrity compared to the pMBMECs (Steiner et al., 2011). The immortalized 
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bEnd5s are, however, more readily available in sufficient quantities, with less time-
consuming isolation procedures (Steiner et al., 2011). 
1.6 The proposed in vitro blood-brain barrier model 
An in vitro model is utilized in an attempt to better elucidate physiological and 
morphological mechanisms in order to make inferences about the in vivo BBB. It is 
a basic tool which allows for the study of BBB functionality and can be utilized for 
monitoring drug delivery across the BMVECs (Yang et al., 2007).  
In vitro models of the BBB are composed of EC culture systems retrieved from 
BMVECs. The model requires specific conditions whereby primary brain ECs are 
isolated by enzymatic digestion, making use of different sets of enzymes such as 
collagenase or dispase. Alternatively, brain capillary ECs are retrieved by the use of 
mechanical homogenization and filtration (Cecchelli et al., 1999).  
In vitro BBB models rely on cell cultures of ECs. This is advantageous in that it 
allows for repeatability of experiments and control of factors which are found to be 
more complex within an in vivo location, namely: stress conditions, illness and 
behavior of the animal. The in vitro model is useful in that it reduces animal usage 
in experiments and is able to retrieve useful information about the transport 
mechanisms of a particular drug in a timeous manner, because of its ability to 
provide information on basic mechanisms that establish the BBB with less 
administration of the concentration of specific compounds under investigation which 
allows for quick and greater drug profiling (Weidenfeller et al., 2005; Lundquist et 
al., 2002).  
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Primary cultures of the bEnd5 cells are limited since they are inclined to grow 
slowly, have lower passage numbers and are very sensitive to contamination.  
With reference to the immortalized bEnd5 cell line, not only does it express cellular 
prominent markers of ECs of the in vivo BBB markers of humans, but that of the 
mouse BBB and is, therefore, in alignment with our laboratory in vivo model. It is 
for this reason that the immortalized cell line has been selected for this research 
study. With respect to the morphological and histological characteristics of the 
bEnd5 cells, there is a lack of morphological evidence for what is known about the 
cellular morphology in theory. Morphological research evidence, therefore, needs to 
be generated in order to support its functionality as an in vitro BBB model. 
1.7 The in vitro blood-brain barrier model: Clinical problem 
The model allows for many clinical problems to be evaluated. Most disease 
pathologies are in many ways related to the formation and/or the regeneration of 
blood vessels (BVs), and as a result there is a particular demand to investigate the 
brain ECs, which line the inner surface of the brains’ microvascular capillaries. 
These ECs are pivotal role players in the development and progression of 
neurodegeneration and neuroinflammation, due to it being the main cellular 
constituent forming the restrictive barrier between blood and the brain tissue 
(Navone et al., 2013; Xu et al., 2012). 
In the event of a pathological condition, such as chronic exposure to narcotics, 
namely, alcohol and methamphetamine, the production of ROS is likely to follow. If 
produced in excess, ROS is able to significantly contribute to BBB dysfunction and 
inflammation in the brain by enhancing cellular migration. There is, however, a lack 
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of research conducted, with respect to the molecular mechanism by which ROS 
alters BBB integrity. Studies have demonstrated that ROS causes alterations in BBB 
integrity, which is paralleled by cytoskeleton rearrangements and redistribution and 
disappearance of the TJ proteins, claudin-5 and occludin (Schreibelt et.al., 2007). 
EtOH studies conducted by Xu et al. (2012), found that EtOH was associated with 
morphological changes in the EC, which was confirmed by the formation of 
intercellular gaps in the EC monolayer by the disruption of the cell-to-cell contacts 
between adjacent ECs (Xu et al., 2012). 
1.8 Physiological studies on the blood-brain barrier 
1.8.1 Molecular studies 
Research conducted by Haorah and Heilman et al. (2005) deduced that exposure to 
10-50mM EtOH could result in the activation of myosin light-chain kinases 
(MLCK) within the bovine brain microvascular EC (BBMEC). The expression of 
the EtOH-metabolizing enzyme, cytochrome P-450-2E1 (CYP450) was reported in 
studies conducted on the human coronary ECs (Borlak et al., 2003; Kapucuoglu et 
al., 2003), in human umbilical vein-derived cell lines (Hoebel et al., 1998; Farin et 
al., 1994) and in porcine or bovine ECs (Farin et al., 1994). It was found that 
CYP450-2E1 results in acetaldehyde (AA) and ROS production, which activated 
MLCK mediated phosphorylation, consequently mediating the phosphorylation of 
the claudin-5 TJ protein. In the literature, it is clearly stated that claudin-5 is a major 
part of the TJs in the BBB (Nitta et al., 2003), thus, a decrease in the expression of 
this particular protein and increases in its phosphorylation could result in the BBB 
loosening after EtOH exposure (Haorah and Heilman et al., 2005). 
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1.8.2 Permeability studies 
BBB permeability to drugs that are needed for treating CNS disease is becoming 
increasingly important in order to treat diseases by way of transcellular and 
paracellular drug diffusion processes, metabolism and active transport (Gumbleton 
and Audus, 2001). Transendothelial electrical resistance (TEER) is a measure of the 
integrity across a cell monolayer in culture and is a tool by which to determine the 
permeability across it. This bioelectrical measurement qualitatively measures cell 
monolayer health and quantitatively measures changes in the permeability across an 
in vitro BBB.  
In vivo, the BBB exhibits high TEER and is impermeable to charged particles, 
proteins, ions and hydrophilic molecules and hormones that could mimic specific 
neurotransmitters (Tanobe et al., 2003; Colgan et al, 2008). Unlike peripheral 
endothelium, cultures of brain ECs show high TEER in vitro (Weidenfeller et al., 
2005). The literature has reported on narcotics, such has alcohol, to be a major factor 
influencing the onset of neurodegenerative disorders via the loss of BBB integrity 
(Haorah and Knipe et al., 2005). According to research conducted by Haorah and 
Heilman et al. (2005), it was found that at physiological concentrations of EtOH 
(50mM) resulted in significant increases in permeability of a BBMEC monolayer, 
whereas, the lower concentrations had no effect on permeability. In addition, after a 
50mM EtOH exposure (0.5-2 hrs) the expression of TJ proteins (ZO-1, claudin-5 
and claudin-3) decreased in its intensity. 
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1.9 Experimental model 
The experimental model (in vitro) was incorporated to further understand 
complications which occur within a clinical setting. 
 
Figure 6. Schematic diagram of a hypothetical BBB in vitro using the bicameral system (Siddiqui et 
al., 2011) 
1.9.1 Factors inducing cellular proliferation 
The close proximity of the cells in deep brain regions make up the functional unit, 
denoted as the neuro-vascular unit, as was previously mentioned earlier in the text. 
During normal and pathological development this unit secretes various neurotoxic 
peptides and bioactive factors, triggering changes in the homeostasis of the cerebral 
microenvironment. The brain microcapillaries, as the anatomical foundation for the 
BBB, provide the BBB with nutritive support. These capillaries are mainly 
comprised of the single layer of ECs which are in close proximity (approximately 
2µm). The ECs of the BBB modulate the molecular transport between brain 
interstitial fluid and the systemic circulation, with perivascular neurons and glia 
(astrocytes, microglia and oligodendrocytes). The vascular ECs are functionally 
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connected and are able to secrete multiple neurotoxic peptides and bioactive factors, 
which triggers changes in brain homeostasis (Zhao et al., 2006). 
Intercellular signaling, inevitable among cell populations in culture, are influenced 
by cell density as well as its surrounding environment. Cell growth or proliferation, 
in turn, is strongly influenced by surface area, which accelerates the process of 
cellular attachment and contact inhibition between adjacent cells. In order to manage 
intercellular paracrine signalling, distance can be achieved by altering the density of 
the cells and subsequently altering the paracrine distance between neighboring cells. 
Signaling expression of growth factors is, thus, enhanced by autocrine or paracrine 
signal transduction. These are critical parameters involved in the controlling of 
subsequent cell proliferation (Kim and Dean, 2009).  
1.9.2 Optimizing the cell monolayer using hydrocortisone as a blood-brain 
barrier enhancing glucocorticoid 
Glucocorticoids (GCs) have been used effectively to improve the BBB in vitro. 
(Förster et al., 2008). Barrier tightening effects of GC treatment have been 
demonstrated for cerebral endothelial cells in vitro (Hoheisel et al., 1998; Förster et 
al., 2008). Reports demonstrate GC’s ability to up-regulate TJ proteins and increase 
barrier properties of human and mouse microvascular EC lines (Förster et al., 2005; 
Förster et al., 2008; Kashiwamura et al., 2011). Based on research performed on 
swine, porcine in vitro cultures of BMVECs had modified electrical properties of its 
monolayer of brain ECs after being treated with the GC, hydrocortisone (HC). 
Physiological concentrations of HC (500nM) have thus been found to significantly 
enhance the barrier properties of porcine brain capillary endothelial cells (PBCEC) 
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in serum-free culture conditions (0% Fetal Bovine serum) (Hoheisel et al., 1998; 
Weidenfeller et al., 2005). Studies performed by Hoheisel et al (1998), showed that 
TEER was in fact elevated after the withdrawal of serum while in the presence of 
physiologically relevant levels of HC.  
The functional differentiation of EC by the flow-induced forces as well as by the 
presence of HC has been found to improve the mouse brain capillary EC (MBCEC) 
barrier properties and the tightness of the EC monolayer to the existing in vivo 
model, rendering it an ideal in vitro model for human BBB research (Cardoso et al., 
2010; Weidenfeller et al., 2005). 
In addition, very few studies have been performed on the human brain 
microvasculature. One particular study conducted, using the human cell line 
consisting of hCMEC/D3 cells, strongly proposed the stabilization of BBB function 
as a mode of GC action on a molecular level (Förster et al., 2008).  
This particular study proved the administration of GCs to induce the expression of 
the targets occludin 2.75±0.04-fold and claudin-5 up to 2.32±0.11-fold, which most 
likely contributed to the more than three-fold enhancement of TEER, reflecting 
barrier integrity (Förster et al., 2008).  
Filamentous actin (F-actin) is one of the main constituents of eukaryotic 
cytoskeleton. Globular actin (G-actin) polymerizes to form the F-actin (Glogauer et 
al., 1998; Gardel, 2004). F-actin is linked to TJs and integrins and takes part in the 
regulation of cell-cell and cell-substrate contacts. In vitro studies performed on 
MBCEC in the presence of serum-containing media and HC-supplemented media 
showed that with serum withdrawal, actin delocalizes within the cell body and 
demonstrates a filamentous distribution in the longitudinal direction of the cells. 
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Along with these changes are a modulation of the cytoskeleton and changes in the 
mechanical properties of cells. The HC, thus, enhanced the barrier properties after 
its effect on the actin (Weidenfeller et al., 2005). 
Reduced TEER, correlating to increased paracellular permeability, occurs when the 
basolateral surface of the brain endothelia, usually subjected to serum-free 
interstitial fluid in vivo, is exposed to serum (Nitz et al., 2003; Hoheisel et al., 1998). 
This is endorsed by research conducted on PBCEC where it has been established 
that serum, within normal concentrations of 10% v/v, weakens the barrier of 
PBCEC, especially when exposed to the basolateral side (Nitz et al., 2003). 
TEER, can be indicative of the restrictiveness of the paracellular pathway to solute 
transport and may be influenced by variables, such as the extent to which cell-to-cell 
interaction occurs at the TJs, the type of culture environment to which the 
basolateral surface is exposed and the accumulation of F-actin in the cytoplasmic 
margins which ultimately affects TEER readings (Rist et al., 1997).  
1.10 Toxicological effects of Ethanol 
1.10.1 Pertinent information on ethanol metabolism  
For the purpose of this study, the scope of the research investigations is limited to 
the effects of EtOH. The metabolism of the EtOH within the brain endothelium 
generates oxidative and nitrosative byproducts which play a strong role in oxidative 
damage to the BBB, thereby, increasing the permeability of toxic substances 
(Haorah and Heilman et al., 2005; Haorah and Knipe et al., 2005). The literature has 
reported that the moderate consumption of alcohol/EtOH (in the range of 10-20mM) 
can have transient effects on cell function by way of interacting with certain proteins 
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and cell membranes. EtOH, as discussed previously, is able to produce damaging 
molecules as a result of its metabolism which results in the formation of ROS, 
namely super oxide radicals (O2
-
), hydroxyl radicals (OH
-
), single oxygen (O2) or 
peroxyl radicals (RO2
-
) (Munin and Edwards-Lévy, 2011). 
EtOH metabolism occurs via two pathways, namely the oxidative and nonoxidative 
pathways. The oxidative pathways involve either the addition of oxygen or the 
removal of hydrogen, via the enzymes alcohol dehydrogenase (ADH), CYP450 and 
catalase (Zakhari, 2006). The nonoxidative metabolism involves two pathways, the 
first is a reaction catalyzed by the enzyme fatty acid ethyl ester (FAEE) synthase to 
form FAEE molecules and the second is a reaction governed by the enzyme 
phosolipase D (PLD), which forms a phospholipid known as phosphatidyl ethanol 
(Zakhari, 2006).  
 
Figure 7. Nonoxidative metabolic pathway for EtOH (Zakhari, 2006) 
The first and primary oxidative pathway of EtOH metabolism occurs via ADH, 
which is a cytosolic enzyme catalyzing the conversion of alcohol to acetaldehyde. 
Associated with the reaction are intermediate electron carriers namely: Nicotinamide 
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adenine dinucleotide (NAD
+
), reduced by two electrons to form NADH. The 
CYP2E1 prevalent in the cells’ microsomes metabolize alcohol to acetaldehyde at 
increased concentrations of alcohol (Gemma et al., 2006; Zakhari, 2006; Manzo-
Avalos and Saavedra-Molina, 2010). Acetaldehyde, a metabolite of EtOH, is further 
metabolized in the mitochondria, primarily by aldehyde dehydrogenase 2 (ALDH2) 
forming acetate and NADH and catalase, found within peroxisomes. These 
metabolic reactions require the use of hydrogen peroxide (H2O2) for the oxidation of 
alcohol (Manzo-Avalos and Saavedra-Molina, 2010; Zakhari, 2006) 
A second pathway, known as the microsomal ethanol-oxidizing system (MEOS), 
assists in removing toxins through CYP2E1 and functions similar to ADH by 
converting the alcohol to aldehyde. The reaction is aerobic and requires reduced 
NADPH for the formation of NADP and water (Manzo-Avalos and Saavedra-
Molina, 2010; OECD SIDS, 2004).  
The third pathway for the metabolizing of EtOH involves catalase found within the 
cellular organelle, the peroxisome. It is capable of causing the oxidation of minute 
amounts (2%) of EtOH in the presence of an H202-generating system, forming 
acetaldehyde in the absence of NAD as a co-factor (Weiner, 1987; Manzo-Avalos 
and Saavedra-Molina, 2010).  
EtOH metabolism in non-liver tissues does not possess alcohol dehydrogenase 
(ADH), such as brain and brain regions (Zakhari, 2006). The enzymes involved in 
the EtOH metabolism of the brain and its associated areas are CYP450 and catalase. 
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Figure 8. Oxidative metabolic pathways of EtOH in brain cells 
(Deitrich, 2006) 
The brain cell metabolizes EtOH, producing acetaldehyde by the breakdown of 
H2O2 to H2O via the enzyme catalase, which is found within the subcellular, 
peroxisomes (See Fig 8.). This catabolic process requires the presence of H2O2. 
CYP2E1 is present within the cytosol of brain cells and the enzyme aldehyde 
dehydrogenase (ALDH), present in both the mitochondria and cytosol, functions in 
the conversion of acetaldehyde to acetate (Deitrich, 2006).  
1.10.2 Ethanol-induced pathology of the mitochondria 
The mitochondrion plays a pivotal role in cellular metabolism via ALDH, which 
involves the catalysis of acetaldehyde into acetate, as mentioned above. Upon the 
dissemination of this particular enzyme, acetaldehyde begins to leak into the 
vascular system, leading to biomolecular damage of lipids, proteins and nucleic 
acids. This may result in the intoxicative effects related to alcohol consumers 
(Manzo-Avalos and Saavedra-Molina, 2010). 
Thus, alcohol consumption affects the mitochondria’s ability to function. This will 
have a direct effect on the metabolic activity of the cell and its overall viability 
(Agarwal, 2001; Manzo-Avalos and Saavedra-Molina, 2010). Elevated levels of 
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acetaldehyde have been found to induce toxic effects by the inhibition of 
mitochondrial functioning and subsequent reactivity (Manzo-Avalos and Saavedra-
Molina, 2010).  
Microvessels, which are the main components of the BBB, are vulnerable to 
oxidative damage, during alcohol-induced stress, resulting in oxidative damage 
within the vessels of the brain (Alikunju et al., 2011). The EtOH-metabolizing 
enzymes, such as the ADH and CYP2E1 as well as catalase were found to localize 
within brain microvascular endothelial cells (Haorah and Knipe et al., 2005).  
Chronic abusers of alcohol are at risk of suffering from neurocognitive deficits, 
neuronal injury and neuronal loss. The literature has reported on alcohol-elicited 
BBB damage and its involvement in the progression of neuroinflammation and 
neuronal loss (Harper 1998; Parsons 1998; Abdul Muneer et al., 2011). 
There is, therefore, a desperate need to develop novel therapeutic strategies in which 
potential antioxidant candidates may be used in the treatment and/or prevention of 
BBB associated disorders. Furthermore, identification of indigenous, natural 
compounds which are easily accessible and financially viable to the general 
population of a developing country, such as South Africa, is always a critical factor 
to consider when identifying such candidates. 
1.11 Rooibos - Aspalathus linearis 
Aspalathus linearis (A.linearis), commonly known as “rooibos” or “red-bush” is a 
leguminous shrub, indigenous to the Cederberg mountains and within a regional 
context, involves areas such as Citrusdal, Clanwilliam and Nieuwoudtville in the 
WC of SA (Joubert et al., 2008). It is used for the manufacture of fermented rooibos 
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herbal tea which is derived from the leaves and stems of the fynbos plant, A.linearis 
(Marnewick, 2011). For the purpose of this research study fermented rooibos herbal 
extract/tea will be denoted as Rf. 
1.11.1 Fermentation of rooibos  
Most of the teas produced globally, are fermented. The fermentation process 
involves the enzymatic oxidation of polyphenols and other components found in the 
tea leaves. The initial step for the processing of non-fermented tea, involves an 
enzymatic inactivation process carried out by way of heat (Joubert et al., 2005). The 
rooibos is harvested during hot summer months by topping whole bush to 
approximately 45cm, with active growth not being more than 50cm - without flower 
growth - in order to avoid producing poor quality/weak tea. The leaves turn red-
brown when the shredded plant material becomes “fermented,” which occurs in 
ambient temperatures, followed by sun drying between 38-42°C (Joubert and De 
Villiers, 1997). The age of the rooibos and the cultivation areas are major factors 
influencing the fermentation time (Joubert, 1994) and the shredding of the leaves is 
what causes the enzymatic oxidation of the polyphenols, resulting in the browning 
of the plant (Joubert, 1996). 
Rf, is a unique beverage since it is rich in volatile components, minerals and ascorbic 
acid, it is caffeine-free and has low tannin content (such as gallic acid) (Rabe et al., 
1994). Rf has consequently gained much popularity for its anecdotal remedies and 
medical value with respect to its antioxidant (AO) activity, attributed to its high 
polyphenolic content (Joubert et al., 2008).  
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1.11.2 Protective antioxidant properties of Aspalathus linearis  
Recent reports have shown that consumption of Rf noticeably improved the lipid 
profile as well as the redox status - both relevant to heart disease - in adults at risk 
for developing cardiovascular disease. The AO properties are attributed to the 
polyphenolic factors found within the herbal tea (Marnewick et al., 2011). It is for 
this reason that the health benefits of rooibos are directly attributed to its phenolic 
content (Niwa and Miyachi, 1986; von Gadow et al., 1997). 
A.linearis, contains a variety of bioactive phenolic compounds such as 
dihydrochalcones, flavonols, flavones and flavanols particularly the unique C–C 
linked dihydrochalcone glucoside, aspalathin (Koeppen and Roux, 1966). Numerous 
studies have reported on the in vitro AO activity of rooibos, (Yoshikawa et al., 1990; 
Ito et al., 1991; Lamosŏvá et al., 1997; von Gadow et al., 1997; Joubert et al., 2004), 
as well as in vivo activity in experimental rats (Marnewick et al., 2003). Studies 
show that rooibos treatment resulted in inhibition of lipid peroxidation in rat liver 
(Kucharska et al., 2004).  
The polyphenol AOs identified in Rf include: the monomeric flavonoids aspalathin, 
nothofagin, quercetin, rutin, isoquercitrin, luteolin, vitexin, isovitexin and 
chrysoeriol. Currently, rooibos is the only natural source of aspalathin (Erickson, 
2003) used as a therapeutic compound. 
More specifically, aspalathin, and nothofagin, similar in structure to aspalathin and, 
therefore, has similar AO capabilities, are present in relatively large amounts in 
unfermented rooibos and are the most abundant monomeric flavonoids. Some of the 
aspalathin and nothofagin are, however, oxidized to other substances during 
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fermentation; thus, Rf contains less of these polyphenols than the unfermented form. 
The change in polyphenol composition is the reason why the tea changes color with 
fermentation (Erickson, 2003). Aspalathin seems to contribute to the AO capabilities 
of rooibos, but it is not as well studied as quercetin and luteolin. (Erickson, 2003). 
Prior research carried out on A.linearis, has demonstrated its ability to reduce 
deleterious effects of agents of oxidation on human health, as a result of the 
presence of the flavonol, quercetin, the flavone, luteolin, with their antispasmodic 
properties and five additional glycosides, the dihyrochalcone, aspalathin, the 
flavones, orientin and isoorientin, and the flavonols, isoquercitrin and rutin (Rabe et 
al., 1994). 
A typical cup of rooibos tea contains an array of polyphenols (See Table 2.), but in 
order to make more clinically appropriate inferences about physiological effects of 
Rf, plasma concentrations of selected flavonoids need to be identified after a cup of 
tea is consumed. Consumption of a typical cup of Rf is a good source of AOs. This 
is supported in work carried out by Breiter et al. (2011) where traces of flavonoids 
were detected within the blood plasma, after the consumption of 500ml of Rf. 
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Table 2. The composition of a typical cup of Rf (amount of flavonoids in aqueous 
extract of A.linearis) (mg/g ± SD) 
Flavonoid mg/g±SD 
*Aspalathin 1.234 ± 0.010 
Isoorientin 0.833 ± 0.007 
Orientin 1.003 ± 0.010 
Vitexin 0.330 ± 0.002 
Rutin 1.269 ± 0.006 
Isovitexin 0.265 ± 0.002 
Isoquercitrin and Hyperoside 0.429 ± 0.002 
Luteolin 0.029 ± 0.001 
Quercitrin 0.107 ± 0.002 
Chrysoeriol 0.022 ± 0.003 
Total 5.521 ± 0.003 
*Note: Extracts were prepared by pouring 60ml of hot distilled water on 1g of Rf 
and steeping it for 10 min. The solution was cooled and filtered 
(Bramati et al., 2002). 
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Table 3. Detection of the maximum quantity of unchanged flavonoids within the 
plasma of volunteers (in nM) and % recovery rates of these respective flavonoids 
after the ingestion of 500ml of an aqueous extract of Rf (Breiter et al., 2011). 
Flavonoid Peak amount 
of flavonoids (nM) 
Plasma concentration  
(% recovery rate in nM) 
*Aspalathin 1.9719 0.17 
Isoorientin 0.0639 0.18 
Orientin 0.7243 1.00 
Vitexin 0.2892 2.25 
Rutin 0.4686 1.49 
Isovitexin 0.0611 0.69 
*Note: The sample of tea was prepared by pouring 500ml of boiling water on 10g of 
Rf and steeping it for 10 min. The % recovery rate displays the actual recovered 
amounts of flavonoids (in nM), found within the plasma, relative to the ingested 
amount (Breiter et al., 2011). 
1.11.3. Polyphenols 
Polyphenols are a diverse class of chemicals found in various plants, fruits, 
vegetables, wines and an array of teas. It is a term used to characterize a compound 
which presents with one or more benzene rings which can be subdivided into 
flavonoids, stilbenes (resveratrol) and tannins (See Fig. 9 and Fig. 10) (Hagerman et 
al., 1998). Polyphenolic compounds, ubiquitous in plants, have gained much 
popularity for its antioxidative action and modulation of several protein functions 
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and its role as an anti-inflammatory agent (Joubert and Ferreira, 1996). In addition, 
it is well known for its epidemiological influence in the prevention of 
neurodegenerative disorders and chronic diseases including cancers (Vanzour et al., 
2010). The free radical scavenging mechanisms by which polyphenols neutralize 
ROS involve the breaking of free radical chain reactions. In addition, polyphenols 
function in the suppression of free radical formation by the regulation of enzyme 
activity and chelating metal ions which are role players in free radical formation. 
These metals include: copper and iron, and are chelated through multiple hydroxyl 
groups and carbonyl moieties (Fraga et al., 2010; Perron and Brumaghim, 2009; 
Vladimir et al., 2012). 
1.11.4 Classification of polyphenols 
 
Figure 9. Polyphenolic profile (http://www.frenchglory.com/polyphenols_classification.pdf) 
Polyphenols are common in plants, functioning as pigments and sunscreens, as 
insect attractants and repellants and as antimicrobials and AOs. A polyphenol group 
is subdivided into smaller groups such as flavonoids and phenolic acids (See Fig. 9). 
The polyphenols may also be classified as monomeric (molecules containing a 
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single unit) or polymeric (larger molecules containing more than one unit) 
(Erickson, 2003). 
1.11.5 Phenolic structure of aspalathin 
 
Figure 10. Basic chemical structure of aspalathin (http://www.chemspider.com/Chemical-
Structure.26286888.html) 
1.11.6 Aspalathin 
Aspalathin, constitutes the major flavonoid of Rf, however, most of its polyphenolic 
nature is attributed to flavanones and unknown polymeric substances (Marais, 1996; 
von Gadow et al., 1997; Joubert, 1996). Aspalathin undergoes cyclization during 
oxidation to form the flavanones: dihydro-orientin and dihydro-isoorientin, of which 
the dihydrochalcones are more effective as AOs than the aforementioned 
flavanones. Rf was reported to possess significant AO activity, with inhibition 
activity of 83.43%. Thus, this AO activity can be attributed to the oxidation products 
of aspalathin in Rf (Dziedzic et al., 1985; von Gadow et al., 1997). 
While the AO capacity of green and black tea is well documented, more studies 
need to be conducted on the rooibos tea. Due to the oxidative process involved in the 
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fermentation of rooibos, it contains lower amounts of flavonoids, such as aspalathin 
in comparison to the unfermented rooibos and, therefore, has a lower AO capacity 
(Stanley et al., 2001). In vitro studies, have however, reported on the AO activity 
within the Rf, which was comparable to both green and black tea (Snijman et al., 
2009; Breiter et al., 2011). Rf expresses a polyphenolic profile which has the 
potential to aid in the recovery of a negative change in the bEnd5 cell’s metabolic 
status as a result of oxidative stress, based on its AO capacity (See Table 3.). Thus, 
it possesses the potential to ameliorate the effect that generic narcotics have on a 
biological system and more specifically on the bEnd5 cell line. 
1.12 Antioxidants and the blood-brain barrier integrity 
The reduction-oxidation (redox) state of cells is known to impact strongly on 
cellular functions such as the glutathione s-transferase mediated elimination of 
electrophilic xenobiotics and some serve as the end-products of lipid peroxidation 
(Rebrin et al., 2005; Marnewick, 2011). Redox activity within a cell is used as an 
important indicator of the oxidative status of the brain parenchyma in vivo. 
The body employs three main phases of protection against free radical attack: 
preventative AOs, scavenging AOs and repair enzymes. In addition, nonenzymatic 
AOs are involved in the neutralization of ROS (Rahman, 2007). The preventative 
AOs are associated with the inhibition of free radical production such as metal 
binding proteins, albumin, transferrin, myoglobin and ferritin, which bind metals 
such as iron and copper (Leopoldini et al.,2011; Rahman, 2007). The scavenging 
enzymatic AOs remove the ROS upon formation. These include enzymes such as, 
superoxide dismutase, glutathione, peroxidase and catalase, The repair enzyme 
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functions in DNA repair enzymes which function in the repairing of damaged 
biomolecules. In addition, the nonenzymatic AOs, include, carotenoids and 
polyphenols, namely, flavonoids (Rahman, 2007). 
 
Figure 11. Antioxidant neutralization of ROS production 
(http://www.esc.rutgers.edu/publications/general/fs1065.htm) 
1.13 Problem statement 
The high rate of alcohol abuse and prevalence of FASD, with its effect on the South 
African socio-economic status, is a problem that simply cannot be ignored. This 
study, therefore, aims to produce a body of scientific knowledge that will support 
and improve on the existing awareness of the detrimental effects of alcohol abuse, 
from an occasional and long-term perspective - on the BBB, and the advocating of 
therapeutic mechanisms to ameliorate these effects. 
The research focused on investigating the compromising effects of selected alcohol 
concentrations on the BBB and how these effects can be reduced or eradicated by 
using rooibos, a plant known for its high AOs and is widely used and cheaply 
available to all sectors of the South African population.  
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Although research has been conducted on rooibos, none focuses on its effects on the 
BBB and little is known about clinical interventions reversing the alcohol-induced 
effects on the BBB. Given the devastating socio-economic impact of alcohol abuse 
on SA, much research is required not just to understand mechanisms of BBB 
disruption by alcohol, but to reverse or neutralize the effect of this adverse outcome. 
1.13.1 Rationale 
The highly selective BBB is crucial to the brain as it maintains the homeostatic 
milieu of the brain microenvironment. The role of the BBB should never be 
underestimated, as the very function of the brain’s neurons, depend on the strict 
regulation and management of the extracellular environment. Should the BBB 
become compromised by primary or secondary alcohol effects, it could result in the 
disruption of the normal functioning of neurons, resulting in spontaneous action 
potentials, irregular motor, sensorial and psychological function. The ECs form the 
anatomical basis of the BBB and constitute the route by which the transport of 
substances (which may be toxic), viruses or bacteria within the plasma, are regulated 
and controlled (Nitta et al., 2003; Rubin and Staddon, 1999). 
Literature has stated, emphatically, that EtOH affects the brain by means of ROS 
production (Dietrich, 2006; Zakhari, 2006). This supports the research findings on 
alcohol’s association in BBB impairment as being strongly correlated to oxidative 
stress (Haorah and Knipe et al., 2005). Trolox, which has high AO potential, has 
been shown to reverse certain detrimental effects of EtOH on the BBB (Ramirez et 
al., 2009). This study investigated whether the AOs present in rooibos and widely 
used in South African communities, is able to reverse these harmful effects.  
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There is a desperate need to develop novel therapeutic strategies in which potential 
AO candidates may be used in the treatment and/or prevention of alcohol-related 
diseases and conditions such as FASD associated disorders. Furthermore, 
identification of indigenous, natural compounds which are easily accessible and 
financially viable to the general population of a developing country such as SA, is 
therefore, a critical factor to consider when identifying such candidates in an effort 
to ameliorate the negative physiological effects that alcohol abuse has on the 
integrity of the BBB. Rooibos herbal tea extract, high in AOs, fulfills all the criteria 
as a suitable candidate.  
1.14 Research aims and objectives 
1.14.1 Aims 
(i) To chemically analyse the AO capacity of an aqueous extract of A.linearis. (ii) 
To analyse the in vitro effect of EtOH and fermented A. linearis aqueous extract 
separately and in combination on physiological parameters of the bEnd5 cells line 
model of the BBB. 
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1.14.2 Objectives 
(i) Chemical analysis of fermented A. linearis to determine: 
• The total polyphenol content  
• The total flavonol content  
• To analyse the oxygen radical scavenging properties of fermented A. linearis  
(ii) In vitro analysis on bEnd5 cells: 
Control and experimental (alcohol exposed, rooibos exposed and combination of 
alcohol and rooibos exposed) groups analysed in order to determine: 
• Cell viability by measuring the % mitochondrial activity for selected 
concentrations of alcohol and fermented rooibos and combinations of the 
compounds at selected intervals. 
• The effect of selected concentrations of alcohol and fermented rooibos on 
cellular proliferation at selected time intervals. 
• The effect of alcohol and fermented rooibos and combinations of the 
compounds at selected time intervals on TEER.  
(iii) In an attempt to morphologically characterize the BBB bicameral model system, 
investigation of the growth of bEnd5 monolayers and its development on mixed 
cellulose inserts using high resolution SEM was performed in a sequential manner. 
The addition of electron microscopy would further endorse the ultrastructural 
characteristics of the bEnd5 cells of the in vitro BBB model. 
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1.15 Research question/ hypothesis 
The hypothesis for this study is that selected concentrations of fermented A.linearis 
will modulate the adverse alcohol/EtOH-induced changes to the in vitro mouse BBB 
physiology. 
 
 
 
 
CHAPTER 2: Materials and Methods 
 
47 
 
CHAPTER 2: Materials and Methods 
The in vitro analysis was carried out in order to investigate generic responses of 
bEnd5 cells to acute (24 hrs) and chronic (daily: 24-144 hrs) exposure to EtOH and 
an aqueous extraction of fermented rooibos (A. linearis/ Rf), separately, as well as in 
combination, on the bEnd5 cells. Selected physiological parameters were 
investigated – namely, mitochondrial activity (MA), cellular proliferation, 
permeability and morphological studies - to investigate the functional and 
morphological characteristics of the bEnd5 cells. The initial phase of the study was 
to chemically analyze an aqueous extract of A.linearis in order to determine its 
polyphenol content and antioxidant (AO) capacity.  
2.1 Preparation of an aqueous herbal infusion of A.linearis 
A.linearis (harvested in the WC, in the Cederberg Mountains of Clan William) was 
prepared by steeping the dried leaves in boiling water for 30 min. A 20% aqueous 
extract was pre-filtered through cheesecloth and subsequently through whatman no.4 
followed by no.1 (Sigma, South Africa) filter paper. The filter extract was stored at -
20˚C, protected from light. The Rf aqueous extract was used directly after dilution 
with distilled water to a specified concentration of 20%. Sample precipitates were 
removed by centrifugation for 3 min at 4000rpm and the supernatant was used for 
the chemical analysis. Stock standard series were prepared and the selected amount 
of standard stock solutions were added to the diluents in the respective tubes (See 
Appendix B, Table 1-6.). 
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2.2 Chemical analysis of fermented rooibos (A.linearis) 
Analysis was carried out by the Cape Peninsula University of Technology (CPUT), 
Oxidant Research Laboratory, Bellville, Cape Town, SA. Rf was obtained from the 
South African Rooibos Council (SARC, batch no. P06-02KK) and the total 
polyphenol, flavonol and flavanol content of Rf was determined. AO assays 
included: ferric reducing AO power (FRAP) assay (Benzie and Strain, 1996), 
oxygen radical absorbance capacity assay (ORAC) assay, the ABTS (2, 2’-azinobis 
(3-ethyl-benzthialozine-6- sulphonic acid) (TEAC-Trolox equivalent AO capacity) 
assay (Thaipong et al., 2006). 
2.2.1 Measurement of polyphenols 
2.2.1.1  Principle of polyphenolic measurements 
The analysis utilized the Folin Ciocalteu reagent, with gallic acid as the standard to 
measure total polyphenol content in a sample. The principle of the Folin Ciocalteu 
method involved the oxidation of polyphenolics in alkaline medium with 
molybdenum and tungsten. This formed a blue chromophore complex. The blue-
coloured complex together with the polyphenols was measured 
spectrophotometrically at 750nm (Bajčan et al., 2013). 
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2.2.1.2  Chemical requirements and sample handling for the 
quantification of polyphenols 
The chemicals utilized in the quantification of polyphenols included: 10% EtOH and 
Folin Reagent (Merck, Cat no.109001) and 7.5% sodium carbonate (NaCO3) 
(Sigma-Aldrich, Cat no.223530) which was stored at room temperature (RT). Gallic 
acid (Sigma-Aldrich, Cat no.G7384) was prepared by dissolving 40mg in 50ml of 
10% EtOH to give a stock concentration of 800mg/L. The control was prepared by 
dissolving 10mg of the gallic acid into 50ml of 10% EtOH solution to give a final 
concentration of 200mg/L. All solutions were prepared on the day of analysis. The 
sample was prepared on ice and all samples were held in storage at -40
o
C. 
2.2.1.3  Sample analysis 
For the standards, 25l of gallic acid was added to each well of a clear 96-well 
microtiter plate (Lasec SA, Cat no.PGRE655180). For the controls, 25l of the 
control was added to wells while 25l of the sample was added to the designated 
experimental wells, in triplicate (See Appendix B, Table 7. Plate layout and 
concentrations). 125l Folin reagent was added to all wells. The plate was left for 5 
min at RT, prior to the addition of 100l Na2CO3 to each well. The plate was left for 
2 hrs at RT in the dark. The plate was read using a Multiskan
TM
 plate reader at 760-
765nm. 
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2.2.2 Ferric reducing antioxidant power assay  
2.2.2.1  Principle of the Ferric reducing antioxidant power assay 
The FRAP assay was used for assessing AO power. The AOs were used as 
reductants in a redox-linked colorimetric method, employing an easily reduced 
oxidant present in excess. At low pH values, reduction of a ferric tripyridyltriazine 
(Fe
3+
-TPTZ) complex to the ferrous (Fe
2+
) form, which has an intense blue colour, 
can be monitored by measuring the change in absorption at a wavelength of 593nm. 
The reaction is non-specific, in that any half-reaction that has a lower redox 
potential than that of the ferric or ferrous half-reaction will drive the ferric (Fe
3+
) to 
ferrous (Fe
2+
) reaction. The change in absorbance is, therefore, directly related to the 
reducing power of the electron donating AOs present in the reaction mixture (Benzie 
and Strain, 1996; Benzie and Szeto, 1999).  
2.2.2.2  Chemical requirements and sample handling for the FRAP assay 
The chemicals required for the FRAP assay included: 300mM acetate buffer, pH 3.6 
which was comprised of 1.627g sodium acetate and 16ml glacial acetic acid 
(Saarchem, Cat no.1021000) made up to 1L with distilled water (dH20). A 40mM of 
HCl and 10mM TPTZ (2, 4, 6-tri [2-pyridyl]-s-triazine) (Sigma-Aldrich, Cat 
no.T1253) comprised of 0.0093g TPTZ and 3ml of 40mM HCl. A 20mM iron (III) 
chloride hexahydrate (Sigma-Aldrich, Cat no.F2877) solution was made up with 
0.054g FeCl3.6H2O and 10ml dH20. For the measurement of FRAP, L-ascorbic acid 
(Sigma-Aldrich, Cat no.A5960) was used as a standard. A stock concentration of 
1mM L-ascorbic was prepared by dissolving 0.0088g of ascorbic acid in 50ml dH20. 
400M of a control stock of L-ascorbic acid was prepared by dissolving 0.00352g of 
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ascorbic acid in 50ml dH20. All solutions were prepared on the day of the chemical 
analysis. All samples were stored at -40C. 
2.2.2.3  Sample analysis 
The FRAP solution (straw-coloured) was prepared in a 50ml conical tube. The 
following reagents were added: 30ml acetate buffer, 3ml TPTZ solution, 3ml FeCl3 
solution, and 6.6ml dH20. For the standards, 10l of ascorbic acid was added to each 
well of a clear 96-well microtiter plate. For the controls, 10l of the control was 
added to wells while, 10l of the sample was added to the designated experimental 
wells in triplicate. (See Appendix B, Table 7. Plate layout and concentrations). 
300l of the FRAP reagent was added to all wells with a multichannel pipette. The 
final volume of the assay was 310l. It was not necessary for all the wells to be used 
on the plate at one time. The plate was incubated for 30 min in the incubating oven, 
set at 37°C and was read using a Multiskan
TM
 plate reader at a wavelength of 
593nm. 
2.2.3 Oxygen radical absorbance capacity assay  
2.2.3.1  Principle of the oxygen radical absorbance capacity assay 
The ORAC method was used to analyze the lipid-soluble AO samples by 
introducing randomly methylated beta-cyclodextrin (RMCD) in a 50% acetone 
water mixture. The mixture made lipid-soluble AOs soluble in phosphate buffer. The 
assay was both reliable and sensitive and was based on the inhibition of the peroxyl-
radical (free radical) induced oxidation and, thereby, measured the peroxyl radical 
absorbance capacity of AOs and serum or other biological fluids using Trolox as a 
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standard (Prior et al., 2003). This method can be performed with a fluorometry plate 
reader, using a 96-well microtiter plate to perform simultaneous kinetic analysis of 
many samples and to reduce the amount of sample required. The excitation 
wavelength was set at 485nm and the emission wavelength was set at 520nm (Prior 
et al., 2003).  
2.2.3.2  Chemical requirements and sample handling for the ORAC assay 
The chemicals required for the ORAC assay included: hexane (Saarchem, Cat 
no.2868040 LC) stored at RT, acetone/water/acetic acid solution (AWA) solution 
which consisted of 700ml acetone (Saarchem, Cat no.1022040 LC), 295ml dH20 and 
5ml glacial acetic acid. A 75mM, pH 7.4, phosphate buffer was prepared and 
consisted of two solutions. 
Solution 1 was prepared by weighing out 1.035g sodium di-hydrogen 
orthophosphate-1-hydrate (NaH2PO4.H2O) (Sigma-Aldrich, Cat no.S9638) and 
dissolving it in 100ml of double distilled water (ddH2O). Solution 2 was prepared by 
weighing out 1.335g di-sodium hydrogen orthophosphate dehydrate 
(Na2HPO4.2H2O), (Merck, Cat no.5822880EM) and dissolving it in a 100ml of 
ddH2O. The pH was rechecked before each assay in order to maintain consistency. 
18ml of solution 1 was mixed with 82ml of solution 2, in order to obtain 75mM, pH 
7.4 phosphate buffer. The stock solution of fluorescein sodium salt (C20H10Na2O5) 
was stored at 4C in a dark container (Sigma-Aldrich, Cat no.F6377). A 0.0225g of 
C20H10Na2O5 was weighed and dissolved in 50ml phosphate buffer. The 25mg/ml 
peroxyl radical, denoted as AAPH (2, 2'-Azobis (2-methylpropionamidine) 
dihydrochloride (Sigma-Aldrich, Cat no.440914). 0.5M Perchloric acid (PCA) 
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(Saarchem, Cat no.494612) consisted of 195ml dH20 mixed with 15ml 70% PCA. 
For the measurement of ORAC, Trolox (Sigma-Aldrich, Cat no.238831) was used as 
a standard. A 500µM of Trolox standard concentration was prepared by dissolving 
0.00625g of 6-Hydroxy-2,5,7,8-tetra-methylchroman-2-carboxylic acid (Sigma-
Aldrich, Cat no.238831) in 50ml phosphate buffer and was mixed until dissolved. A 
250µM of Trolox control was prepared by dissolving 0.00312g of 6-Hydroxy-
2,5,7,8-tetra-methylchroman-2-carboxylic acid in 50ml phosphate buffer. All 
solutions were prepared on the day of analysis. All samples were prepared on ice 
and were stored at -40
o
C. 
2.2.3.3  Sample analysis 
For the standards, 12l of Gallic acid was added to each well of a clear 96-well 
microtiter plate. For the controls, 12l of the control was added to wells, while 12l 
of the sample was added to the designated wells in triplicate (See Appendix B, 
Table 7. Plate layout and concentrations). From the fluorescein stock solution, 
10µl was added into 2ml phosphate buffer (in an Eppendorf tube), diluted as 
follows: 240µl of this solution was added to 15ml phosphate buffer using a 15ml 
screw cap tube. 138µl of the fluorescein/buffer solution was added to all wells of a 
black 96-microwell plate. 6ml of the phosphate buffer was added to the weighed 
AAPH and mixed well until dissolved. 50l of this solution was transferred to each 
well. The final volume of the assay was 200l. The plate was read using a 
Multiskan
TM
 plate reader with an excitation wavelength set at 485nm and the 
emission wavelength at 530nm. 
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2.2.4 ABTS (TEAC) radical cation scavenging assay 
2.2.4.1  Principle of the ABTS (TEAC) assay 
The ABTS radical cation scavenging assay was based on the capacity of a sample to 
inhibit the ABTS radical (ABTS
+
) (Zulueta et al., 2009). It was developed for the 
determination of the total AO status of body fluids and in food extracts. AOs added 
to this system could either scavenge the ABTS formed or interfere with the radical 
generating process. Measurement of the absorbance at a specific time after addition 
enables the calculation of a percentage scavenging (RE and Pellegrini et al., 1999). 
The radical cation (ABTS
+
) can be monitored by measurement of one of its 
characteristic absorption maxima at 645nm, 734nm and 820nm.  
2.2.4.2  Chemical requirements and sample handling for the ABTS 
(TEAC) assay 
The chemicals required for the ABTS assay included: 7mM ABTS diammonium salt 
(Sigma-Aldrich, Cat no.A1888) and 140mM potassium-peroxodisulphate, both 
prepared fresh (Merck, Cat no.105091). The ABTS solution was prepared 24 hrs 
before starting the assay. The potassium-peroxodisulphate solution was added to the 
ABTS solution and left in the dark at RT. Trolox was used as a standard for the 
ABTS assay. 1mM of the standard was prepared by dissolving 0.0125g of Trolox 
(Sigma-Aldrich, Cat no.238831) in 50ml of EtOH. In addition, 200M of the control 
was prepared by dissolving 0.0025g of Trolox in 50ml of EtOH. All samples were 
prepared on ice and were stored at -40
˚
C.  
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2.2.4.3  Sample analysis 
For the standards, 25l of Trolox was added to each well of a clear 96-well micotiter 
plate. For the controls, 25l of the controls was added to wells, while 25l of the 
sample was added to the designated wells, in triplicate (See Appendix B, Table 7. 
Plate layout and concentrations). The ABTS solution was diluted with EtOH by 
adding 1ml of ABTS to 20ml of EtOH. The absorbance was read at approximately 2 
(0.1) nm. From the ABTS solution, 300l was added to each well. The plate was 
left for 30 min at RT and was read using a Multiskan
TM
 plate reader at 734nm with a 
temperature set to 25C. 
2.2.5 Measurement of flavonols 
2.2.5.1  Principle of flavonol measurements 
The flavonol analysis made use of quercetin as the standard for determining total 
phenolics at a wavelength of 360nm. All solutions were prepared on the day of 
analysis. 
2.2.5.2  Chemical requirements and sample handling for quantifying 
flavonols 
The chemicals required for the measurement of flavonols included: 10% EtOH, 95% 
EtOH, 0.1% HCl (Saarchem, Cat no.100319 LP) mixed in 95% EtOH and 2% HCl. 
For the measurement of flavonols, quercetin was used as a standard. The standard 
solution consisted of 4mg quercetin (Sigma-Aldrich, Cat no.Q0125) which was 
dissolved in 50ml of 95% EtOH. The control was made by dissolving 1.5mg 
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quercetin in 50ml 95% EtOH. All samples were stored at -40C between subsequent 
analysis steps.  
2.2.5.3  Samples analysis 
For the standards, 12.5l of quercetin was added to each well of a clear 96-well 
microtiter plate. For the controls, 12.5l of the control was added to wells, while 
12.5l of the sample was added to the designated wells, in triplicate (See Appendix 
B, Table 7. Plate layout and concentrations). A 12.5l solution which consisted of 
0.1% HCl and 95% EtOH was added to each well, followed by the addition of 225l 
2% HCl to each well. The plate was left for 30 min at RT. The absorbance was read 
at a wavelength of 360nm with the temperature set to 25°C using a Multiskan
TM
 
spectrum plate reader. 
2.2.6. Measurement of flavanols  
2.2.6.1  Principle of flavanol measurements 
Flavanol analysis was carried out by using 4-dimethylaminocinnamaldehyde 
(DMACA) which reacts with flavanols to form a characteristic light blue colour and 
is measured at a wavelength of 640nm. The DMACA assay is an efficient technique 
which quantifies proanthocyanidins, which are condensed forms of tannins, in foods 
and beverages (McMurrough and McDowell, 1978; Kelm et al., 2005). The 
DMACA method used acid (acid butanol). The acid hydrolyzed the 
proanthocyanidins into their carbocation unit (extension unit) and the flavan-3-ol 
unit (terminal unit). The proanthocyanidin is largely ubiquitous in nature and highly 
prevalent in staple diets (Hummer and Schreier 2008; Wallace and Giusti 2010). 
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2.2.6.2  Chemical requirements and sample handling for quantifying 
flavanols 
The chemicals utilized in the quantification of flavanols included: 32% HCl-
methanol (HCl-MeOH), 250ml HCl (Saarchem, Cat no.100319 LP) which was 
added to 750ml MeOH (Saarchem, Cat no.4164080 LC) and mixed well. A 0.25g of 
DMACA (Merck, Cat no.822034) was weighed and 500ml HCl-MeOH mixture was 
added and mixed until dissolved. Catechin was used as a standard for the 
measurement of flavanols. A 1mM of catechin hydrate standard (Sigma-Aldrich, Cat 
no.C1251) was prepared by dissolving 0.0145g of catechin hydrate in 50ml MeOH. 
A 200M of the control was prepared by dissolving 0.0029g catechin hydrate in 
50ml of MeOH. All solutions were prepared on the day of analysis and all samples 
were stored at -40C.  
2.2.6.3  Sample analysis 
For the standards, 50µl of catechin was added to each well of a clear 96-well 
microtiter plate. For the controls, 50µl of the control was added to wells, while 50µl 
of the sample was added to the designated wells, in triplicate (See Appendix B, 
Table 7. Plate layout and concentrations). 250µl of DMACA was added to all the 
wells to initiate the reactions. The plate was left for 30 min at RT and absorbance 
was read at a wavelength of 640nm using a Multiskan
TM 
spectrum plate reader. If 
any of the flavanol values did not fit to the scale of the standard curve range, after 
the initial absorbance readings were taken, samples were diluted by pipetting 100l 
of the sample supernatant into a new Eppendorf and 900l of MeOH was added to 
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effect a 10-fold dilution. The flavanol assay with the diluted sample was then 
repeated. 
2.3  In vitro analysis of bEnd5 cells 
2.3.1  Bio-reagents  
The following reagents were required for in vitro analysis: EtOH (Sigma-Aldrich, Cat 
no.E7023) and Rf (SARC, Batch no.P06/02/KK), which was prepared as an aqueous 
extract. The bio-reagents for culturing cryopreserved cells were analytical grade. The 
standard cell culture medium utilized was Dulbecco’s modified eagles media 
(DMEM-BioWhitakker/Lonza
®
, Cat no.12-604-F) supplemented with 1% anti-biotic- 
Penicillin/ Streptomycin Amphotericin B mixture (Whitehead Scientific (Pty) Ltd, 
Cat no. 17-745E), 1% sodium pyruvate (GIBCO
®
, Cat no.11360), 1% non-essential 
amino acids (NEAA) (BioWhitakker/Lonza
®
, Cat no.13-114E) and 10% fetal bovine 
serum (FBS) (GIBCO
®
, Cat no.10500), Trypsin (0.25%) (Whitehead Scientific (Pty) 
Ltd, Cat no.BE 02-007E), phosphate buffer saline (PBS) (Sigma-Aldrich, cat 
no.D8662), Trypan blue (Sigma-Aldrich, Cat no.T-8154) The transwell inserts used 
for the TEER/ bioelectrical studies were purchased from MERCK 
(Millipore/MERCK, cat no.PIHA01250), cellular proliferation assay kit XTT II was 
purchased from Roche products (Pty) Ltd (Cat no.11465015001), hydrocortisone 
(Sigma-Alrich, Cat no.H0888), Dimethyl Sulphoxide (Whitehead Scientific (Pty) 
Ltd, Cat no.sc-358801) High resolution SEM studies utilized gluteraldehyde (Fluka, 
Cat no.49626), carbon tape (PELCO Tabs
TM
, Cat no. 16084-1), and aluminium stubs 
(Agar Scientific, Cat no. AGG301). 
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2.3.2  The immortalized mouse brain endothelial cell line 
The immortalized mouse brain endothelioma (bEnd5) cell line (Highveld 
Biologicals – agents from American Type Culture Collection (ATCC)) was derived 
from brain endothelial cells of BALB/c mice. Immortalization was done by 
transfecting the primary cells with the retrovirus coding for the polyoma middle T-
antigen. The bEnd5 cells expressed endothelial specific proteins: PECAM-1, 
Endoglin, MECA-32, Flk-1 which was determined by fluorescein-activated cell 
sorting (FACS). The bEnd5 cells possessed an adherent mode of growth and were 
able to maintain their endothelial-like morphology (Reiss et al., 1998).  
2.3.3  Tissue culturing of bEnd5 cells 
2.3.3.1  Operating principle 
Tissue culture is based on establishing a tissue construct for use in studies pertaining 
to cell-cell and cell-matrix interaction. Subculture and/ or tissue culture is employed 
in order to populate cells by applying selective nutrients within a selective medium 
in order to generate an elevation in cell growth and for the generation of replicate 
cultures of a particular cell type (Freshney et al., 2006). 
The in vitro model of the BBB used in this study mimicked the in vivo situation in 
that the EC is the central component of the in vivo BBB and the experimental model 
employed in this study used an established cell line (bEnd5 cell line). The cells in 
the BBB model displayed both morphological and functional characteristics of the 
ECs in an in vivo condition, with the expression of TJ proteins together with a 
plethora of intercellular junctional proteins acting as a seal between the paracellular 
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compartments of adjacent ECs, characteristic of ECs in the in vivo state (Nits et al., 
2003).  
2.3.3.2  Tissue culture procedure 
Cryopreserved bEnd5 cells were removed from the -80ºC freezer and thawed in a 
37ºC water bath. Quick thawing assisted with the removal of water crystals which 
could potentially damage cells. The bEnd5 cells were grown in DMEM, 
supplemented with 10% FBS, 1% anti-biotic: Penicillin and Streptomycin, 1% 
sodium pyruvate and 1% NEAA (Reiss et al., 1998; Steiner et al., 2011). 
Cells were centrifuged at RT for 5 min at 1000rpm and the top of the cryovial was 
wiped with 70% EtOH, to prevent contamination and the supernatant was discarded. 
The cell pellet was re-suspended in 1ml medium and transferred to a 25cm
2
 (50ml) 
tissue culture (TC) flask containing the desired amount of supplemented DMEM. A 
desired amount of bEnd5 cells (µl) were pipetted into the 50ml TC flask. Cells were 
incubated and cultures were maintained in an incubator set at 37°C and 5% carbon 
dioxide (CO2) for 24 hrs until the cell culture expanded to confluence. After 24 hrs 
the cells were checked for attachment, a media colour change and cell confluence, 
using standard light microscopy (Inverted-phase microscope). 
At 80-90% confluence, the bEnd5 cells, grown in a TC flask, were trypsinated. The 
media was decanted and 2-3ml PBS was used to rinse cells in order to remove any 
residue of media (DMEM) and remove unattached cells. The PBS was aspirated and 
decanted as waste. A 1ml of trypsin (0.25%) was added to the TC flask and 
incubated at 37ºC and 5% CO2 for 10-15 min. Trypsin (a proteolytic enzyme) 
dislodged the anchored cells by digesting the protein bonds that attached cells to the 
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floor of the TC flask (Huang and Hsing et al., 2010). If cells did not dislodge, further 
incubation for 1-2 min was carried out. In order to neutralize the solution, containing 
trypsinated cells, an equivalent amount (1ml) of media (DMEM) was added to the 
trypsinating cells. The detached cells were aspirated into a 15ml conical centrifuge 
tube (Biosmart Scientific, Cat no.PBIOT15) and centrifuged at RT for 5 min at 
2500rpm. After centrifugation the supernatant was decanted and the appropriate 
amount of media was added to the cell pellet and resuspended until the pellet was 
dissolved. The required volume of cell suspension was added to TC flasks 
containing the appropriate amount of media. 
A cell count, using Trypan blue (TB), proceeded after resuspension of the cell pellet, 
if necessary. This was carried out in order to seed an accurate amount of cells, 
specified for a particular assay/study. Cells were exposed to selected concentrations 
of EtOH, Rf and combinations of the two compounds. The concentrations were 
made up using v/v dilutions with supplemented DMEM, a 20% Rf stock and a 
800mM EtOH stock, made from 99.9% EtOH. 
2.4  Trypan blue assay  
2.4.1.  Operating principle 
TB is a carcinogenic dye used for staining and identifying non-viable cells with 
compromised membranes. This assay differentiates between live and dead cells and 
is, therefore, able to determine both cell viability and cell toxicity. Non-viable cells 
absorb and retain the TB due to their non-selective permeability, whereas viable 
cells do not absorb the dye. Non-viable cells were stained blue and the viable cells 
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luminesced when viewed using standard light microscopy (Freshney et al., 2006; 
Mascotti et al., 2000). 
2.4.2  Experimental treatments 
2.4.2.1  Treatment with ethanol and fermented rooibos (A.linearis) 
After a cell count, a cell density of 5x10
4
 cells was seeded in 30, 35x10mm petri 
dishes (Cell Star, Cat no.627 160), using a sample number of 5 (n=5; day=0). The 
selected, physiologically relevant (25mM) (Barnes and Singletary, 2000) and 
supraphysiological (50mM, 100mM, 200mM and 400mM) concentrations of EtOH 
were utilized and Rf concentrations (%) (1, 0.05, 0.025, 0.0125, 0.0625) were 
utilized. At 24 hrs, after seeding cells, all treatments of the particular compounds 
were acutely exposed (once-off), including controls (exposed to standard 
supplemented DMEM). The cells were incubated at 37˚C and 5% CO2. After the 
respective time intervals of exposure to the compounds lapsed, the bEnd5 cells were 
trypsinated to get cells into suspension in order to perform the TB assay to 
determine live cell number, % live cell number and % cell toxicity was determined 
for 24, 48, 72, 96, 120 and 144 hrs.  
800mM of an EtOH stock solution was prepared and filtered using a 0.45µm filter 
and selected concentrations made up by the use of 2-fold serial dilutions. The 
selected concentrations were added to the respective cell-containing petri dishes and 
after 24, 48, 72, 96, 120 and 144 hr exposure to the compound the bEnd5 cell 
number was determined.  
Rf was filtered using a 0.45µm filter and selected concentrations were carried out by 
making 2-fold dilutions in a v/v ratio. The selected concentrations of % Rf were 
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exposed to the respective cell-containing petri dishes and after 24, 48, 72 and 96 hr 
exposure the bEnd5 cell number, % cell viability and % cell toxicity was 
determined. 
2.4.2.2  Cell count using the Neubauer hemocytometer 
An established ratio was used to score viable and non-viable cells, for the purpose of 
the counting method employed, using the Neubauer hemocytometer. A 0.4% TB 
solution was prepared using an isotonic solution (i.e. PBS, pH 7.2). The TB cell 
suspension was made up of 10μl cells, 30μl TB and 60μl DMEM. The bEnd5 cells 
were added to the solution last as TB would cause cell death after prolonged 
exposure. A 10µl of the TB cell suspension was added onto the respective sections 
of the hemocytometer and was observed under an inverted-phase contrast 
microscope (Zeiss). Cells were scored and changes in cellular proliferation were 
determined. 
The percentage cell viability and cell toxicity was determined using the following 
equations: 
1) The % cell viability was determined using the following equation: 
Cell Viability (%) =
No. unstained cells
Total no. cells
  x 100 
 
2) The % cell toxicity was determined using the following equation: 
Cell Toxicity (%) =
No. stained cells
Total no. cells
 x100 
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2.5 XTT cell viability assay 
2.5.1  Operating principle 
The 2.3-bis (2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide 
(XTT) assay is a colorimetric cell assay used to determine the mitochondrial activity 
(MA), for the non-radioactive quantification of cellular proliferation in response to 
growth factors, cytokines and nutrients (Roche Applied Science, 2005) and the 
mitochondrial dehydrogenase (MDH) activity, which is only active in viable cells. 
The assay was based on the cleaving/reduction of the yellow tetrazolium salt (XTT) 
to an orange water-soluble formazan dye by metabolically active cells. This 
conversion only occurred in viable cells. The formazan dye formed was soluble in 
aqueous solutions and can be directly quantified using a scanning multi-well 
spectrophotometer-ELISA plate reader (Roche Applied Science, 2005; Biotium, 
Inc., 2011; Smith and Hunter, 2008). 
An increase in the number of cells resulted in an increase in the overall activity of 
MDH in the cell sample. This increase was directly proportional to the amount of 
orange formazan product formed, as monitored by the absorbance (nm). For the 
purpose of this study, the assay focused on investigating the mitochondrial activity 
of the bEnd5 cell. Cells were incubated with XTT (2.5mg/ml in DMEM) for 4 hrs at 
37°C and 5% CO2. The remaining formazan crystals were formed and quantified by 
determining absorbance readings at a wavelength of 450nm, using a colorimetric 96-
well microtiter plate reader. 
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2.5.2 Experimental Treatments 
2.5.2.1  Treatment with ethanol and fermented rooibos (A.linearis) 
The bEnd5 cells were seeded at a density of 2x10
3
 cells/well (n=5; day=0) in 100µl 
of supplemented DMEM, in a 96-well TC microtiter plate. The cells were allowed to 
attach to the wells overnight (24 hrs). Culture media (supplemented DMEM) was 
removed and the cells were treated with selected concentrations of % Rf using a 
range of: 0.05, 0.025, 0.0125, 0.00625 and 0.003125 and EtOH (mM) using a range 
of: 25, 50, 100, 200, 400 and 800 mM. In combination, cells were exposed using 
0.05% and 0.1% Rf with 25mM, 50mM and 100mM EtOH. A 24, 48, 72 and 96 hr 
incubation period was carried out for both Rf and EtOH and combination treated 
cells. The cells were treated both daily (chronic) and once-off (acute) for each 
treatment. 50μl of yellow, reconstituted-XTT solution was added to the compound-
treated cells making up a final volume of 150μl/well, followed by incubation for 4-
24 hrs at 37ºC and 5% CO2. Orange formazan product was formed, which was 
spectrophotometrically quantified using an ELISA plate reader. Absorbance was 
read at a wavelength of between 450-500nm and % MA was determined using the 
following equation: 
% MA =
Experimental absorbance abs − Media abs
Control abs − Media abs 
  x 100 
 
*Note: Care was taken by refraining to check cells before a 24 hr time lapse, as it 
could disturb the cells and ultimately disturb attachment. 
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2.6 Transendothelial electrical resistance across a bEnd5 cell monolayer 
2.6.1  Operating principle 
Transendothelial electrical resistance (TEER) was based on measuring the membrane 
potential and resistance across an EC monolayer as a model of the BBB in vitro. It 
was used to assess the integrity of the cell membrane by quantitatively measuring cell 
confluence and qualitatively measuring cell monolayer health. These are important 
measurements required for studying bioelectrical changes in transendothelial 
permeability. 
(www.gbo.com/bioscience; www.millipore.com/millicell) . 
2.6.2 Experimental model of the blood-brain barrier 
 
Figure12. Schematic diagram of a bicameral chamber representing a confluent monolayer of the 
bEnd5 cells in vitro 
(http://www.pharmadirections.com/_blog/Formulation_Development_Blog/post/Biopharmaceutics_C
lassification_System_and_In-vitro_membrane_models/) 
The laboratory model of the BBB in vitro employed the use of a bicameral chamber, 
illustrating a tridimensional architecture, comprised of a hollow, fiber, filter insert- 
substrate membrane scaffolding (Millicell
®
, Cat no. PIHA 012 50). The insert was 
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designed so that it simulated the physiological structure of the basement membrane. 
Thus, it is made up of mixed cellulose esters and closely mimics the basement 
membrane.  
The BBB model mimicked the in vivo BBB in that ECs constitute the main 
component of the BBB. This bEnd5 cell line, utilized in this model, effectively 
represented these conditions as these cells expressed polarized morphology and TJs, 
as in the in vivo situation. The bioelectrical resistance across the bEnd5 monolayer 
was investigated as an inversely proportional indicator of changes in transendothelial 
permeability, thus, changes in resistances were directly related to a change in 
permeability and subsequently affected changes in paracellular seals which could 
have indicated whether TJs were compromised or not (Nitz et al., 2003). The cells 
were grown on the mixed cellulose esters membrane (transwell filter insert) which 
mimicked the in vivo basement membrane. It displayed distinct apical and basolateral 
compartments which simulated the luminal (blood/plasma) and abluminal (brain) 
compartments of the physiological conditions which exist within the in vivo brain 
microenvironment surrounding the BBB. 
2.6.3 The extracellular insert membrane 
TEER was assessed post-treatment across the confluent bEnd5 cell monolayer, using 
an Ohm Millicell-ERS
®
 (Electrical Resistance System/Volt-Ohm meter) 
(Millipore
TM
, Cat no. MERS 000 01). The Millicell
®
 24-well tissue culture inserts 
(Millicell
®
, Cat no.PIHA012) with a pore size of 0.45μm, filtration diameter of 
12mm and an effective filtration area of 0.6cm2 was used. The filter membrane of the 
insert contained mixed cellulose esters, according to the manufacturers’ 
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specifications. Millicell
®
-inserts were placed in 24-well TC microtiter plates (Adcock 
Ingram, Cat no.3524). High resolution SEM was used to elucidate the structure of 
this extracellular membrane support. 
2.6.4 Seeding for TEER  
The bEnd5 cells were seeded on non-coated culture inserts (Millicell
®
, Cat no. 
PIHA012 ) at a cell density of 1x10
6
 cells/well/insert, at 37ºC and 5% CO2 (n=4; 
day=0). The bEnd5 cells were allowed to attach to the bottom of the filter insert 
overnight, until the cells expanded to confluence. The bioelectrical effect of 500nM 
hydrocortisone (HC), EtOH, Rf and combinations of the compounds was 
bioelectrically investigated for 24, 48, 72, 96, 120 and 144 hrs, by recording TEER 
readings. 
2.6.5 Measuring the resistance across a bEnd5 cell monolayer 
The 24-well TC plates containing bEnd5 cells, seeded on the membrane insert, were 
removed from the 37˚C incubator and were allowed to acclimatize to ambient 
temperatures for 20-30 min. Aseptic techniques were employed to maintain culture 
sterility. The electrodes were placed in EtOH for 15 min, followed by exposure to 
PBS for 15 min which served as an electrolyte solution for the stabilization of the 
electrode interface.  
The mode of the epithelial Volt-Ohm meter was switched to resistance (“R”) and the 
power switched on. The electrode was immersed in the 24-well plates, positioning the 
probe such that the shorter electrode was immersed in the media inside the filter, 
which represented blood and the longer electrode placed through the basolateral 
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access hole in the media within the growth plate/well, which represented the brain. 
Resistance was measured, holding the electrode static for 5min or until the meter 
indicated a stable resistance reading for the respective solution, thereafter, the 
resistance reading was recorded. All readings were taken in duplicate, thrice per day 
for conclusive results. 
Care was taken to ensure that the shorter electrode did not make contact with cells 
growing on the membrane to prevent the risk of piercing the cell monolayer and the 
thin insert membrane. Which, in the event of breakage, would create an open circuit 
between the apical and basal compartments. 
2.6.5.1 True resistance across an insert membrane 
TEER baseline resistance (true resistance) readings, (a Millicell® insert “without” 
cells) was subtracted from the resistance reading for each condition “with” cells 
(Millipore
TM
 ) using the following equation: 
True resistance = (Experimental reading-Blank reading) X 0.6cm
2
 
2.7 Optimization of TEER and experimental treatments 
2.7.1 Optimization of TEER using hydrocortisone  
EC monolayers were treated in a time-dependent manner in the presence of a 
physiologically relevant level of hydrocortisone (HC) (500nM) (Sigma-Aldrich, Cat 
no.H0888-5G) (Weidenfellar et al., 2005; Hoheisel et al., 1998) in combination with 
DMEM containing: 10% FBS or 0% FBS (serum free media-SFM). This was done in 
order to determine which culture conditions generated optimal TEER readings. The 
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bEnd5 cells were subjected to daily exposure of HC-treated media (chronic 
treatment). For optimal TEER conditions a cell culture environment containing 
500nM HC-supplemented SFM was established. 
*Note: Media was replaced every morning for 24-144hours (6 days) before TEER 
measurements were recorded to prevent the influence of pH changes in the media to 
affect resistance readings across the bEnd5 cell monolayer. 
With respect to %Rf concentrations: 0.1, 0.05, 0.025, 0.0125 and 0.00625 was used. 
After 24 hrs, media was replaced as follows: The blank always contained SFM 
(DMEM with 0% FBS), the control was replaced with SFM supplemented with 
500nM HC. Rf and EtOH concentrations were replaced with the same, respective Rf 
and EtOH concentrations made up with SFM supplemented with 500nM HC. 
2.7.2 Effect of ethanol on TEER 
The bEnd5 cells were seeded at a density of 1x10
6
 cells/well/insert (n=4; day=0) 
using supplemented DMEM (with 10% FBS). Upon cell confluence, after 24 hrs, 
supplemented-DMEM was removed and the EC monolayers were treated by daily 
(chronic) exposure to EtOH, within an optimized TEER system. The EtOH range 
used was both within physiological (25mM) and a supraphysiological range (50mM, 
100mM and 200mM) (Barnes and Singletary, 2000) in the presence of 500nM HC-
supplemented SFM. TEER was measured using the Millipore
TM
 electrical resistance 
apparatus (Millicell-ERS
®
 epithelial Volt-Ohm meter -Millipore
TM
). 
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2.7.3 Effect of fermented rooibos (A.linearis) on TEER 
The bEnd5 cells were seeded at a density of 1x10
6
 cells/well/insert (n=4; day=0) 
using supplemented DMEM. Upon cell confluence, the culture media was removed 
and the EC monolayers were treated by daily (chronic) exposure to %Rf, within an 
optimized TEER system. The % Rf range used was: 0.1, 0.05, 0.025, 0.0125 and 
0.0625 in the presence of 500nM HC-supplemented SFM. TEER was measured using 
the Millicell-ERS
®
 epithelial Volt-Ohm meter -Millipore
TM
. 
2.7.4 Effect of combination treatments of ethanol and fermented rooibos 
(A.Linearis) on TEER 
The bEnd5 cells were seeded at a density of 1x10
6
 cells/well/insert (n=4; day=0) 
using supplemented DMEM (with 10% FBS). Upon cell confluence, supplemented-
DMEM was removed and the EC monolayers were treated by daily exposure to %Rf 
concentrations (0.0.5% and 0.1%) in combination with EtOH concentrations of 
25mM, 50mM and 100mM, within an optimized TEER system, in the presence of 
500nM HC-supplemented SFM. TEER was measured using the Millicell-ERS
®
 
epithelial Volt-Ohm meter -Millipore
TM
. 
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2.8   Electron Microscopy 
2.8.1 Scanning Electron Microscopy 
The use of the high resolution scanning-electron microscope (SEM) has become 
very advantageous as a result of its ability to produce images using both high 
magnification and great depth of field (DOF). Since SEM is able to make use of 
high levels of magnification, it aids in bridging the gap between the light 
microscope, which produces more superficial images and the transmission electron 
microscope (TEM). The micrographs of a typical SEM contain a substantial amount 
of information addressing the morphological and topographical information about a 
specimen (Postek et al. 1980). In recent years SEM has become widely employed by 
various fields of study, from the physical to biological sciences. During analyses of 
biological specimen, SEM imaging generates a three-dimensional image which 
provides useful information about the cell membrane’s surface morphology and 
topography.  
2.8.2 Operating principle 
A typical SEM includes an electron gun which emits electrons, which are then 
accelerated to high kinetic energy (in excess of 20 keV) by means of an electron 
high tension tank – this generates an electron beam. The beam passes through a 
series of electromagnetic lenses, apertures and coils which aid in focusing the thin 
primary electron beam onto a specimen. The primary electron beam moves through 
a vacuum within the microscope and scans over the surface of the specimen. Upon 
interaction of the primary electrons (i.e. the electron in the beam) with the specimen, 
secondary electrons are emitted from the specimen surface, which are then collected 
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by a detector, which processes these to form an electronic image (Postek et al., 1980; 
Ayache et al., 2010) (See Fig. 13 below). In this work, only the secondary electrons 
generated from the specimen surface were used to form an image. Figure 14 shows 
a cross-sectional schematic of the lay-out of a typical SEM, in which the 
components as discussed above are shown.  
 
Figure 13. Schematic representation of the different signals that are generated upon interaction 
of the primary electron beam with the specimen surface (Yao and Wang, 2005) 
 
Figure 14. Schematic representation of a SEM column (Postek et al., 1980) 
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2.8.3 Resolution and Depth of Field 
The limit of resolution of the standard light microscope is a limiting factor in better 
understanding the BBB. SEM enables the investigation of the cell membrane surface 
structures and in so doing, enables distinguishing between healthy cell structures in 
relation to altered cell morphology. For the purpose of this study images of the 
bEnd5 cell monolayer was observed at a resolution of approximately 1nm. 
The resolution of any given image is referred to as a measure of the distance at 
which the two objects/entities are observed, such that a distinction can be made 
between the two different entities. The limit of resolution can be determined by the 
follow equation (Abbe’s equation): 
𝑑 =
0.612𝜆
𝑛𝑠𝑖𝑛 ∝
 
where d = limit of resolution 
𝜆 = wavelength of the energy source 
n = refractory index of the medium through which the energy source travels 
α = aperture angle 
Another important factor during analyses using SEM is the DOF, which refers to the 
extent of the zone on a specimen which appears acceptably in focus (Postek et al., 
1980). A good quality SEM image will contain a large DOF so that an appreciable 
portion of the specimen is in focus. 
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Mathematically the relationship for the DOF is given by:  
𝐷𝑂𝐹 =
0.612𝜆
𝑛𝑠𝑖𝑛 ∝ 𝑡𝑎𝑛 ∝
 
2.8.4 Factors affecting resolution and DOF 
The first affecting factor is the aperture size. An aperture is a minute hole in a strip 
of metal that is placed in the path of the electron beam. It functions in restricting 
electron progress down the machine column. The aperture plays a role in stopping 
off-axis or off-energy electrons. An additional influencing factor is the working 
distance, which is referred to as the distance between the final lens and the upper 
portion of the specimen as shown in Fig. 15 below. The working distance has been 
found to influence the DOF as shown in Fig. 15. At low working distances, a large 
aperture angle is found, which results in a small DOF. Conversely, at large working 
distances, small aperture angles are created, resulting in larger DOFs. In addition, a 
reduced working distance has been found to decrease spherical aberration (a defect 
of the electromagnetic lens system) resulting in a more focused beam and 
subsequently an image with higher resolution (Postek et al., 1980) 
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Figure 15.  Illustration of the effects of working distance and aperture size on resolution and 
DOF (Cummings, 2006) 
2.8.5 Protocol for imaging a biological specimen using high resolution SEM 
2.8.5.1  Chemical fixation 
A large amount of biological samples tend to be delicate in its native state and as a 
result they are prone to damage with excessive handling during sample preparation 
procedures. For the basis of microscopical studies, two means of fixation may be 
carried out, namely, chemical fixation and/or cryofixation (Ayache et al.,2010). 
However, for the purpose of this study we have employed chemical fixation 
procedures. Chemical fixation involves the stabilization and preservation of strongly 
hydrated biological samples such as, cells and tissue in their native state; this is 
achieved by the formation of new chemical bonds within the sample, making its 
proteins insoluble. These proteins become bridged and transformed into a cross-
linked network and this new network formation reduces specimen distortion during 
the process of dehydration (Ayache et al., 2010).  
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Chemical fixation typically involves the use of aldehydes such as, paraformaldehyde 
or gluteraldehyde or the oxidant, osmium tetroxide, which is generally used for post-
fixative purposes. Fixatives are usually made up within a concentration range of 0.5-
4% in a buffer with suitable pH of balanced salts (Postek et al., 1980; Ayache et al., 
2010). 
For the purpose of this research study, the bEnd5 cells were grown on a support 
(12mm Millicell
®
 transwell insert). The cells were seeded using densities of 1x10
4
 
and 1x10
6
 cells/well (day = 0; n = 3) and incubated at 37°C and 5% CO2 overnight. 
After 24 hrs, cells were exposed to complete culture medium (supplemented 
DMEM) for 24, 48, 72, 96, 120 and 144 hrs.  
A 2.5% solution of gluteraldehyde (BioChemika/Fluka- Sigma-Aldrich, Cat no. 
49626) was prepared in standard buffer- PBS solution (pH 7.2) (Faso et al., 1994) on 
the day of sample preparation. After exposure to standard DMEM-F12, at the 
respective time intervals, the mixed cellulose ester insert membrane, containing 
bEnd5 cell growth, was removed using forceps. The insert was inverted and the 
fibrous filter removed using a lancet. The specimen was placed in the 2.5% 
gluteraldehyde solution and after an hr lapsed the specimen was removed and 
washed in PBS (without gluteraldehyde) for 5 min (x2) and, thereafter, washed in 
dH2O for 5 min (x2) 
The cell specimens were removed from the dH20 and placed in: 50%, 70%, 90%, 
95% and in 100% EtOH for 10 min each. The specimen was removed from the 
100% EtOH after 10 min and placed in a fresh solution of 100% EtOH before drying 
(Faso et al., 1994). 
*Note: All EtOH solutions were made up by diluting it in dH2O/de-ionized H2O 
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2.8.5.2  Critical point drying 
Critical point drying (CPD) was performed on the fixated, dehydrated cells using an 
Hitachi HCP-2 CPD. CPD is conceptualized when liquid is placed in a container 
(sealed) leaving some vapor space and the container is heated; the vapor pressure 
would become greater and at the same time the liquid would expand and become 
less dense. The combination of temperature and pressure at which the density of the 
vapor is the same as the liquid, is the critical density also known as the critical point 
(CP). At this point the surface tension is zero and there is no difference between 
liquid and gas. The pressure at which the distinction between liquid and vapor 
disappears is the critical pressure (73.8 kg/cm
2
). The temperature is denoted as the 
critical temperature, at this point (Bozzola and Russell, 1999). 
The dehydrated cells, grown on top of the cellulose supports, were removed from the 
100% EtOH solution and placed inside a 10mm diameter aluminium basket, whose 
bottom was covered with filter paper. These baskets were then placed inside the 
CPD chamber. This process was done as quickly as possible to prevent drying of the 
sample in air. For the injection of CO2, the valve of the Hitachi CPD was slowly 
opened and the chamber was filled with CO2 within 50-80% of the chamber 
capacity. Injection of CO2 was done gently in order to prevent specimen damage. 
The amount of liquid nitrogen injected is important. It must be between 50% and 
80% of the total chamber volume, as the chamber would not reach the CP with 
inadequate liquid. Once filled, the inlet valve and the CO2 cylinder valve were 
closed. The temperature control dial was set to 20˚C. The power lamp glowed red 
and the fan switched off if the chamber reached 20˚C. The chamber was allowed to 
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reach the respective temperature for a 10-20 min time lapse (depending on the 
hardness of the sample).  
The purpose of CPD was to rid the biological specimen of EtOH without distortion 
of the specimen. The CP of CO2 is (31˚C, 73.8 kg/cm
2
) – at this temperature and 
pressure the supercritical CO2 replaces the 100% EtOH without disturbing the native 
state of the cells. The temperature control dial of the Hitachi CPD was set to 37˚C 
and the pressure was monitored carefully, ensuring that it increases to the CP 
(73.8kg/cm
2
 or more). If the pressure increased to more than 180kg/cm
2
 the exhaust 
valve was opened gently, in order to discharge liquid. Thereafter, a time lapse of 3-5 
min was allowed, until the power lamp glowed red and the fan switched off, 
indicating that the chamber had reached 37˚C. The temperature was kept at 37˚C and 
the leak valve was opened. As the gas steadily discharged, the pressure gauge 
decreased down to a zero. This completed the drying process of the cells.  
2.8.5.3  Sputter coating and SEM imaging 
After CPD, the biological specimens were placed onto double-sided sticky carbon 
tape (PELCO Tabs
TM
, Cat no. 16084-1), which covered aluminium stubs with a 
diameter of 12.5mm and 8mm pin size (Agar Scientific, Cat no. AGG301). Carbon 
was used to avoid spurious readings which occur with a metal. Thereafter, the stub, 
containing the specimen was placed in a Quorum Q150T ES sputter coater for the 
coating of the biological specimen. The sample was coated with gold-palladium at a 
ratio of 60:40, Au: Pd. An electrical field was created between a gold-palladium stub 
and the biological sample. The chamber was pumped with Argon gas, which was 
stripped of its electrons creating plasma, which aided in the coating of the sample 
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with the gold palladium. The sample was imaged using a Zeiss Auriga high 
resolution field-emission gun SEM, which was operated at electron beam energy of 
5keV.  
All images were taken using an in-lens secondary electron detector, which allowed 
for high resolution imaging. For all samples, a nominal working distance of 5mm 
was used. 
2.9  Statistical analysis 
Results were expressed as the mean±SEM. Medcalc (version 11.6.1) was used to 
statistically analyze the data. Significant differences between groups were 
determined by using the Mann-Whitney Rank-Sum test for independent (unpaired) 
samples, which were not normally distributed. A probability of P<0.05 designated 
statistical significance. 
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Chapter 3: Results 
3.1 Chemical analysis and determination of antioxidant capacity of 
fermented rooibos (A.linearis) herbal tea 
The chemical analysis and characterization of an aqueous extract of fermented 
rooibos (Rf) were executed at the Cape Peninsula University of Technology (CPUT), 
Oxidant Research Laboratory, Bellville, Cape Town, South Africa under the 
supervision of Prof. J. Marnewick. Chemical analysis was carried out to determine 
the polyphenol, flavonol and flavanol content. Analysis revealed that the sample 
contained significant amounts of polyphenols which included aspalathin, an array of 
flavonols, as well as small amounts of flavanols. Antioxidant (AO) assays on the Rf 
sample included ferric reducing antioxidant power (FRAP) assay oxygen radical 
absorbance capacity assay (ORAC) assay, and the ABTS (2, 2’-azinobis (3-ethyl-
benzthialozine-6- sulphonic acid) (TEAC-Trolox equivalent antioxidant capacity) 
assay.  
The chemical analysis showed a total polyphenolic content of 54.34mg/g (dry 
weight) and 1086.24mg/100ml (aqueous Rf), the presence of flavonols of 7.80mg/g 
(dry weight) and 156.05mg/100ml (aqueous Rf) and flavanols of 4.55mg/g (dry 
weight) and 90.96mg/100ml (aqueous Rf). Spectrophometric data also demonstrated 
1.065mg/g aspalathin (dry weight) and 21.3mg/100ml (aqueous Rf). 
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AO assays demonstrated that the aqueous extract exhibited antioxidant potential. 
Table 4. Polyphenolic composition of an aqueous extract of fermented A.linearis  
 Equivalents Quantity/100ml 
(Expressed as 
aqueous Rf) 
Quantity/gram 
(Expressed as dry 
weight Rf) 
Polyphenols    
Total Polyphenols 
 
Gallic acid (GAE) GAE  
1086.24mg 
GAE 
54.34mg 
Aspalathin Aspalathin 21.3mg 1.065mg 
Flavonols Quercetin (QE) QE 
156.05mg 
QE 
7.80mg 
Flavanols Catechin (CE) CE 
90.96mg 
CE 
4.55mg 
Antioxidant 
Assays 
   
FRAP Ascorbic acid 
(AAE) 
AAE 
 7395µmol 
AAE 
 370µmol 
ORAC Trolox TE 
21149µmol 
TE 
1057µmol 
ABTS Trolox TE 
 4906µmol 
TE 
 245µmol 
 *AAE= Ascorbic acid equivalents  *CE   = Catechin equivalents 
*GAE= Gallic acid equivalents  *QE   = Quercetin equivalents 
*TE   = Trolox equivalents 
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Figure 16. Illustration of HPLC results illustrating polyphenols present in an Rf sample. 
Chromatographic analysis of the Rf sample generated a prevalent absorbance value of 16.024 mAU, 
confirming the presence of aspalathin.  
Flowrate: 1ml/min 
Column temperature: 23°C 
Column: YMC-Pack Pro C18, 150 x 4.6mm I.D. 
Runtime: 30 minutes 
Detection wavelength: 287nm 
Injection volume: 20ul 
Mobile phase A: Water containing 300ul/L Trifluoroacetic acid 
Mobile phase B: Methanol containing 300ul/L Trifluoroacetic acid 
Gradient: 
0 min: 35 % B 
0-5 min: 35% B 
5-25 min: 35% B to 80% B 
25-28 min: 80% B to 35% B 
28-30 min: 35% B 
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3.2 Trypan blue assay 
3.2.1 Effect of acute ethanol exposure on live cell count 
Figure 17. Effect of acute EtOH exposure on live cell count of bEnd5 cells compared to controls for 
selected time intervals. The *, denoted statistically significant differences in live cell numbers, 
between the experimental samples relative to controls. Data was represented as mean ± SEM (n=5). 
Statistical significance was determined at a P-value <0.05 (See Methods); (See Appendix C, Table 
1).  
At 24 hrs, no significant differences in cell numbers was observed, relative to the 
controls with the exception of 200mM EtOH where a significant decrease in live cell 
numbers was observed, relative to the controls (P<0.027). At 48 hrs, statistically 
significant differences in cellular proliferation was observed across all 
concentrations (25mM-400mM) of EtOH with the exception of 100mM EtOH, 
compared to the controls (P<0.009). At 72 hrs statistically significant suppression in 
cell numbers were reflected across all EtOH concentrations in comparison to the 
controls (P<0.027). After 72 hrs, a dose-dependent suppressive effect in cellular 
proliferation occurred for acute exposure to EtOH. At 96 hrs significant decreases in 
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live cell number was observed across all EtOH concentrations from 25mM to 
400mM EtOH, relative to the control (P<0.0001). In addition, all time intervals 
demonstrated a significant decrease in cell numbers at the highest concentration of 
EtOH (400mM) which was unable to recover for the entire experimental timeframe 
(P<0.0001) (See Fig. 17). 
3.2.2 The toxic effect of acute ethanol exposure on bEnd5 cells 
The Trypan blue % viability was approximately within the 100th percentile across 
the experimental time interval from 24-144 hrs. The effect of the EtOH (mM) 
concentrations showed little to no toxicity (See Table 5. below). 
Table 5. Effect of acute EtOH exposure on % toxicity using the Trypan blue assay. 
EtOH (mM) 24hr 48hr 72hr 96hr 120hr 144hr 
Ctrl 0.00 0.00 0.00 0.00 0.00 0.00 
25 1.71 0.00 0.00 0.00 0.00 0.54 
50 0.00 0.00 0.00 0.00 0.00 0.00 
100 0.00 0.00 0.00 0.175 0.00 0.00 
200 0.00 0.00 0.00 0.00 0.00 0.33 
400 0.00 0.00 0.00 0.00 0.00 0.00 
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3.2.3 Effect of acute fermented rooibos exposure on live cell count 
 
Figure 18. Effect of acute exposure to Rf on live cell count of bEnd5 cells compared to controls at 
selected time intervals. Our dose range was chosen based on its biphasic effects on the bEnd5 cell 
line, thus, this was the concentration required. The *, denoted statistically significant differences in 
cell numbers, between the experimental samples relative to controls. Data was represented as mean ± 
SEM (n=5). Statistical significance was determined at a P-value <0.05 (See Methods); (See 
Appendix C, Table 4).  
The initial effect at 24 hrs, resulted in all of the Rf concentrations reflecting an 
increase in cellular proliferation, with statistical significant increases at: 0.125%, 
0.25% and 0.5 % Rf (P<0.049), relative to the controls. At 48 hrs, 1% Rf remained 
significantly (P<0.002) lower than the controls and 0.5% Rf appeared similar to the 
controls, with no statistically significant differences, however, the remaining Rf 
concentrations (0.0625%-0.25%) caused significant increases (P<0.001) in cellular 
proliferation, relative to the controls. At 72 hrs, exposure to the lowest Rf 
concentration (0.0625%) expressed cell numbers significantly greater than the 
control (P<0.0002), thereafter, a dose-related decrease was observed from 0.125% to 
1% which resulted in cell numbers significantly lower than the control samples 
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(P<0.0043). At 96 hrs, all concentrations resulted in cell numbers significantly 
suppressed to values below those of the controls (P<0.007). The control showed a 
linear increase in cell numbers over time, whereas 0.25% Rf becomes significantly 
suppressed over time and a negative effect takes longer to occur for the lower 
(0.0625% and (0.125%) concentrations of Rf (See Fig 18). 
3.2.4   The toxic effect of acute fermented rooibos exposure on bEnd5 cells 
The Trypan blue % viability was approximately within the 100
th
 percentile across 
the experimental time interval from 24-96 hrs. The effect of the % Rf concentrations 
showed little to no toxicity (See Table 6. below). 
Table 6. Effect of acute Rf exposure on % toxicity using the Trypan blue assay. 
% Rf 24hr 48hr 72hr 96hr 
Ctrl 1.53 0.13 0.00 0.58 
0.05 4.17 0.51 0.00 1.96 
0.0625 0.00 0.00 0.00 0.52 
0.125 0.43 0.06 1.00 0.11 
0.25 0.23 0.00 0.30 2.47 
0.5 1.53 0.31 0.56 0.65 
1 1.73 0.00 0.57 0.20 
 
*Note: The toxicity is reflective of the cidal and/or the anti-proliferatory effect of 
the EtOH and Rf on bEnd5 cell viability and proliferation as defined by the number 
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of dead cells, compared to the total number of cells (See Methods, Chapter 2, 
Section 2.4.2.2.). 
3.3 Effect of selected compounds on mitochondrial activity using the 
reduced formazan (XTT) assay 
Most experiments in the literature operate on a 96 hr time interval. For the purpose 
of this research study in some instances the timeframe needed to be extended beyond 
the 96 hrs, to 120 hrs or 144 hrs, if necessary. The mitochondrial activity (MA) 
reflected the amount of formazan formed within the assay which is reflective of a 
relative amount of MDH activity (See Chapter 2; 2.5.1: Materials and Methods). 
3.3.1 Effect of acute ethanol exposure on bEnd5 mitochondrial activity 
 
Figure 19. Effect of acute EtOH exposure on bEnd5 MA in comparison to controls at selected time 
intervals. The *, denotes statistically significant differences between experimental samples, compared 
to the controls. Data was represented as mean ± SEM (n=5). Controls were normalized to 100% and 
data was expressed, relative to the control. Statistical significance was determined at a P-value <0.05 
(See Methods); (See Appendix C, Table 2). 
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At 24 hrs, acute exposure to EtOH elevated the bEnd5 cell MA, relative to the 
controls. The lower concentrations of EtOH caused the bEnd5 cell MA to elevate, 
with only 50mM EtOH being significantly greater than controls (P<0.006), while the 
higher concentrations of 600mM and 800mM EtOH expressed significantly 
suppressed MA (P<0.018). At 48 hrs the MA was significantly suppressed across all 
EtOH concentrations, relative to the controls (P<0.055). By 72 hrs the effect of the 
concentrations 25mM-200mM showed no significant differences, whereas the 
highest concentrations of 400-800mM EtOH were still significantly suppressed 
compared to the controls (P<0.009). All cells expressed normal MA between 96-120 
hrs so that at 120 hrs only one concentration displayed some difference, with 
significance only observed at 600mM EtOH exposure, relative to the controls 
(P<0.0095) (See Fig. 19).  
3.3.2 Effect of chronic ethanol exposure on bEnd5 mitochondrial activity 
 
Figure 20. Effect of chronic EtOH exposure on bEnd5 MA in comparison to controls at selected time 
intervals. The *, denotes statistically significant differences between experimental samples and 
controls. Data was represented as mean ± SEM (n=5). All controls were normalized to 100% and data 
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was expressed, relative to the control. Statistical significance was determined at a P-value <0.05 (See 
Methods); (See Appendix C, Table 3). 
As opposed to the acute EtOH, which exposed cells for a 24 hr period, during 
chronic exposure cells were exposed to media daily, with the same EtOH 
concentrations. At 24 hrs, chronic EtOH exposure to the bEnd5 cells elevated its 
MA across all EtOH concentrations. This result was only significantly different for 
the higher concentrations of 600mM and 800mM EtOH treatments when compared 
to the controls (P<0.018). At 48 hrs, EtOH visibly suppressed MA across all EtOH 
concentrations compared to all the respective time intervals of exposure, with 
significant differences observed at the lowest concentration of 25mM EtOH and the 
higher concentrations of 400mM, 600mM and 800mM EtOH (P<0.037). Compared 
to the acute suppression, it is greater at 72 hrs at the lower concentrations, with no 
significant differences between the control and EtOH exposed cells. In the range of 
100mM-400mM the bEnd5 MA was significantly elevated (P<0.025) and 
significantly suppressed at 800mM (P<0.004). By 96 hrs the concentrations 
displayed an elevation in MA, thereafter, expressing results similar to that of the 
control, however, the two highest concentrations were highly suppressed, compared 
to controls (P<0.018) and this phenomenon occurred for most of the experimental 
timeframe, from 24-144 hrs (See Fig. 20). 
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3.3.3 Effect of acute fermented rooibos exposure on bEnd5 mitochondrial 
activity 
 
Figure 21. Effect of acute Rf exposure on bEnd5 cell MA in comparison to controls at selected time 
intervals. The *, denotes statistically significant differences between experimental samples and 
controls. Data was represented as mean ± SEM (n=5). All controls were normalized to 100% and data 
was expressed, relative to the control. Statistical significance was determined at a P-value <0.05 (See 
Methods); (See Appendix C, Table 6). 
There appears to be a biological effect that takes place where, at every 48 hrs a 
pattern of suppression and elevation in MA occurs. At 24 hrs the three lower 
concentrations of Rf expressed significant suppression (P<0.0010) and no effect at 
the higher concentrations in comparison to the controls. On day 2, at 48 hrs, the MA 
appears to reflect statistical differences across all experimental samples, 
significantly greater than the controls (P<0.0105), with the exception of 0.025% Rf 
which was showed slight suppression in MA. At 72 hrs, slight suppression is seen 
across all Rf concentrations with no significant differences observed, only at the 
lower concentration (0.003125%) and middle concentration (0.025%) of Rf 
compared to the control (P<0.007). At 96 hrs, exposure all concentrations 
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maintained MA which was statistically different to the controls. Significant 
elevation in MA was observed between the Rf concentration range from 0.003125% 
- 0.05% (P<0.046), with the exception of 0.1% which was unable to recover 
throughout the experimental timeframe, showing significant suppression in MA 
(P<0.0051) (See Fig. 21). 
3.3.4 Effect of chronic fermented rooibos exposure on bEnd5 mitochondrial 
activity 
 
Figure 22. Effect of chronic Rf exposure on bEnd5 cell MA in comparison to controls at selected 
time intervals. The *, denotes statistically significant differences experimental samples and relative to 
controls. Data was represented as mean ± SEM (n=5). All controls were normalized to 100% and data 
was expressed, relative to the control. Statistical significance was determined at a P-value <0.05 (See 
Methods); (See Appendix C, Table 7). 
Chronic exposure to Rf resulted in bEnd5 cells reaching MA between 60% and 80% 
at 24 hrs, showing clear suppression in MA. Chronic Rf exposure suppressed the 
MA across all Rf concentrations relative to the control samples, with the three lower 
concentrations showing statistical significance at 24 hrs (P<0.0010). At 48 hrs 
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significant (P<0.0001) suppression was observed at the lower concentrations 
(0.003125% and 0.00625%) of Rf and significant (P<0.008) elevation at the higher 
concentrations (0.0125%-0.025%), relative to the controls. At 72 hrs MA was 
similar to the controls with statistical significance observed and at 0.1% Rf 
(P<0.047). At 96 hrs two effects of MA was observed: the lower concentrations 
(0.003125-0.0125% Rf) reflected results similar to the controls, however, higher 
concentrations (0.025-0.1 % Rf) showed significant suppression in MA, to 
approximately 80%, relative to the controls (P<0.019). The results suggest that 
daily/chronic exposure to Rf maintained, if not, normalized MA, with Rf 
concentrations expressing a similar effect as the control (See Fig. 22). 
3.3.5 Effect of combination treatments of ethanol with fermented rooibos on 
bEnd5 mitochondrial activity 
In view of the starting hypothesis, that Rf would alleviate the effects of EtOH, 
combinations of EtOH and Rf on the BBB ECs were investigated. The selected 
EtOH concentrations ranged from 25mM to slightly elevated physiological values of 
50mM-100mM. The effect of EtOH on the MA of the bEnd5 cells, across the EtOH 
concentration range, did not statistically differ from each other, but differed from the 
controls and only within the first 48 hrs (See Fig. 19 and Fig. 20). Thus, 
combination experiments were limited to 48 hrs as that was the only experimental 
timeframe in which changes occurred in response to EtOH treatments. Rf treatments 
of 0.05% and 0.1% was utilized as it affected the MA in a predictable manner which 
was not statistically different from the controls (See Fig. 21 and 22).  
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3.3.5.1  Effect of acute combination treatments of ethanol with 0.05% 
fermented rooibos on bEnd5 mitochondrial activity 
 
Figure 23. Comparison between acute treatments of EtOH and Rf compounds in combination. Fig. 
23A, B and C represented the comparison between acute exposure to 25mM, 50mM and 100mM 
EtOH in combination with 0.05% Rf in relation to individual EtOH compounds treatments. The data 
was represented as mean±SEM (n=5) with the *, representing statistically significant differences 
between the EtOH concentration and the combination and the #, representing significant differences 
between the controls and the respective compound treatments. All controls were normalized to 100% 
and data was expressed, relative to the control. A P-value <0.05 designated statistical significance 
(See Methods); (See Appendix C, Table 8A). 
Acute EtOH exposure to the bEnd5 cells elevated MA of the bEnd5 cells at 24 hrs, 
across all treatment conditions. This result was only significantly different for 
50mM when compared to the controls (P<0.0102) (See Fig. 23B). In all cases the Rf 
combination treatments resulted in a reversal of this elevation, however, this 
reversal, was only statistically significant at the 50mM and 100mM EtOH group 
(P<0.029) (See Fig. 23B and 23C).  
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At 48 hrs, EtOH depressed MA, with significant differences across all treatments 
(P<0.005) (See Fig. 23A, B and C) and the combination had no statistical effect on 
MA, with the exception of the 25mM EtOH group in combination with 0.05% Rf, 
relative to the control at 48 hrs (P<0.005). 
3.3.5.2   Effect of chronic combination treatments of ethanol with 0.05% 
fermented rooibos on bEnd5 mitochondrial activity 
 
Figure 24. Comparison between chronic EtOH compound treatments and combination treatments of 
EtOH and % Rf. Fig. 24A, B and C represents the comparison between chronic exposure to 25mM, 
50mM and 100mM EtOH in relation to combination treatments of the compounds. The data is 
represented as mean±SEM (n=5). The *, representing a significant difference between the EtOH and 
the combination treatment and the #, represented significant differences between the control and the 
respective compound treatments. All controls were normalized to 100% and data was expressed, 
relative to the controls. A P-value <0.05 designates statistical significance (See Methods); (See 
Appendix C, Table 8B). 
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Chronic EtOH exposure to the bEnd5 cells elevated MA of the bEnd5 cells at 24 hrs, 
across all treatment conditions, with significant differences observed at 25mM and 
100mM EtOH treatments, compared to the controls (P<0.027) (See Fig. 24A and 
C). In all cases the Rf/EtOH combination treatments at 24 hrs resulted in a reversal 
of this elevation. The reversal, as a result of the combination treatments, only 
showed statistically significant suppression in MA in the 50mM (P<0.008) and 
100mM EtOH groups (P<0.007) (See Fig. 24B and C).  
At 48 hrs, EtOH displayed a trend indicating depression of MA, however, this was 
not found to be statistically different from the controls (See Fig. 24A, B and C). 
Only the combination of 25mM EtOH and 0.05% Rf, exhibited a statistically 
significant increase compared to the controls (P<0.007) (See Fig. 24A).  
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3.3.5.3 Effect of acute combination treatments of ethanol with 0.1% fermented 
rooibos on bEnd5 mitochondrial activity 
 
Figure 25. Comparison between acute EtOH and combination treatments. Fig. 25A, B and C 
represents the comparison between acute exposure to 25mM, 50mM and 100mM EtOH in relation to 
combination treatments of the EtOH and 0.1% Rf. The *, denotes statistical significance between the 
EtOH and the combination treatment and the #, represented the statistically significant difference 
between the selected compound treatments and the control. All controls were normalized to 100% 
and data was expressed, relative to the controls. A P-value <0.05 designated statistical significance. 
The data is represented as mean±SEM (n=5) (See Methods); (See Appendix C, Table 8C).  
Acute EtOH exposure to the bEnd5 cells established a clear trend of elevation in the 
MA at 24 hrs, across the EtOH concentration range, although significant differences 
were not achievable, in comparison to the controls, given the small population group 
(See Fig. 25A, B and C). Only at physiological concentrations of 25mM EtOH, did 
we find a statistically significant (P<0.011) reversal of the EtOH-induced effects, in 
comparison to the controls. (See Fig. 25A).  
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At 48 hrs, a trend was observed for the EtOH groups. EtOH depressed the MA, with 
significant differences across all treatments compared to the controls (P<0.005) (See 
Fig. 25A, B and C). No significant differences were observed between the effect of 
the EtOH relative to the combination treatments across the respective treatment 
conditions, with the exception of the combination treatment of the 25mM EtOH 
group and 0.1% Rf, which was significantly decreased, compared to the controls 
(P<0.007) (See Fig. 25A). With reference to the combination treatments, the 25mM 
EtOH group showed no significance at 25mM, however, at 50mM and 100mM, a 
trend was established, where the combination reversed the effects of the EtOH. 
3.3.5.4 Effect of chronic combination treatments of ethanol with 0.1% 
fermented rooibos on bEnd5 on mitochondrial activity 
 
Figure 26. Comparison between chronic EtOH and combination treatments. Fig. 26A, B and C 
represents the comparison between chronic exposure to 25mM, 50mM and 100mM EtOH and a 
combination of EtOH and 0.1% Rf. The data is represented as mean±SEM (n=5) with the *, 
representing a significant difference between the EtOH concentration and the combination and the #, 
represented significant differences between the controls and the compound treatments. All controls 
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were normalized to 100% and data was expressed, relative to the controls. A P-value of <0.05 
designates statistical significance (See Methods); (See Appendix C, Table 8D). 
Chronic EtOH exposure to the bEnd5 cells elevated its MA at 24 hrs, across all 
EtOH treatments (25-100mM), with no significant differences observed across all 
treatments in comparison to the controls. Statistically significant differences were 
observed between the EtOH treatment (25-100mM) and the combinatory groups of: 
25mM-100mM in combination with 0.1% Rf, (P<0.045) (See Fig. 26A, B and C). A 
reversal of the EtOH effect on MA by the Rf combination treatments was only 
observed in the 25mM EtOH group vs 0.1% Rf, with no statistical significant 
decrease (See Fig. 26A). There was, however, a trend at the use of the higher, 
50mM-100mM EtOH in combination with 0.1% Rf groups, resulting in an elevation 
in MA, similar to, if not more viable than the EtOH treatment effects, with no 
statistical significant differences observed. 
At 48 hrs, a trend was observed for the EtOH treatment groups. The EtOH groups 
depressed MA, with no significant differences across all treatments, compared to the 
controls (See Fig. 26A, B and C). Significant differences were, however, observed 
between the effect of the EtOH groups in comparison to the combination treatments 
in the 25mM and 100mM EtOH group vs 0.1% Rf, which showed a significant 
decrease from the EtOH treatments, in comparison to the combination treatments 
(P<0.006) (See Fig. 26A and C). 
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3.4 Transendothelial electrical resistance 
3.4.1 Effect of chronic exposure to ethanol and fermented rooibos on 
transendothelial electrical resistance 
3.4.1.1 Effect of chronic ethanol exposure on transendothelial electrical 
resistance 
 
Figure 27. Effect of chronic exposure to EtOH-supplemented media in the presence of 
physiologically relevant levels of HC (500nM) on TEER measurements across the bEnd5 cell 
monolayer compared to controls (cells+SFM/HC-supplemented media) at selected time intervals. 
Data is represented as mean ± SEM (n=4). The *, denoted statistically significant differences in the 
TEER over time between experimental samples, relative to the controls. Statistical significance was 
designated at a P-value <0.05 (See Methods); (See Appendix D, Table 1). 
A dose-dependent effect was reflected at 24 hrs. All EtOH concentrations exhibited 
significantly elevated increases in TEER, relative to controls (P<0.026). At 48 hrs 
resistance across the cell monolayer began to plateau with no significant differences 
observed across all concentrations. At 72 hrs, no differences were seen, with the 
exception of 50mM where a minute, but significant increase in TEER was observed, 
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relative to the controls (P<0.0001). Between 96-120 hr time intervals, only small, 
yet significant changes occurred in resistance readings. At 96 hrs only 50mM EtOH 
exposure resulted in a significantly decreasing effect, in comparison to the controls 
(P<0.004) and at 120 hrs, significant differences were only seen at the greatest 
concentrations of 200mM, relative to the control (P<0.003). At 144 hrs no 
significant differences were observed when compared to the control. A time-
dependent effect, across the entire experimental timeline (24-144 hrs), is negligible 
(See Fig. 27).  
3.4.1.2 Effect of chronic fermented rooibos exposure on transendothelial 
electrical resistance 
 
Figure 28. Effect of chronic Rf exposure on TEER compared to controls (cells+SFM/HC-
supplemented media) at selected time intervals. The *, denotes statistically significant differences in 
the TEER of the experimental samples relative to the controls. Data was represented as mean ± SEM 
(n=4). Statistical significance was designated at P<0.05 (See Methods); (See Appendix D, Table 2). 
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A significant increase (P<0.05) in resistance was observed at 24 hrs, 48 hrs and 72 
hrs, reflecting a dose-dependent increases in TEER across all experimental samples, 
generating resistance reading significantly greater than the control samples (P<0.01). 
At 96 hrs, no differences were observed between the experimental samples and the 
controls. At 120 hrs, significant, dose-dependent increases in TEER were observed 
across all Rf concentrations, relative to the control (P<0.0005) and at 144 hrs 
significant increases in TEER was observed from 0.00625% - 0.05% Rf, relative to 
the control (P<0.007) (See Fig. 28).  
3.4.1.3 The effect of chronic exposure to ethanol in combination with 0.05% 
fermented rooibos on transendothelial electrical resistance 
Figure 29. Effect of chronic Rf exposure (0.05%) in combination with EtOH: 25mM, 50mM and 
100mM on TEER compared to controls (cells+SFM/HC-supplemented media) at selected time 
intervals. The *, denotes statistically significant differences in TEER, between the experimental 
samples and controls. Data was represented as mean ± SEM (n=4). Statistical significance was 
determined at P<0.05 (See Methods); (See Appendix D, Table 3). 
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A synergistic regression in TEER is exhibited in the combination treatments for Rf 
(0.05%) and EtOH (25mM-100mM), with a time and dose-dependent effect 
reflected from 24 hrs to 144 hrs exposure. At 24 hrs significant increases were 
observed across all combination treatments of Rf vs EtOH, relative to the controls 
(P<0.0001). At 48 hrs, a visible decrease in TEER, from 24 hrs was reflected. No 
significant differences were observed, relative to the control, with the exception of 
100mM EtOH/0.05% Rf combination treatment, which showed statistically 
significant (P<0.047) elevation in TEER. Optimal TEER readings were reached at 
72 hrs, with significant (P<0.047) decreases observed across all combination 
treatments, relative to the control. At 96 hrs, all treatments reflected TEER values 
lower than the control, with the 0.05% and 50mM EtOH combination treatment 
expressing significant decreases in TEER, relative to the control (P<0.0006). At 120 
hrs a gradual decrease in TEER occurred with all treatments normalizing and 
exhibiting TEER values similar to the control, with the exception of the 0.05% Rf 
and 100mM EtOH combination which was significantly (P<0.023) greater than the 
control and at 144 hrs all TEER values normalized, however, the 0.05% Rf and 
25mM combination reflected significant decreases in TEER relative to the control 
(P<0.0006) (See Fig. 29). 
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3.4.1.4 The effect of chronic exposure to ethanol in combination with 0.1% 
fermented rooibos on transendothelial electrical resistance 
Figure 30. Effect of chronic Rf exposure (0.1%) in combination with EtOH: 25mM, 50mM and 
100mM on TEER compared to controls (cells+SFM/HC-supplemented media) at selected time 
intervals. The *, denotes statistically significant differences in TEER, between the experimental 
samples and significant differences in TEER between combinations treatments relative to controls. 
Data was represented as mean ± SEM (n=4). Statistical significance was determined at P<0.05 (See 
Methods); (See Appendix D, Table 4). 
A synergistic regression is produced in the combination treatments with 0.1% Rf and 
EtOH. A time and dose-dependent effect is observed from 24 hrs to 144 hrs 
exposure. At 24 hrs a significant increase in TEER was observed across all 
treatments of 0.1% Rf in combination with 25mM, 50mM and 100mM EtOH, 
relative to the controls (P<0.0001), however, from 48 hrs, a visible decrease in 
TEER was observed, with a statistically significant (P<0.002) increase in TEER 
seen at the 0.1% Rf and 100mM EtOH combination treatment, relative to the control. 
At 72 hrs, significant (P<0.0001) decreases were observed across all combination 
treatments in comparison to the control and from 96 hrs-144hrs a gradual decrease in 
0
5
10
15
20
25
30
24 48 72 96 120 144
R
es
is
ta
n
ce
 (
Ω
.c
m
2
)
Time (Hours)
Control
25
50
100
* 
* *
EtOH mM
 
 
 
 
CHAPTER 3: Results 
 
105 
 
TEER was observed over time, however, no significant differences were observed 
when compared to the controls (See Fig. 30). 
3.5 High resolution scanning electron microscopy 
3.5.1 Imaging cell confluence on a 12mm insert membrane 
High definition SEM was employed to capture the ultrastructures of established 
confluent bEnd5 cell monolayers. In order to achieve optimal TEER readings, a 
closed circuit needed to be created, by the establishment of a 100% confluent bEnd5 
cell monolayer. This was carried out by investigating the effect of cell density on the 
rate in which to achieve confluence using two cell densities of: 1x10
4
 and 1x10
6
 
cells/well/insert. The bEnd5 cells, seeded at a density of 1x10
6
 cells/well/insert 
effectively achieved 100% confluence within 24 hrs. The cells were treated with 
standard culture medium (supplemented DMEM-F12). This study was performed in 
order to validate the formation of a confluent bEnd5 cell monolayer, to investigate 
the bEnd5 cell surface topography of cells grown in close proximity and surface 
morphology of the bEnd5 cell after being subjected to a flow-based model. 
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In the context of this study, a confluent monolayer for investigating the bioelectrical 
and morphological characteristics of a bEnd5 cell monolayer was investigated. Two 
cell densities were employed in this study. 
 
Figure 31. Comparison of bEnd5 cell confluence. (A) Semi-confluent (20%) bEnd5 cells distally 
located (1x10
4
 cells/well/insert) and (B) represented a confluent (100%) bEnd5 monolayer with cells 
in close proximity (1x10
6
 cells/insert/well) grown on a 12mm diameter mixed cellulose insert. 
SEM micrographs revealed spherical and oval-like cell shapes. Semi-confluent and 
confluent monolayers were formed after 24 hrs exposure of of bEnd5 cells to 
standard DMEM-F12. The ECs were seeded at a density of 1x10
4
 cells/well/insert 
on a mixed cellulose ester filter insert , with a diameter of 12mm and a 0.45μm pore 
size (Millicell
TM
) (A) and these cells achieved approximately 20% comfluence by 24 
hrs. cells appeared to be distally dispersed and, therefore, showed subsequent 
increased paracrine distance. Cells did no present with any vesicle formation or 
blebs on the surface topography. Sparse cells lacked in cell-to-cell communication, 
similar to work described by Dejana, (2004). Conversely the bEnd5 cells seeded at 
1x10
6
 cells/well/insert exihibited vesicle formation on its surface and visible 
cytoplasmic projections with numerous intercellular bridges formed between 
adjacent cells.  
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Figure 32. 100% Confluent bEnd5 cell monolayer seeded at a density of 1x10
6
 cells/well/insert 
(insert=12mm diameter) after 24 hr exposure to DMEM-F12. 
(A) Demonstrated bEnd5 cells grown to confluence on a mixed cellulose insert 
membrane surface. The bEnd5 cells were seeded at 1x10
6
 cells/insert/well 
(Millicell
TM
 insert). The insert was 12mm in diameter, 0.45μm pore size and was 
placed in a 24-well microtiter plate. After 24 hrs the bEnd5 cells established a 
monolayer. (B) Demonstrated and enlarged image (10μm) of a densely packed 
monolayer captured at 100μm (A). The bEnd5 cells grew in close proximity, with 
very short paracrine distances between neighboring/adjacent cells. 
 
Figure 33. Establishment of the bEnd5 cell basement membrane after 24 hrs bEnd5 cells were grown 
in supplemented DMEM-F12 at a cell density of 1x10
4
 cells on a 12mm mixed cellulose esters insert. 
The basal surface of the EC seemed to produce a basement-membrane like matrix 
which attached itself to the surface of the insert. The laying down of a basement 
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membrane is crucial for the orientation of a cell as it allows the cell to distinguish 
between its apical and basolateral surfaces and, therefore, facilitates cell growth. The 
bEnd5 cell demonstrated the laying down of a fibrous network which embedded 
itself into the mixed cellulose ester membrane support structure on the basal surface 
of the cell. In addition it demonstrated two cells in close proximity showing focal 
contact with each other and the extracellular mixed cellulose ester membrane 
surface. The junctions found between cells are important as they are associated with 
the cell cytoskeletal arrangement and subsequent apical and basolateral orientation, 
which is essential for lumen determination (Dejana, 2004). 
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Figure 34. bEnd5 cell division in one cell grown on a mixed cellulose esters insert membrane 
The bEnd5 cell demonstrated a bulging type of formation of its plasma membrane 
on its anterior lateral end. Based on literature this bulging is classified by a term 
called “blebbing”. A bleb is defined as a balloon-like, quasi-spherical protrusion of 
the plasma membrane. The blebs are evident within healthy cells during specific cell 
cycle stages (Barros et al., 2003). The bEnd5 cell, in this figure, demonstrated 
potential cell division which was either being initiated or has failed to occur. The 
cell membrane has been laid down in preparation for the extrusion of subcellular 
contents, but the completion of the actual process may have been inhibited, with the 
notion that blebs are filled from the cell body (Barros et al., 2003). With reference to 
work conducted by Barros et al. (2003), the specific cell could be undergoing 
apoptosis which is also characterized by blebbing, followed by a process known as 
apoptotic volume decrease (AVD) which results in a decrease in the intracellular 
pressure resulting in a collapsed appearance of the bleb, similar to work described 
by Barros et al. (2003) (See Fig. 34). 
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Figure 35. Cell-to-cell protein interactions between adjacently located bEnd5 cells grown on a mixed 
cellulose ester insert membrane. 
Cell-to-cell protein junctions are expressed between adjacent bEnd5 cells grown in 
close proximity. These junctions demonstrated sites of attachment on the domains of 
neighboring cells and in so doing allowed for the adherens of adjacent bEnd5 cells, 
forming a continuous network of cross bridges in the EC monolayer. The 
intercellular cross bridges  are potential transmembrane adhesive proteins at the 
endothelial junctions which aid in holding the cells together and in so doing, assists 
with TJ formation. After a 24 hr exposure to standard DMEM-F12 protein 
complexes were formed. Based on work done by Dejana, (2004), the AJs are formed 
in the initial stages of intercellular contact and it can, therefore, be presumed that 
these protein cross bridges may be part of the AJ family of proteins, such as VE-
cadherin (Dejana, 2004) (See Fig. 35). 
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Figure 36. Cytoplasmic projections on the lateral border in the cleft between adjacent bEnd5 cells 
seeded at a density of 1x10
6
 cells/well/insert. 
The edges of the cell membrane surface appeared to express flap-like cytoplasmic 
extensions which was similar to research finding by Faso et al. (1994). The lateral 
border of the EC demonstrated visible extentions of the cell membrane toward the 
neighboring EC. The amorphic structure of the cell membrane demonstrated 
cytoplasmic projections along the entire lateral border of the cell, attaching to the 
neighboring cell which further supported its adherens-like protein nature, unlike TJs, 
which are prevalent on the apical surface of the EC, the AJs are more abundant 
along the cleft as described by Dejana, (2004). 
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Figure 37. Formation of the schematic illustration of an EC glycocalyx (Yao et al., 2007) (A) and the 
glycocalyx of the bEnd5 cell membrane surface in vitro (B). 
The bEnd5 cell surface expressed the formation of a bush-like structure of proteins 
on its apical surface. In theory, based on research findings reported, this protein coat 
is prevalent on the EC plasma membrane and is composed of glycosaminoglycans 
and glycoproteins and is usually formed upon exposure to shear stress as a result of 
fluid filled pathways (Martini, 2006; Adamson et al., 1992). The animated diagram 
of a typical EC glycocalyx is depicted in Fig. 37A, which showed the formation of  
protein-like structures on the apical surface of an EC. Fig. 37B demonstrated the 
appearance of the bush-like  layer, which was inclined to cover the bEnd5 cell 
surface as a protective mechanism. The presumed “glycocalyx” appeared to be 
closely associated with the luminal (apical) region of the bEnd5 cell and in addition, 
it appeared more dense/clumped at the cell-to-cell junctions, compared to a more 
dispersed appearance, thinner looking, across the cell surface, similar to work 
described by Adamson et al. (1992). 
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Chapter 4: Discussion 
4.1 Introduction: Importance of the blood-brain barrier integrity 
The brain endothelium of the BBB is the major constituent vital to the functioning of 
the CNS (Navone et al., 2013). It is uniquely responsible for the regulation of the 
movement of substances between the blood and brain parenchyma, and is therefore, 
central to the brain as a regulator of the milieu in which the neurons function. The 
BBB is, thus, crucial for the regulation of a homeostatic brain microenvironment, 
within very strict parameters, which allow for the function of neurons (Haorah et al., 
2005; Manzo-Avalos et al., 2010; White, 2003).  
Should the BBB fail in regulating the passage of substances, the very function of the 
brain itself will be compromised. Any such compromising of the BBB will result in 
increased permeability which in turn results in the unregulated passive diffusion of 
substances into the brain tissue through the paracellular and transcellular pathways 
(Brown et al., 2007). Brain capillary ECs are distinctly different from all other ECs. 
They are characterized by a lack of fenestrations, low levels of transcellular 
endocytosis, expression of peptide transporters in a polarized manner and they form 
a low permeability barrier between the brain and blood (Kneisel and Wolburg, 
2000), while the permeability of the paracellular pathways are regulated by TJs, 
which are not found in the systemic capillary system. Brain ECs are vulnerable to 
oxidative stress, which is generally caused by agents inducing ROS production. The 
literature has established that EtOH is a major contributor in the production of ROS, 
which causes oxidative damage within capillary endothelium and surrounding 
structures within the brain (Alikunju et al., 2011). It is surprising that EtOH affects 
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the BBB, due to it being classified as a small lipophilic molecule and its entry into 
the brain is unable to be regulated as it passively passes through the cellular 
components of the BBB (Banks, 2009; Rubin and Staddon, 1999). EtOH has the 
ability to disrupt the intracellular redox state, by dysregulating intracellular 
pathways and causes an imbalance in the redox status of the cell (Brocardo et al., 
2011). This mechanism involves the brain’s exposure to EtOH, which results in an 
elevation in the activity of the EtOH-metabolizing enzymes, subsequently causing 
an increased production of ROS. These metabolic processes are primarily produced 
within the mitochondria as a by-product of EtOH metabolism (Manzo-Avalos et al., 
2010). 
Since oxidative stress causes brain cells to become highly susceptible to oxidative 
injury (Lakhan et al., 2009; Won et al., 2002; Alikunju et al., 2011), the introduction 
of AOs’ as a means to potentially combat the rise in ROS production brought about 
by EtOH is clinically, potentially significant. Commercial rooibos (fermented 
A.linearis/ Rf), is known for its AO capacity as a result of its high polyphenolic 
content (Marnewick et al., 2003; Lamosŏvá et al., 1997; von Gadow et al., 
1997).This study focused on Rf as a source of AO’s, to counterbalance the EtOH-
induced ROS production and in so doing, alleviate its subsequent pathophysiological 
impact. The working hypothesis is based on Rf’s ability to protect against EtOH-
induced changes to an in vitro BBB model system.  
Four phases of investigation were carried out in order to ascertain how the AO 
capacity of Rf could attenuate the adverse effects of EtOH on an in vitro model of 
the BBB. The phases were conducted as follows: (1) The chemical analysis of an 
aqueous extract of A.linearis; (2) the study of cell morphology using electron 
micrographs of bEnd5 cell monolayers to assess and validate the establishment of 
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confluent bEnd5 cell monolayers, essential for bioelectrical experimentation, using a 
bicameral system; (3) in vitro analysis of the effects of both Rf and EtOH separately 
and (4) in vitro analysis of these effects in combination on selected physiological 
parameters of the bEnd5 cells.  
4.2 Chemical analysis of fermented rooibos  
Chemical analysis for Rf, showed high levels of a multitude of AOs’ (See Results 
Table 4.), however, aspalathin is the dominant AO, as can be seen in the HPLC 
results which further endorsed its prevalence by illustrating large amounts of 
aspalathin (16.024 mAU) (See Fig. 16). As rooibos is administered largely within 
the South African population as a tea it is useful to relate the experimental 
concentrations relative to that of a cup of tea. Drinking a cup of rooibos tea results in 
approximately 0.17nM of aspalathin in the plasma (Breiter et al., 2011). Our study 
investigated an Rf concentration range of (0.003125-1%), which translates to 
0.06nM-2nM, and approximates to 0.3-12 cups of tea.  
The literature reports emphatically on Rf’s therapeutic potential. The traditional uses 
of Rf within a South African context include: the alleviation of infantile colic, 
allergies, asthma and dermatological problems (Joubert et al., 2008). Over and 
above its medicinal value, Rf is also enjoyed in SA during the summer months as a 
cold lemon infused beverage and more recently has gained popularity in coffee and 
tea shops, served as “espresso, cappuccino, or latte” (Anon, 2006; Joubert et al., 
2008). The latest concept was introduced in recent news (Cape Times, 21 October 
2014), reporting on the implementation of Rf in the commercial making of wine 
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products as a means to alleviate the potential harmful effects of alcohol within the 
wine product (See Appendix F for article). 
4.3 Effect of ethanol on cellular proliferation and mitochondrial activity 
4.3.1 Effect of ethanol on cellular proliferation 
The cellular proliferatory pattern in this study, demonstrated bEnd5 cellular 
proliferation to be greatly suppressed at 24 hrs with the higher concentrations of 
200mM and 400mM showing marked cell suppression in comparison to the controls. 
Thereafter, a marked increase in proliferation at 48 hrs was observed. Studies 
conducted by Mikami et al. (1997), described the impact of EtOH on a fibroblastic 
cell line of mouse connective tissue, after exposure to a range of 12.5-200mM EtOH 
for a short-term (3 and 26 hrs), and reported on a marked reduction in cellular 
proliferation and an inhibition in cell growth, especially to the higher concentrations 
of EtOH (100 and 200mM) after 3-26 hrs. For the timeframe of 24-48 hrs, this study 
endorsed our research as it appears that at 48 hrs cells have recovered and have 
started to proliferate at a rate higher than the controls. A shortcoming of Mikami et 
al. (1997), is that the study ended at 24 hrs. Our study extended the investigation 
time up to 144 hrs and it was only at 72-144 hrs where a distinct pattern of 
suppression in cell proliferation of bEnd5 cells occurred, after acute exposure to 
EtOH (See Fig. 17). Significant suppression in cellular proliferation occurred in 
EtOH exposed cells which was observed from 72 hrs through to 144 hrs and was 
consistent. The suppression in this study is supported by reports in the literature 
which have clearly implicated EtOH effects on hepatocytes and astrocytes, reporting 
that EtOH at 20-217mM was able to suppress cellular proliferation (Higgins, 1987; 
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Mikami et al., 1997). In addition, EtOH has been reported to cause an increase in 
hepatocyte ROS production, resulting in a mild degree of cytotoxicity (Bailey and 
Cunningham, 1999). 
The EtOH proliferation experiments show a decrease in cell proliferation, which 
could be due to two possibilities: (i) cells died, due to the toxic effects of EtOH and 
(ii) a decreased rate of cell division could be implicated. Our toxicological results 
confirmed, surprisingly, that cells did not die, across the entire selected EtOH 
concentration range (See Results, Table 5).  
Energy is crucial for cell division and as EtOH is well known to be implicated in 
cellular metabolic pathways and thus, would affect the energy quotient of the cells. 
For this reason, the function of the mitochondria was investigated. In addition, 
malfunction of the mitochondria has been linked to an increase in ROS production, 
which is also reported to affect cell division. 
*Energy quotient: The amount of ATP available for the cells’ metabolic processes. 
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4.3.2 bEnd5 Mitochondrial activity as an indicator of cell viability 
4.3.2.1 Introduction: The role of the mitochondria  
An array of neurodegenerative diseases have been directly linked to an over 
production of ROS, which is mostly produced within the mitochondria of a cell as a 
by-product of cellular metabolism/respiration. There is, therefore, a close 
relationship between ROS and the MA (Kirkinezos et al., 2001). The function of the 
mitochondria has been discussed at length in the literature review. It plays a pivotal 
role in the metabolism of EtOH which can be achieved via both oxidative and non-
oxidative pathways which are involved in ROS generation. In the brain EC, EtOH is 
metabolized via catalase and CYP2E1 to acetaldehyde which occurs in the cytosol.  
The acetaldehyde is the main by-product of the oxidative metabolism of EtOH 
which contributes to cell and tissue damage and is further metabolized to acetate via 
ALDH2, in the presence of nicotinamide adenine dinucleotide (NAD+) within the 
mitochondria (Zakhari, 2006). The by-products formed are: acetate, an increased 
NAD+:NADH ratio and increased ROS production. Thus, the ROS producing steps 
involves CYP450 and mitochondrial metabolism. EtOH metabolism, in extrahepatic 
tissue, such as the brain, does not, however, involve the enzyme ADH, only CYP 
P450 and catalase (Zakahri, 2006). Literature has reported that EtOH alters the 
mitochondrial function by decreasing respiratory rates and subsequent ATP levels 
(Manzo-Avalos et al, 2010). Literature has reported that mitochondrial levels of 
ROS may increase upon chronic consumption of EtOH (Manzo-Avalos et al., 2010). 
ROS are major role players in the modulation of cell function causing an array of 
pathological conditions when prevalent both chronically and transiently, at 
supraphysiological levels (Moldovan et al., 2006).  
 
 
 
 
CHAPTER 4: Discussion 
 
119 
 
Furthermore, the mitochondrial dehydrogenase (MDH) activity is indicative of the 
cells’ metabolic rate and by extension an indicator of cell viability (Seeley and Tate 
et al., 1995; Mikami et al., 1997). The XTT assay measures, quantitatively, MDH 
and thus, is a measure of the cells metabolic activity (See Chapter 2; 2.5.1: 
Methods and Materials for the operating principle by which the XTT assay is 
performed). 
4.3.3   The correlation between the effects of ethanol on bEnd5 mitochondrial 
activity and cellular proliferation 
Our data shows that after 24 hr exposure to EtOH there was an increase in 
mitochondrial activity (MA) which is reflective of an increase in the production of 
ATP and a subsequent increase in energy availability to the cell. With respect to 
cellular proliferation, however, 24 hr EtOH exposure shows no difference from the 
controls (See Fig 17, Fig 19. and Fig 20.).  
In view of our hypothesis, it was surprising that, although the MA was not 
suppressed at 24 hrs, suppressive effects of EtOH only came into effect at 48 hrs, 
which speaks to the secondary causes of EtOH’s ability to interfere with pathways 
of ATP production (Cunningham et al., 2004). The decrease in MA, observed at 48 
hrs, after a 24 hr episode of EtOH exposure (acute experiments), was suppressed to 
approximately 20-60 % (See Fig.19 and Fig. 20). This depression of MA is 
indicative of a potential decrease in ATP production, and thus, a decrease in the 
availability of energy for crucial cellular activities. It is, therefore, not surprising that 
the decrease in energy availability, as depicted in a decrease in MA at 48 hrs, 
resulted in the suppression of cellular proliferation between 72-96 hrs (Fig. 17). The 
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implication of the energy suppression is crucial to cell division and therefore, at 
72hrs a decrease in cellular proliferation occurred, which extended to 144 hrs.  
Peculiarly, MA returned to normality by 72 hrs, but this was not able to reverse the 
long-term impact on cellular proliferation, extended to 144 hrs. These results report, 
for the first time, that a single exposure to EtOH causes long-term depression in 
bEnd5 cellular proliferation, and thus, potentially compromise the ability of the 
brain to regulate its homeostatic environment. Although the mitochondria responded 
by returning to normality, in both acute and chronic experiments, this has little effect 
on the suppressed proliferation profile of the cells thereafter. This may be due to 
secondary effects of increased ROS production, as the mitochondria responds to the 
adverse effects of alcohol exposure. 
The decrease in MDH activity reflects a decrease in MA and ultimately a decrease in 
the production of energy. Literature has reported on the ability of alcohol 
metabolism to develop oxygen deficits (hypoxia), within liver tissue and this in turn 
inhibits the liver cells’ ability to produce ATP (Cunningham et al., 2004). It is 
emphatically reported that the mitochondria, being a source of ROS, utilizes 
approximately 2% of O2 in ROS production, under aerobic conditions, especially in 
the formation of superoxide (O2
-
) and hydrogen peroxide (H2O2) (Vladimir et al., 
2012). In the liver mitochondria of the rat the generation of ROS was estimated to 
range between 8.3x10
-11
 mol/L and 4.8x10
-9
 mol/L, upon exposure to EtOH. (Bailey 
and Cunningham, 1999).  
When comparing acute and chronic exposure to MA, suppression was maintained 
for chronic (daily) exposure. Only high concentrations, showed increased 
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suppression of MA, which differed from the acute exposure to EtOH, where MA 
showed recovery at all EtOH concentrations.  
4.4  Effect of fermented rooibos on cellular proliferation, mitochondrial 
activity and toxicity 
4.4.1 Effect of fermented rooibos on cellular proliferation 
In our research study, exposure to Rf resulted in a dose-dependent suppression in 
cellular proliferation of the bEnd5 cells, with increasing amounts of AO exposure, 
which became more acute with time. These effects may have occurred due to an 
imbalance between ROS production and the introduction of AO. This imbalance is 
able to cause the same effect as ROS, as an excess in AO could promote a similar 
effect to excess ROS (Joubert et al., 2005). Our cells only responded to doses 
between (0.00625-1%) Rf, which translates on a “cup of tea” scale to approximately 
0.5-12 cups. Thus, it is plausible that these effects will be observed in vivo, after 
drinking a cup volume of Rf. The initial effect of Rf resulted in a biphasic response 
from 24-72 hrs, but by 96 hrs all concentrations decrease relative to the control. 
Using aspalathin as a plasma marker, the literature indicates that drinking a cup of 
tea would result in similar values for aspalathin (See discussion 4.2 Chemical 
analysis of fermented rooibos). Exposure to high concentrations of Rf extract in a 
clinical context, could be achieved by means of administering Rf extract in a tablet 
form. Surprisingly, toxicity tests show almost 0% toxicity (See Table 6) of the 
bEnd5 cells, irrespective of a decline in the cell population, with respect to its cell 
numbers (x10
5
/ml), which show approximately 100% live cells (See Appendix C, 
Table 5). Thus, Rf is not killing cells, but potentially has an impact on the rate of 
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cell division. An increase in the concentration of Rf caused the same effect as EtOH, 
as AOs are harmful on its own and are only useful in the presence of oxidants, 
where its scavenging properties can be observed. The results endorse the harmful 
effects of ROS or oxidant species on cellular proliferation, thus, affecting the mitotic 
division of the cells. In addition, cellular proliferation is endorsed by the effects of 
Rf on MA, which is discussed in the following section. 
4.4.2 Effect of rooibos - induced changes on bEnd5 mitochondrial activity 
For both acute and chronic exposure to Rf, a directly proportional relationship was 
observed for Rf concentrations at 24 hrs. Rf resulted in suppression of the MA within 
24 hrs, thereafter, all concentrations of Rf, but the highest concentrations, was 
elevated in a cyclic diurnal manner in both 48 hrs and 96 hrs (See Fig. 21 and Fig. 
22).  
Rf, has been investigated as a potential antidote, because it results in an elevation in 
AOs and EtOH results in an increase in ROS, subsequently compromising the BBB. 
The antidotal effect is produced when ROS, produced as a result of EtOH exposure, 
is countered upon the introduction of AOs found in Rf. A biphasic response was 
seen at 24 hrs, and although we do not understand the exact mechanism by which 
this biphasic response occurs, plausible responses of biphasic data are well 
documented in the literature (Svedružić et al., 2012). One hypothesis which attempts 
to understand it, involves the effect of substances on protein conformation. Low 
concentrations of Rf may potentially have caused a change in the protein 
conformation, resulting in increased activity of the enzyme MDH and at higher Rf 
concentrations a conformational change in proteins may have resulted in a decrease 
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in MDH activity, thus, we observed a biphasic effect across a range of Rf 
concentrations. For this reason we conducted these studies with a low amount of 
moles as it generated a molecular and a subsequent physiological response within 
the bEnd5 cells. 
4.4.3 Combinatory effect of ethanol and fermented rooibos on mitochondrial 
activity 
The MA data, for the effect of EtOH on bEnd5 cells, revealed that at 48 hrs 
significant suppression of MA occurred (See Fig. 19 and 20), which resulted in the 
suppression of cellular proliferation from 72 hrs to 144 hrs (See Fig. 17). The 
working hypothesis of this study was based on evidence that EtOH produces its 
effects via ROS production and that the introduction of Rf, an extract high in AO, 
would reverse these effects.  
Combination treatments could not reverse the suppressive effects, but in turn 
exacerbated it. This result may have occurred due to an imbalance in the redox 
status of the cell. Research conducted by Kirkinezos et al. (2001) further supported 
this conclusion with research findings reporting on incidences where the exogenous 
antioxidants exceeded the endogenous redox capacity of the cells mitochondria, 
causing cells to undergo stress, ultimately altering the normal functioning of its 
mitochondria (Kirkinezos et al., 2001).  
During oxidative stress brain cells become highly susceptible to oxidative injury, 
due to the inadequate availability of both endogenous and exogenous AO levels in 
the brain (Lakhan et al., 2009; Won et al., 2002; Alikunju et al., 2011). A.linearis, 
known for its AO capacity as a result of its high polyphenolic content (Marnewick et 
al., 2003; Lamosŏvá et al., 1997; von Gadow et al., 1997) has been postulated to 
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protect against EtOH-induced changes to the rate of MA and subsequent cell 
viability.  
The mitochondrial suppression may have resulted due to a synergistic effect caused 
by the oxidant nature of EtOH, and the potential pro-oxidant nature of the 
polyphenols found within Rf (Joubert et al., 2005), potentially causing an imbalance 
in the redox status of the cells mitochondria. Studies performed on raw polyphenolic 
elements of A.linearis found it to be comprised of antioxidants and/ pro-oxidants 
and, therefore, it is imperative to take into account the interaction of polyphenolic 
segments with free radicals in order to better elucidate the AO/pro-oxidant 
properties of A.linearis (Joubert et al., 2005).  
Despite the fact that it has been suggested that flavonoid compounds may possibly 
contribute to a certain level of cytotoxicity due to their mutagenic properties; their 
ability to act has pro-oxidants and their ability to inhibit certain enzymes, research 
has shown exogenous AOs to have neuroprotective functions in various animal 
studies involving acute nervous system injury and neurodegenerative diseases 
(Calabrese et al., 2009). 
Research reports have found AOs’ seemed to target subcellular levels, specifically 
the mitochondria (Chaturvedi et al., 2008; Yang et al., 2009). AO such as 
ubiquinone, lipoic acid and Vitamin E and nitrous soin traps have been targeted to 
the mitochondria (Murphy and Smith, 2007) and have shown neuroprotection in 
many models of neurodegenerative diseases and alcohol neurotoxicity (Silver-
Marsiglio et al., 2005). 
A range of neuroprotective mechanisms have been used based on mitochondrial 
protection from oxidative stress. Several classifications of mitochondrial defenses 
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have been developed. These include: inhibitors of ROS formation; exogenous AOs; 
agents that may increases reducing power necessary for ROS detoxification and 
simulation of genes which improve mitochondrial defenses (Ankarcrona, 1995; 
Perez-Pinzon et al., 2012). Based on results generated in this research study, Rf does 
not ameliorate or reverse EtOH effects, but rather exacerbates it in combination, in 
terms of the MA of the bEnd5 cells. 
4.5 Endorsement of the BBB model 
4.5.1 The high resolution morphological characteristics of an endothelial cell 
monolayer 
The bicameral system was set up using bEnd5 cells, grown on a mixed cellulose 
insert membrane surface, within a 24-well microtiter plate. The insert was reported 
by the manufacturer to have a characteristic pore size of 0.45µm. This implies that 
molecules of a maximum size of 450nm or less were able to pass through the porous 
membrane surface. The insert was essentially used for the orientation and facilitation 
of bEnd5 cell growth, thus, the presence of a specialized extracellular membrane 
surface is important for a cell to lay down its basement membrane. 
The purpose of conducting high resolution SEM studies was to validate the in vitro 
bicameral model, from the perspective of how a monolayer is established three 
dimensionally and to evaluate how physiologically relevant EtOH concentrations 
(25mM) (Barnes and Singletary, 2000) impacted this monolayer from a 
morphological point of view.  
Better elucidation of mechanisms regulating the BBB is aided by in vitro systems 
(Brown et al., 2007). The cell based models have greatly impacted brain research, in 
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that it provides knowledge on the morphology, physiology and pathophysiology of 
the BBB (Ceccheli et al., 1999; Nakagawa et al., 2009). 
4.5.2 Effect of cell density on characteristic cell-to-cell interaction: Comparison 
between high and low cell densities 
Cells seeded using two cell densities were investigated to inform us regarding the 
impact of cell density on cell monolayer confluence in a bicameral system. A low 
cell seeding density was studied in order to determine the effect of cell development 
in the absence of adjacent cells and their paracrine influences. In addition, we 
investigated the impact of a high cell seeding density on how cells develop in close 
proximity of each other. Under a low cell seeding density cells were observed, 
which were dispersed where paracrine influence was minimal. In our results the 
bEnd5 cells were benign of proteins, vesicle formation and blebs, in terms of the 
cells surface topography. These cells did not present with any vesicle formation on 
the surface topography, only a cell membrane surface was visible (See Fig.34.). 
These cells lacked in cell-to-cell communication, similar to work described by 
Dejana, (2004). Conversely the bEnd5 cells seeded at 1x10
6
 cells/well/insert 
established a confluent monolayer. These cells were decisively different, exhibiting 
high, convoluted membrane structrures, which included: vesicle formation on its 
surface and visible cytoplasmic projections with numerous intercellular junctional 
complexes formed between adjacent cells (Fig. 31B, 35, 36). The results endorses 
the fact that cells grown at higher cell densities express tremendous protein 
interaction. Thus, cells in close proximity exhibited shorter paracrine distances, and 
therefore, increased cell-to-cell paracrine communication which further endorses a 
confluent monolayer as a result of paracrine factors causing cells to engage with 
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each other. For this reason, a deduction can be made that a greater seeding density 
exhibited shorter paracrine distance and, therefore, increased cell-to-cell paracrine 
communication which was similar to findings described in research conducted by 
Kim and Dean et al. (2009). Thus, in ECs, cells tend to exhibit different 
morphological characteristics, which are highly influenced by the degree of 
confluence or sparsity of its cell monolayer (Dejana, 2004). 
The relationship between cell density and cell-to-cell signaling are important 
parameters to consider when optimizing an experimental model and is essential for 
establishing a closed circuit, which is necessary for the commencement of studies on 
the bioelectrical effect of compounds/ substances on the structural integrity of the 
BBB in vitro. 
4.5.3 The basement membrane 
Intrinsic to the development of all epithelia, is the development of a basement 
membrane, this is true for the endothelium of the BBB as well. The basement 
membrane is important for the cell to morphologically evolve apical and basolateral 
surfaces. This SEM study demonstrated, for the first time, the process of laying 
down a bEnd5 EC basement membrane (See Fig.33), which seamlessly integrated 
itself into the extracellular mixed cellulose ester membrane of the insert. Thus, the in 
vitro model mimicked the in situ morphology by the establishment of a basement 
membrane. Although a basement membrane has been observed using transmission 
electron microcopy (TEM), this is the first time that the establishment of a basement 
membrane was visualized under high resolution SEM, emanating from a single cell, 
which is the forerunner of the monolayer. This fibrous network which formed the 
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basal lamina is known to consist of a myriad of proteins which include glycoprotein 
families, such as: laminin, collagen IV, nidogens and heparan sulfate (HS) 
proteoglycans. In addition, it contains the proteoglycan, agrin HS, found within the 
basement membrane of brain microvessels (Barber et al., 1997). This is an essential 
protein in that it is closely associated with the expression of claudins (Rascher et al., 
2002; Luissint et al., 2012). Additionally the protein, B1-integrin, aids in the 
attachment of the brain ECs to the basement membrane which highly influences the 
expression of claudin-5 localization at the TJs (Osada et al., 2011) and brain EC 
polarity. Thus, the establishment of the basement membrane in the monolayer 
allowed for the cell to be expressed morphologically and functionally in alignment 
with the in situ morphology of the Brain ECs, thereby, endorsing the BBB model. 
4.5.4 Shear stress and the glycocalyx 
In vivo, the heterogenous nature of blood in combination with the hemodynamic 
forces generated by the flow of blood contributes to shear stress in BMVECs 
(Luissint et al., 2012). The application of high resolution SEM in this study made it 
possible to observe the surface topography of a monolayer of bEnd5 cells grown on 
an insert for the first time. The apical surface gave rise to the formation of a thin 
fibrous network. The literature reports that the bEnd5 cells developed a surface 
extracellular network, comprised of proteoglycans, glycoproteins and glycolipids, 
commonly referred to as a glycocalyx. (Damiano et al., 2002). The 
glycosaminoglycans (GAGs) are linear type polydisperse heteropolysaccharides 
which are formed by variations of repeat disaccharide units. Some GAG forms 
found, include: chondroitin/dermatan sulfate (CS), HS and Hyaluronic acid (HA). 
The most prominent GAG on the EC, being the HS, constitutes greater than 50% of 
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the GAG profile (Tarbell et al., 2010; Martini, 2006). The in vivo function of the 
glycocalyx is to aid in the reduction of shear stress as a result of blood flow 
(Damiano et al., 2002). The observation of the development of this glycocalyx 
structure on the apical surface of our monolayer also endorses our BBB model of the 
in vivo scenario, as the literature hypothetically relates the development of the 
glycocalyx as a response to shear stress. It was postulated that in our model, shear 
stress was introduced with flow forces caused by the daily changing of media in the 
insert of our bicameral model, subjecting the bEnd5 cell monolayer to a degree of 
flow, further concretizing this model, making it analogous to the in vivo situation. 
Irrespective of its negligible role as a resistance barrier, the glycocalyx serves to 
lubricate and protect as the glycoproteins and glycolipids form a viscous layer on the 
outside of a cell and its components are sticky in nature which aids in anchoring the 
cells (Martini, 2006). It is for this reason that molecular protective barriers, such as 
the glycocalyx, must be acknowledged for their role in acting as a three-dimensional 
molecular sieve (Curry and Michel, 1980). 
The resistance across a bEnd5 cell monolayer could be attributed to an array of 
factors. The influence of both shear stresses as a result of ECs’ subjected to flow, 
cell density and subsequent changes in cell morphology influences the way the EC 
grows in a cultured environment. Standard light microscopy is limited to estimate 
the thickness of an EC monolayer of a biological specimen. In light microscopy, 
bEnd5 cells appear to be polygonal in terms of its cell body structure, exhibiting 
indistinguishable borders (data not shown), similar to work described by Jaffe et al. 
(1973). With reference to electron micrographical information retrieved using SEM; 
three-dimensional (3D) ultrastructures of a confluent bEnd5 cell monolayer were 
able to be investigated. The bEnd5 cells remained attached to the surface of the 
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extracellular baseline, expressed distinct cell borders and were inclined to grow 
towards each other, reflective of its adherent nature (See Fig.31 and Fig.32). Light 
microscopy, however, is a limiting factor in that only two-dimensional (2D) cell 
images could be viewed. 
4.5.5 Elucidating the paracellular space in the light of SEM: Tight junctions 
and adherens junctions 
TJs are found on the apical surface, of the brain ECs. These are intercellularly 
located and functions in inhibiting the paracellular transport of substances into the 
CNS (Schreibelt et al., 2007). In terms of what is known in theory, ECs of the BBB 
contain claudins with two extracellular loops and 4 transmembrane domains which 
interact, heterophillically and homophylically, with claudins on adjacent cells 
(Furuse et al., 1998; Furuse et al., 1999; Schreibelt et al., 2007).  
SEM analysis cannot differentiate between the specific protein molecules’ making 
up the TJs. For this reason, one has to utilize other criteria in making a plausible 
identification of structures. SEM is unable to show substructures and, therefore, we 
only see what protrudes from the cell membrane surface. In theory, it is 
emphatically stated that TJ loops are formed. Thus looking at the paracellular space 
between the monolayer we were able to see intercellular looped structures which can 
be identified as claudins and occludins on the apical surface of the Brain EC. These 
apically located proteins form loop-like structures, which appear tight against each 
other. 
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Figure 38. The micrograph in A. is a paracellular area between 2 cells and depicts the molecular 
interaction between two adjacent cells, SEM looks at the cell from a surface perspective (see XX on 
diagram A); B. is a schematic diagram of the tight junctional protein complexes between two 
adjacent cells (http://www.pharmacology.arizona.edu/images/faculty/davisfig2.gifP). 
Based on the above comparison (See Fig.38), what we see is not loop-like TJ 
structures, but rather for the first time we saw tightly woven rod-like loops on the 
apical surface of the cells which are analogous to the loops represented in the 
schematic diagram above. We, thus, contend that these loops are in fact the TJ 
proteins within the paracellular space.  
Additionally, the experiments in this study seemed to also reveal AJs which were 
seen on the lateral borders, deeper down in the cleft of adjacent cells. AJs which 
Apically located
tight junctional
protein loops 
A
Paracellular cleft 
between adjacent cells
Plasmalemma (Cell 1)
Plasmalemma (Cell 2)
Apical surface vesicles
Plasmalemme (Cell 1)
Plasmalemme (Cell 2)
Paracellular cleft
XX
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function in binding lateral cell surfaces together are supported by our micrographic 
data (Dejana, 2004). SEM data strongly endorses the BBB model used in this study. 
4.6 Bioelectrical studies: Transendothelial electrical resistance 
4.6.1 Introduction: Effect of ethanol and fermented rooibos on transendothelial 
electrical resistance optimization of a monolayer 
Transendothelial electrical resistance (TEER) studies can be defined as a construct 
of the degree of transcellular and paracellular permeability across a brain EC 
monolayer. This bioelectrical study was performed on a TEER system in order to 
determine the integrity of the barrier after its exposure to EtOH, Rf and a 
combination of these compounds, within a bicameral system. The bicameral system 
with a confluent monolayer was established before commencing the measurement of 
TEER.  
4.6.2 Optimization of the monolayer 
500nM of hydrocortisone (HC) was utilized to optimize TEER, by enhancing the 
barrier properties of the bEnd5 cell monolayer (Weidenfellar et al., 2005). The 
optimization of a TEER system was investigated using two regimes of exposure: (i) 
acute exposure (24 hr/ once-off) and (ii) chronic exposure (daily for 24-144 hrs) 
over a period of 6 days. The acute exposure showed a marked increase in TEER, 
relative to the controls. Conversely, chronic exposure to HC in combination with 
serum free media (SFM) resulted in marked increases in TEER compared to the 
controls across the entire experimental timeline (See Appendix E, 1.1 and 1.2). 
Based on literature reported in cancer research, the use of HC is known to slow rapid 
cellular proliferation, and was therefore administered as a means to slow tumour 
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progression (Jacobs and Woods, 1995). In addition, it is also a modulator of TJ 
protein organization in a way that enhances barrier integrity (Weidenfellar, 2005). 
HC (500nM) in combination with SFM generated higher TEER readings in 
comparison with HC and 10% FBS supplemented DMEM-F12 (See Appendix E, 
1.1 and 1.2). As a result, chronic HC and SFM were employed to optimize the 
TEER system for a period of 6 days (24-144 hrs). The TEER results generated after 
the use of both SFM and HC endorsed work conducted by Nitz et al. (2003) who 
reported on the use of HC as a hormonal regulator of BBB permeability (Hoheisel 
1998; Nitz et al., 2003). In addition, it was reported that serum, when in contact with 
the basolateral compartment of the brain microvascular ECs, caused a breakdown in 
the TJs of microvascular ECs in culture and, thus, the presence of serum in normally 
employed concentrations such as 10% (v/v) weakened the barrier properties of 
porcine brain capillary ECs (PBCEC) (Nitz et al., 2003). Based on previous 
research, HC at 500nM was able to result in the reorganization of the actin 
cytoskeleton in porcine and murine brain ECs, resulting in the longitudinal 
reorganization of the ZO-1 and occludin and in so doing re-enforcing barrier 
properties, subsequently resulting in increased TEER (Weidenfellar et al., 2005).  
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4.6.3 The effect of ethanol on TEER 
The literature has reported that EtOH disrupted EC integrity, subsequently 
decreasing TEER (Haorah et al., 2005; Xu et al., 2012) by way of rearranging its 
stress sensitive actin fibers and subsequently changing cytoskeleton dynamics of the 
cell (Xu et al., 2012). On the contrary, the current study showed an increase in 
TEER readings across the bEnd5 cell monolayer, after exposure to EtOH for 24 hrs, 
compared to controls, which reached lower TEER values of approximately 25% 
(See Fig. 27) for the remainder of the experimental timeframe (72-144 hrs). The 
lowest EtOH concentrations had the highest effect on TEER, causing a 24 hr dose-
dependent effect. At 48 hrs, only the supraphysiological levels/concentrations 
showed a drop in TEER, thus, one only sees a physiological effect within a 
physiological range at 24 hrs and this appears to be causing an increase in resistivity. 
For the remainder of the timeframe, cells appear to have adapted to the change in its 
growing environment by decreasing in TEER and reaching values similar to the 
controls. The decrease in TEER may have resulted as it is known that EtOH, by 
definition, causes a decrease in permeability due to ROS production. EtOH is a non-
conducting substance, which when added to media, increases the resistivity of that 
media. It is definitely not due to placing alcohol within the insert, as the 
experimental blank, containing both standard media (supplemented DMEM-F12) 
and EtOH was subtracted to normalize TEER readings. In so doing, it controlled for 
the effect of EtOH on the resistivity of the TEER system, therefore, there must be a 
physiological effect on the monolayer, as it becomes less permeable at 24 hrs, which 
is about a 25% increase in TEER relative to the controls. From 24-144 hrs; however, 
a time-dependent effect across the experimental timeline is negligible (See Fig. 27). 
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4.6.4 Equivalent electrical circuit for TEER experiments 
The electrical equivalent circuit helps in understanding the rationale for TEER. The 
circuit describes the theoretical basis of TEER by expanding the various components 
that reflect a TEER measurement. An equivalent circuit may reflect changes in 
resistivity of the fluid bathing the cells. The resistivity of the media/solution is a 
separate parameter, unrelated to the permeability of the cell monolayer. The effect of 
the apical compartment (Rfa) and the basolateral compartment (Rfb) being in series 
within the equivalent circuit would produce an additive effect on TEER. Thus, a 
change in the ionic content of the media will have a quantitative effect on the 
resistivity. The equivalent circuit of the blank refers to the resistivity of the media, 
insert membrane and the resistance of the fluid in Rfb of the bicameral model, which 
is situated in series. Measuring these quantities will give us an equivalent circuit 
measuring TEER. These effects are subtracted so that we fundamentally eliminate 
the effect of Rfa, RI and Rfb in order to achieve an effective resistance across the cell 
monolayer. The summation of the various populations of channels in different open-
close states on each membrane reflects the permeability of that particular membrane. 
This particular system of permeability refers to the resistance across a cell 
membrane, therefore, the effect of transcellular resistance across the apical surface 
(Ra) and the basolateral surface (Rb) of the cell membrane needs to be considered. 
The transcellular resistance, which is reflective of transcellular permeability, is 
regulated by the ratio of ionic channels open, and therefore, the cell membrane is a 
selective regulator of ionic flow. The paracellular permeability is caused by TJ 
expression, thus, an under or over expression of a specific TJ protein will directly 
influence the permeability across the cell monolayer. The resistance caused by the 
TJs (RTJ) is a non-selective regulator of ion flow and is, therefore, an important 
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consideration when investigating the bioelectrical barrier properties of the bEnd5 
cell monolayer.  
4.6.4.1 True resistance of a monolayer = Rexperiment-Rblank 
 
 
Figure 39. Effective/true resistance of a monolayer using an equivalent circuit.  
Rfb and Rfa reflected the resistance of fluids, which may change the ionic 
composition of the media and influence the resistivity. Fig. 39 represents the various 
components of an electrical circuit which reflects the resistance across the bEnd5 EC 
monolayer. The red solid line represents the paracellular pathway and the solid 
yellow line represents the transcellular pathway. We hereby describe the equivalent 
electrical circuit for the blank resistance measured across a blank insert, containing 
media+compounds which are subtracted in order to establish the true resistance 
across the cell monolayer. 
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4.6.5 Effect of fermented rooibos on TEER 
The bEnd5 cell monolayers were treated with Rf on a daily basis, thus, ensuring that 
cells were exposed to a constant concentration of Rf. A dose-dependent increase was 
observed, followed by a plateau effect (See Fig. 28). After 24 hrs, a cyclic effect on 
the monolayer repeated itself every 48 hrs. Control measures were put in place to 
ensure that the addition of Rf media did not change the resistivity. This was unlikely, 
due to the amount of Rf added. Within 24 hrs of observing the dose-related effect, no 
effect was observed (plateau effect). Thus, the dose-response has to be a 
physiological response whereby the lower concentrations of Rf were able to 
neutralize smaller quantities of ROS species and the greater concentrations of Rf, 
reduced/neutralized greater amounts of ROS production. By reducing the 
ion/oxidant content of the media, it resulted in an increase in resistivity and 
subsequent increase in TEER (See Equivalent electrical circuit, Fig. 39: Rfa and 
Rfb). Thus, it is clear that it is not a resistivity effect, due to the addition of Rf to the 
media. Based on this 48 hr cyclic effect we may deduce that the cell responded by a 
negative-feedback mechanism after its exposure to the antioxidant by producing 
endogenous oxidants, in just sufficient quantities to reduce the dose-response.  
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Figure 40. Directly proportional relationship between antioxidant (AO) concentration’s and ROS 
production. The more ROS neutralized, the greater the ionic depletion of the media, and therefore, the 
greater the resistivity. This providing an explanation for the dose-dependent effect observed, during 
the course of the experiment. 
The cellular components in this environment responded to this suppression in ROS, 
which produced an increase in TEER. ROS production is intimately involved in the 
ionic concentration of the cellular environment. The addition of Rf results in a 
decrease in ROS, causing an increase in TEER, due to the indirectly proportional 
relationship which exists between resistivity and Rf as an antioxidant. The exact 
feed-back mechanism is unknown at this stage in the research, but we can assume 
that the mitochondria are involved and, thus, the response may well be a 
physiological effect. This suggested that the high antioxidant capacity of Rf on the 
bioelectrical properties of the bEnd5 cell has a transient effect by increasing the 
resistivity of the media bathing the bEnd5 cell monolayer. The plateau effect seen at 
96 hrs (See Fig. 28) could be attributed to the compensation of the mitochondrial 
gradient as a result of depletion in the ionic content of the cellular environment. It is 
unlikely that this is an effect at the level of either transcellular/ paracellular 
permeability, as the effect of the various Rf concentrations resulted in a dose-related 
[AO]
X
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[ROS] Resistivity
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effect and was too small to be attributed to an effect on permeability across the 
transcellular pathways.  
4.6.6 Effect of ethanol and fermented rooibos in combination on TEER 
It is well established that the EtOH-induced oxidation caused ROS production, 
resulting in an increase in oxidants and subsequently decreased resistivity, which 
could be attributed to ROS production and the compromising of paracellular TJs 
(Haorah et al., 2005). Our hypothetical position was that concurrent treatment of 
cells with Rf would neutralize the oxidative producing effect of EtOH metabolism 
on the bEnd5 cell environment. However, the effect of EtOH and Rf in combination 
resulted in a dose-dependent decrease in TEER. The impact of EtOH induced an 
increase in ROS production, even with small amounts; thus, Rf concentrations in 
small amounts with EtOH resulted in a decrease in TEER, as EtOH could have 
potentially overpowered the AO effect of the Rf concentrations used. Although, Rf 
may neutralize a substantial amount of oxidants, only a minute amount of oxidants 
are required to produce a permeability effect. 
The results for the effect of EtOH on permeability endorsed findings by Phillips et 
al. (1997) who reported that there was no consistent evidence of any alcohol-
induced effects that could indicate a disruption of the vessels and the endothelial 
TJs. Unpublished results on SEM data clearly showed that the cell monolayer 
remained intact, irrespective of the exposure of EtOH to the monolayer over a period 
of 144 hrs. Adjacent bEnd5 cells were able to tightly adhere to each other 
throughout the experimental timeframe. Thus, this tightly packed cell monolayer 
may have further endorsed the bicameral system. 
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Chapter 5 
5.1 Conclusion 
Our study has shown that alcohol produces profound damage to the BBB and 
subsequently has a long-term ability to compromise the homeostatic 
environment of the neuron. The main findings in this study were that: (a) 
alcohol has a long-term effect on the proliferation of the bEnd5 cells, (b) the 
decrease in cellular proliferation was not caused by the toxic effects of 
alcohol and (c) the decrease in proliferation was linked to a decrease in MA, 
which was linked to the decreasing ability of the cell to produce the 
metabolic energy necessary for cell division.  
The study showed that rooibos (across a physiologically relevant range) did 
not significantly reverse the ROS-induced effects of alcohol, but rather 
exacerbated the effects. Furthermore, rooibos, on its own, caused a redox 
imbalance within the cell, which seemed to cause a long-term, biphasic 
suppression in cell proliferation.  
Our working hypothesis was based on the understanding that the 
combination treatments would reverse the negative effects of EtOH 
exposure. However, this study points to a synergistically negative effect on 
the bEnd5 cells. Theoretically, the introduction of equivalent circuits as a 
means to better elucidate membrane permeability was novel to this model 
and our endorsement of the model in terms of the SEM study has made 
significant progress. 
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Our study, thus, highlights, for the first time the negative effects of both 
EtOH and Rf on the physiological function of the BBB, which may be 
pertinent for human physiology. The ability of bEnd5 cells to remain viable 
after exposure to supra high concentrations of EtOH, shows the extreme 
physiological robustness of these cells. 
5.2 Future Perspectives 
In order to deepen our understanding of how EtOH and Rf affect bEnd5 
cellular proliferation, it is suggested that flow cytometry analysis be 
conducted, to clarify the stage of mitosis in which cell division is inhibited. 
Furthermore, the exciting results found in the SEM component of the study 
could be expanded through investigating the effects of various experimental 
substances on the pathology of the BBB and how introducing a tincture of Rf 
could better ameliorate potential pathology. 
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Table 1. Breakdown of provincial drug related crime trends for the past 5 years 
(Provincial Government, Western Cape, South Africa-Modernisation programme, 
2010) 
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Table 2. Summary of FAS prevalence in various U.S. and selected foreign studies 
by methodology (May et al., 2001) 
Type and 
Location of 
Study 
Years Covered Rate of 
FAS per 
1,000 
births 
Population Source 
Passive 
Method 
        
United States 1979 1992 0.20 General CDC 1993 
  1992 0.37 General CDC 1995 
  1993 0.67 General CDC 1995 
  1981-1986 0.60 African-American Chavez et al. 
1988 
    0.08 Hispanic Chavez et al. 
1988 
    2.90 American Indian Chavez et al. 
1988 
    0.03 Asian Chavez et al. 
1988 
    0.09 White Chavez et al. 
1988 
Atlanta 1981-1989 0.10 General CDC 1997 
Alaska 1977 -1992 0.20 - 0.30 Alaska, non-
native 
Egeland et al. 
1998 
    3.00 - 5.20 Alaska Native Egeland et al. 
1998 
North Dakota 1991 -1994 1.10 - 2.00 General Burd et al. 1996 
Clinic-Based 
Studies 
        
United States Various studies ( 
avg. ) 
1.90 Western World Abel and Sokol 
1987 
  Various studies ( 
avg. ) 
2.20 United States and 
Canada 
Abel and Sokol 
1987 
  Various studies ( 
avg. ) 
0.33 United States Abel and Sokol 
1991 
          
United States 
and  
other countries 
Various studies ( 
avg. ) 
0.97 Western World Abel 1995 
  Various studies ( 
avg. ) 
1.95 United States Abel 1995 
  Various studies ( 
avg. ) 
2.29 African-American Abel 1995 
  Various studies ( 
avg. ) 
0.26 White American Abel 1995 
Active Case 
Ascertainment 
        
United States Various studies ( 
avg. ) 
9.00 Plains Indian May et al. in 
press 
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  1969 - 1982 1.40 Navajo May et al. 1983 
  1969-1982 2.00 Pueblo May et al. 1983 
  1969-1982 9.80 Southwestern 
Plains Indian 
May et al. 1983 
  1969-1982 ( avg. ) 1.80 Southwestern 
Indian 
May et al. 1983 
Washington 
State 
1995-1997 3.10 1st grade 
students        ( 
one county) 
Clarren et al. 
2001 
NOTE: avg. = average; CDC = Centers for Disease Control and Prevention; FAS = fetal 
alcohol syndrome. 
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Table 1. Standard series of gallic acid was prepared for the measurement of 
polyphenols by marking 6 Eppendorf tubes A-F. The stock solution was diluted as 
follows to make a series of standards as described in the table below: 
Tube Gallic acid stock 
solution (l) 
10% EtOH 
 (l) 
Concentration 
(mg/L) 
Well number 
A 0 1000 0 A1-A3 
B 25 975 20 A4-A6 
C 62.5 937.5 50 A7-A9 
D 125 875 100 A10-A12 
E 312 688 250 B1-3 
F 625 375 500 B4-6 
 
Table 2. Standard series of ascorbic acid was prepared for the FRAP assay by 
marking 6 Eppendorf tubes labelled A-F. The amount of standard stock solution and 
diluents were added to each tube, and the stock solution was diluted to make a series 
of standards as follows: 
Tube Ascorbic acid 
stock solution 
(l) 
dH20 
(l) 
Standard 
concentration 
(M) 
Well number 
A 0 1000 0 A1-A3 
B 50 950 50 A4-A6 
C 100 900 100 A7-A9 
D 200 800 200 A10-A12 
E 500 500 500 B1-3 
F 1000 0 1000 B4-6 
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Table 3. Standard series of Trolox was prepared for the ORAC assay by marking 6 
Eppendorf tubes labelled A-F. The stock solution was diluted as follows to make a 
series of standards as described in the table below: 
Tube Standard 
concentration 
(M) 
Trolox 
stock solution 
(l) 
Phosphate 
Buffer 
(l) 
Well number 
A 0 0 750 A1-A3 
B 83 125 625 A4-A6 
C 167 250 500 A7-A9 
D 250 375 375 A10-A12 
E 333 500 250 B1-3 
F 417 625 125 B4-6 
 
Table 4. Standard series of Trolox was prepared for the ABTS (TEAC) radical 
cation scavenging assay by marking 6 Eppendorf tubes A-F. The amount of standard 
stock solution and diluents was added to each tube as described in the table below. 
The stock solution was diluted as follows to make a series of standards as described 
in the table below: 
Tube Trolox standard 
(l) 
EtOH 
(l) 
Trolox conc. 
(M) 
Well number 
A 0 1000 0 A1-A3 
B 50 950 50 A4-A6 
C 100 900 100 A7-A9 
D 150 850 150 A10-A12 
E 250 750 250 B1-3 
F 500 500 500 B4-6 
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Table 5. Standard series of quercetin was prepared for the measurement of flavonols 
by marking 6 Eppendorf tubes labeled A-F. The amount of standard stock solution 
and diluents were added to each tube, and the stock solution was diluted to make a 
series of standards as follows: 
Tube Quercetin 
 stock (µl) 
95 % EtOH  
(µl) 
Quercetin  
(mg/L) 
Well Number 
A 0 1000 0 A1-A3 
B 75 925 5 A4-A6 
C 125 875 10 A7-A9 
D 250 750 20 A10-A12 
E 500 500 40 B1-B3 
F 1000 0 80 B4-B6 
 
Table 6. Standard series of the catechin was prepared for the measurement of 
flavanols by marking 6 Eppendorf tubes labeled A-F. The amount of standard stock 
solution and diluents were added to each tube, and the stock solution was diluted to 
make a series of standards as follows: 
Tube Catechin  
stock (l) 
MeOH  
(l) 
Catechin 
 (M) 
Catechin  
(mg/L) 
 Well 
Number 
A 0 1000 0 0  A1-A3 
B 5 995 5 1.36  A4-A6 
C 10 990 10 2.72  A7-A9 
D 25 975 25 6.8  A10-A12 
E 50 950 50 13.6  B1-B3 
F 100 900 100 27.2  B4-B6 
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Table 7. Plate layout for antioxidant assays (96-well plate) 
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Table 1. Effect of acute exposure to selected concentrations of EtOH on bEnd5 live 
cell numbers, using the Trypan blue assay at selected time intervals (mean±SEM; n=5). 
    EtOH     
Time (hrs)/ 
Compound  
(in mM) 
 
 
24 hrs 
 
 
48 hrs 
 
 
72 hrs 
 
 
96 hrs 
 
 
120 hrs 
 
 
144 hrs 
Ctrl 1.23±0.19 5.18±0.49 25.78±1.97 19.95±0.91 8.43±0.58 21.15±1.17 
25 0.97±0.16 10.83±0.76 19.65±0.85 13.24±0.66 4.82±0.55 13.13±1.03 
50 1.85±0.28 12.16±1.24 14.43±1.03 14.43±0.99 8.41±0.49   4.48±0.35 
100 1.78±0.22 4.68±0.45 16.56±1.14 14.25±1.05 7.36±0.48 3.67±0.48 
200 0.61±0.12 8.75±0.91 11.44±0.89 8.36±0.61 14.58±1.31 7.60±1.02 
400 0.73±0.11 0.45±0.09 1.23±0.17 0.43±0.094 0.00±0.00 0.40±0.09 
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Table 2. Effect of acute exposure to selected concentrations of EtOH on bEnd5 
mitochondrial activity, using the XTT assay at selected time intervals (mean±SEM; 
n=5). 
   EtOH     
Time (hrs)/ 
Compound  
(in mM) 
 
 
24 hrs 
 
 
48 hrs 
 
 
72 hrs 
 
 
96 hrs 
 
 
120 hrs 
 
 
144 hrs 
Ctrl 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 
25 111.00±6.57 79.43±3.31   98.86±5.65 84.64±  5.55   98.62±2.39   77.60±6.45 
50 101.8  ±6.04 76.28±2.20 102.87±6.62 95.62±11.74   97.98±1.94   62.98±3.43 
100   99.67±2.56 77.14±3.08 101.22±6.99 82.39±  5.46   96.85±1.72   76.66±7.48 
200   96.48±7.36 70.76±1.52   94.71±5.86 83.48±  3.36   93.78±2.91   98.08±0.72 
400   86.18±6.23 39.17±2.59   66.36±6.06 97.04±  3.20   97.56±2.15   96.85±3.79 
600   74.14±8.94 48.30±4.08   76.94±3.68 80.59±  2.49   87.80±1.59   97.68±2.12 
800   48.07±1.62 42.46±1.74   45.95±8.29 85.99±  4.57   94.23±1.01   94.18±4.25 
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Table 3. Effect of chronic exposure to selected concentrations of EtOH on bEnd5 
mitochondrial activity, using the XTT assay at selected time intervals (mean±SEM; 
n=5). 
    EtOH     
Time (hrs)/ 
Compound  
(in mM) 
 
 
24 hrs 
 
 
48 hrs 
 
 
72 hrs 
 
 
96 hrs 
 
 
120 hrs 
 
 
144 hrs 
Ctrl 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 
25 111.00±6.57   81.12±5.40   99.27±2.45 100.76±2.68 103.99±1.24   94.36±1.12 
50 101.8  ±6.04   93.69±4.96   97.58±3.97 104.40±2.58   99.34±2.47   96.66±1.48 
100  99.67±2.56   89.72±4.68 124.42±5.74   99.79±2.72 105.23±2.66   96.33±2.57 
200  96.48±7.36   92.55±5.59 125.86±4.55 103.52±2.14   98.27±1.78   98.49±1.79 
400  86.18±6.23   83.71±5.29 121.09±4.39   89.87±4.54   98.43±1.09   88.46±2.45 
600  74.14±8.94   62.36±3.56   90.38±7.69   67.16±3.43   75.41±3.98   13.88±3.66 
800  48.07±1.62   38.16±1.25   46.46±7.28   43.21±6.98   37.56±3.59     8.40±2.22 
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Table 4. Effect of acute exposure to selected concentrations of Rf on bEnd5 live cell 
numbers, using the Trypan blue assay at selected time intervals (mean±SEM; n=5). 
  Fermented 
Rooibos 
  
Time (hrs)/ 
Compound  
(%) 
 
24 hrs 
 
48 hrs 
 
72 hrs 
 
96 hrs 
Ctrl 5.20±0.73 18.00±0.81 28.83±2.10 38.59±1.65 
0.0625  5.64±0.25 28.95±1.07 33.25±0.97 27.13±1.37 
0.125  7.50±0.49 28.88±0.76 26.20±1.17 31.63±2.11 
0.25  7.30±0.68 22.10±2.66 21.30±1.07 25.83±1.36 
0.5  7.08±0.96 18.83±2.16 16.35±1.86 23.00±1.88 
1  4.30±0.18   9.10±2.06   9.25±2.37 15.75±2.27 
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Table 5. Effect of acute exposure to selected concentrations of Rf on bEnd5 % live cell 
number, using the Trypan blue assay at selected time intervals (mean±SEM; n=5). 
  Fermented 
Rooibos 
  
Time (hrs)/ 
Compound (%) 
 
24 hrs 
 
48 hrs 
 
72 hrs 
 
96 hrs 
Ctrl 100.00±0.00 100.00±0.00 100.00±0.00   99.93±0.07 
0.05    98.06±1.25 100.00±0.00 100.00±0.00   99.21±0.45 
0.0625  100.00±0.00 100.00±0.00 100.00±0.00   99.70±0.22 
0.125  100.00±0.00 100.00±0.00   99.41±0.41 100.00±0.00 
0.25  100.00±0.00 100.00±0.00 100.00±0.00   97.53±1.13 
0.5    99.41±0.40 100.00±0.00 100.00±0.00   99.81±0.13 
1    98.27±0.88 100.00±0.00 100.00±0.00 100.00±0.00 
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Table 6. Effect of acute exposure to selected Rf concentrations on bEnd5 mitochondrial 
activity, using the XTT assay at selected time intervals (mean±SEM; n=5). 
  Fermented 
Rooibos 
  
Time (hrs)/ 
Compound (%) 
 
24 hrs 
 
48 hrs 
 
72 hrs 
 
96 hrs 
Ctrl 100.00±0.00 100.00±0.00 100.00±  0.00 100.00±0.00 
0.003125    63.51±3.15 119.19±1.69 105.96±  1.63 113.81±1.79 
0.0625    70.58±6.87 114.13±3.85   96.89±  2.63 119.88±3.99 
0.0125    74.36±8.04 112.19±4.97   95.51±  2.73 112.32±6.26 
0.025    92.60±6.47 109.95±8.72 103.81±  2.49 108.90±4.74 
0.05    96.88±9.63 115.21±2.77 100.69±  2.18 115.47±6.48 
0.1    93.53±4.36   94.55±9.11   94.83±11.86   83.15±7.99 
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Table 7. Effect of chronic exposure to selected Rf concentrations on bEnd5 
mitochondrial activity, using the XTT assay at selected time intervals (mean±SEM; 
n=5). 
   Fermented 
Rooibos 
  
Time (hrs)/ 
Compound (%) 
 
24 hrs 
 
48 hrs 
 
72 hrs 
 
96 hrs 
Ctrl 100.00±0.00 100.00±  0.00 100.00±  0.00 100.00±0.00 
0.003125    63.51±3.51   81.97±  4.52 101.51±  3.86   97.95±8.66 
0.0625    70.58±6.87   86.94±  2.56 105.61±  8.46   95.34±1.22 
0.0125    74.36±8.04 110.02±  8.24 116.63±12.78   91.73±2.87 
0.025    92.60±6.47 109.02±10.95 112.36±7.81 100.10±2.30 
0.05   96.88±9.63 129.43±10.88 109.13±11.04   80.95±5.08 
0.1    93.53±4.36   86.73±  5.28   94.83±11.86   79.33±7.91 
 
  
 
 
 
 
APPENDIX C 
 
188 
 
Table 8A. Effect of acute combination treatments of selected EtOH concentrations 
with 0.05% Rf concentrations onbEnd5 mitochondrial activity, using the XTT assay at 
selected time intervals (mean±SEM; n=5). 
 Acute 
EtOH/0.05%Rf 
  
 
Time (hrs)/ 
Compound(in mM) 
 
24 hrs 
 
48 hrs 
Ctrl 100.00±  0.00 100.00±0.00 
25   92.67±12.33   77.73±2.75 
50   88.66±18.27   93.52±8.06 
100   58.00±16.11   80.57±6.56 
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Table 8B. Effect of chronic combination treatments of selected EtOH concentrations 
with 0.05% Rf concentrations on bEnd5 mitochondrial activity, using the XTT assay 
at selected time intervals (mean±SEM; n=5). 
 Chronic 
EtOH/0.05% Rf 
  
 
Time (hrs)/ 
Compound(in mM) 
 
24 hrs 
 
48 hrs 
Ctrl 100.00± 0.00 100.00±0.00 
25 92.66±12.32 110.98±5.54 
50 88.67±18.27   92.05±8.83 
100 58.00±16.11   79.54±5.73 
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Table 8C. Effect of acute combination treatments of selected EtOH concentrations 
with 0.1% Rf concentrations on bEnd5 mitochondrial activity, using the XTT assay at 
selected time intervals (mean±SEM; n=5). 
 Acute EtOH/0.1% 
Rf 
  
 
Time (hrs)/ 
Compound(in mM) 
 
24 hrs 
 
48 hrs 
Ctrl 100.00±  0.00 100.00±  0.00 
25   81.33±11.77   75.71±  5.70 
50 125.33±11.67 102.02±11.25 
100 124.67±13.14   88.66±  8.26 
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Table 8D. Effect of chronic combination treatments of selected EtOH concentrations 
with 0.1% Rf concentrations on bEnd5 mitochondrial activity, using the XTT assay at 
selected time intervals (mean±SEM; n=5). 
 Chronic 
EtOH/0.1% Rf 
  
 
Time (hrs)/ 
Compound(in mM) 
 
24 hrs 
 
48 hrs 
Ctrl 100.00±  0.00 100.00±  0.00 
25   81.33±11.75   51.52±  8.33 
50 125.33±11.67 101.89±13.81 
100 124.67±13.14   50.38± 3.69 
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APPENDIX D 
Table 1. Effect of chronic exposure to selected concentrations of EtOH on bEnd5 cell 
monolayer permeability, using TEER measurements at selected time intervals 
(mean±SEM; n=4). 
   EtOH    
Time (hrs)/ 
Compound(in mM) 
 
24 hrs 
 
48 hrs 
 
72 hrs 
 
96 hrs 
 
120 hrs 
 
144 hrs 
Ctrl 13.93±0.70 16.20±0.62 14.95±0.21 14.05±021 13.90±0.15 13.88±0.24 
25 19.43±0.54 17.03±0.55 15.30±0.37 13.41±0.40 13.50±0.38 14.48±0.49 
50 18.28±0.73 15.53±0.28 18.33±0.46 12.79±0.28 14.45±0.41 13.35±0.29 
100 16.30±0.59 14.93±0.26 15.65±0.49 13.66±0.27 13.74±0.44 14.20±0.47 
200 16.70±0.71 15.68±0.66 12.85±0.40 14.35±0.21 12.70±0.31 13.58±0.43 
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Table 2. Effect of chronic exposure to selected concentrations of Rf on bEnd5 cell 
monolayer permeability, using TEER measurements at selected time intervals 
(mean±SEM; n=4). 
   Fermented 
Rooibos 
   
Time (hrs)/ 
Compound (%) 
 
24 hrs 
 
48 hrs 
 
72 hrs 
 
96 hrs 
 
120 hrs 
 
144 hrs 
Ctrl 15.03±0.90 13.46±0.77 17.74±0.57 17.73±0.54 12.67±0.37 13.07±0.47 
0.0625 % 18.83±0.57 18.81±0.70 19.99±0.60 18.04±0.71 16.14±0.71 17.53±0.82 
0.0125 % 17.90±0.75 18.34±0.41 21.21±0.48 18.85±0.34 19.50±0.26 20.25±0.76 
0.025 % 21.81±0.67 19.44±0.56 22.76±0.45 17.11±0.71 20.24±0.37 16.95±0.86 
0.05 % 22.29±0.44 18.18±0.66 23.13±0.38 16.12±0.41 21.48±0.35 18.60±1.23 
0.1 % 20.36±0.73 20.22±0.40 25.22±0.36 16.20±0.40 23.44±0.33 15.10±0.68 
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Table 3. Effect of chronic exposure to selected concentrations of EtOH in combination 
with 0.05% Rf on bEnd5 cell monolayer permeability, using TEER measurements at 
selected time intervals (mean±SEM; n=4). 
   EtOH/0.05% 
Rf 
   
Time (hrs)/ 
Compound (in 
mM) 
 
24 hrs 
 
48 hrs 
 
72 hrs 
 
96 hrs 
 
120 hrs 
 
144 hrs 
Ctrl   7.93±1.09 19.25±0.76 23.25±0.56 17.78±0.74 14.20±0.38 12.23±0.85 
25 19.98±0.93 18.20±0.73 22.23±0.34 17.35±0.47 13.16±0.35   8.06±0.68 
50 23.48±0.68 18.90±2.36 22.00±0.48 14.15±0.31 15.03±0.57 12.03±0.81 
100 22.73±0.48 20.60±0.69 20.25±0.58 15.90±0.50 15.76±0.45 12.48±0.82 
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Table 4. Effect of chronic exposure to selected concentrations of EtOH in combination 
with 0.1% Rf on bEnd5 cell monolayer permeability, using TEER measurements at 
selected time intervals (mean±SEM; n=4). 
   EtOH/0.1% Rf    
Time (hrs)/ 
Compound (in 
mM) 
 
24 hrs 
 
48 hrs 
 
72 hrs 
 
96 hrs 
 
120 hrs 
 
144 hrs 
Ctrl   7.93±1.09 19.25±0.76 23.25±0.56 17.78±0.74 14.20±0.38 12.23±0.85 
25 24.10±0.31 17.43±0.98 18.85±0.29 16.08±0.49 14.68±0.42 17.80±0.69 
50 26.33±0.81 19.35±0.64 19.70±0.34 16.98±0.47 13.98±0.26 10.43±0.88 
100 25. 5±0.64 21.93±0.57 18.73±0.39 17.33±0.35 13.78±0.39 11.68±0.89 
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APPENDIX E 
1. Optimization of the TEER across the bEnd5 cell monolayer. 
1.1 Effect of acute treatment with HC (500nM) on TEER in the absence or presence 
of serum. 
 
Figure 1. Effect of acute exposure to media supplemented with HC (500nM) in the absence 
(0%FBS/SFM) and presence (10% FBS) of serum at selected time intervals. The *, denoted 
statistically significant differences in TEER, between the experimental samples relative to the control 
(cells+ DMEM supplemented with 10% FBS) and the #, denoted statistically significant differences 
between media conditions. Data was represented as mean ± SEM (n=4). Statistical significance was 
determined at P<0.05 (See Methods). 
 
It appears that between 24-96 hrs a gradual linear progression in TEER was 
observed across all conditions. At 24 greater TEER readings were reflected in the 
bEnd5 cell monolayers exposed to 0%FBS DMEM-F12 compared to the 10% 
supplemented DMEM-F12 (control) with statistical significance only reflected in 
HC - supplemented treatment conditions, relative to the control (P<0.0071). At 48 
hrs a decrease in resistance was observed across all treatment conditions from the 24 
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hr readings, with statistical significant differences observed, relative to the controls 
(P<0.0001). At 72 hrs the resistance readings began to plateau, reaching an optimal 
reading of approximately 25Ω.cm2 significantly greater than control readings 
(P<0.0001). At 96 hrs The SFM and SFM supplemented with HC (500nM) exhibited 
the significantly TEER readings across the bEnd5 cell monolayer, compared to the 
DMEM supplemented with 10% FBS (control) and the DMEM supplemented with 
serum (10% FBS) and HC (500nM) which only managed to reach 20Ω.cm2 and 
below (P<0.0001). At 120-144 hrs TEER readings begin to regress, however, the 
SFM and HC-supplemented SFM remained significantly high, relative to the control 
readings (P<0.0023). 
1.2 Effect of chronic treatment with HC (500nM) on TEER in the absence or 
presence of serum. 
 
Figure 2. Effect of chronic exposure to media supplemented with HC (500nM) in the absence 
(0%FBS/SFM) and presence (10% FBS) of serum at selected time intervals. The *, denotes 
statistically significant differences in TEER, between the experimental samples, relative to the control 
(cells + DMEM supplemented with 10% FBS) and the #, denoted statistically significant differences 
between media conditions. Data was represented as mean ± SEM (n=4). Statistical significance was 
determined at P<0.05 (See Methods). 
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A visible media effect on TEER across the bEnd5 monolayer was observed between 
the HC-supplemented media and the media unsupplemented with the HC, across the 
entire experimental timeframe. Significant increases in TEER occurred in both SFM 
and DMEM-F12, supplemented with 10% FBS and 500nM HC compared to media 
conditions unsupplemented with HC. However, between SFM/HC-supplemented 
media and 10%FBS/HC- supplemented media, 0% FBS/HC showed a significant 
increase in TEER in comparison to controls at 24 hrs (P<0.0001). At 48, 72, 96, 120 
and 144 hrs a significant increase in TEER was observed across all treatment 
conditions compared to controls (P<0.0001). However, the greatest TEER readings 
were generated using the SFM media supplemented with 500nM HC which was 
consistent across the entire timeline, maintaining approximately 45Ω.cm2. 
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APPENDIX F 
Cape Times Article 
Date: 21 October 2014 
 
 
 
 
 
